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Glycosaminoglycans (GAGs) mediate a variety of biological processes through 
their interactions with proteins. To advance our understanding of these interactions, it is 
necessary to explore the structural characteristics and physico-chemical properties of 
GAGs. The major focus of the research presented in this dissertation is the structural 
analysis of GAG oligosaccharides with emphasis on the chemical modification and 
isolation of oligosaccharides with unique structures. Reactions for the solvolytic de-N-
sulfation, chemoselective N-acetylation, and reduction of reducing end residues with 
sodium borohydride were employed to obtain oligosaccharides containing amide and free 
amine moieties with unique structural elements. The impact of oligosaccharide primary 
structure on elements of secondary structure in aqueous solution was explored using 1H 
NMR.  
The role of rare, but biologically important 3-O-sulfated glucosamine residues in 
heparan sulfate related oligosaccharides was examined. Possible salt bridge formation was 
probed through the measurement of amino proton temperature coefficients, amino proton 
solvent exchange rates, and comparison of the carboxylate and amino group pKa values of 
 vii 
de-N-sulfated Arixtra (dNSA). Reduced amino proton temperature coefficients, 
accelerated exchange rates measured by exchange spectroscopy (EXSY), and altered pKa 
values of amino and carboxylate groups provided evidence that the dNSA 3-O-sulfated 
glucosamine amino group is likely involved in salt bridge with the neighboring 3-O-sulfo 
group and possibly with carboxylate group of the adjacent iduronic acid residue. This 
hypothesis was supported by the results of molecular dynamics simulations.  
 The effect of oligosaccharide structure on the solvent exchange behavior of GAG 
oligosaccharide amide group protons was evaluated through comparison of temperature 
coefficients, activation energy barriers, and pH titrations of oligosaccharides containing 
amide groups. A library of 20 oligosaccharides differing in size, glycosidic linkage, 
saccharide type, and sulfation position and extent, allowed the examination of the effect of 
charge repulsion by nearby negatively charged sulfate and carboxylate groups on the 
hydroxyl ions responsible for catalyzing amide proton exchange. This charge repulsion 
effect calls into question the validity of using exchange rates and activation energies for 
detection of hydrogen bonds without support from temperature coefficients measured for 
labile protons. 
 
  
 viii 
Table of Contents 
 
 
1. CHAPTER ONE. Introduction 1 
1.1. Glycosaminoglycans 3 
1.1.1. Structural variability and complexity 3 
1.1.2. Significance of GAG structure to physiological processes and 
interactions with proteins 
8 
1.2. Challenges in structural studies of GAGs: The bottom-up approach 11 
1.2.1. Polysaccharide depolymerization 12 
1.2.1.1. Enzymatic digestion 12 
1.2.1.2. Chemical depolymerization 14 
1.2.2. Isolation of depolymerized oligosaccharides 17 
1.2.2.1. Size-exclusion chromatography 17 
1.2.2.2. Strong anion-exchange chromatography 19 
1.3. Structure elucidation 20 
1.3.1. Mass spectrometry 22 
1.3.2. Solution state NMR 22 
1.4. The examination of labile protons in the study of GAG secondary  
structure 
24 
1.4.1. Chemical exchange and the NMR time scale 25 
1.4.2. Chemical exchange and the labile protons of GAGs 28 
1.4.3. Experimental approaches for studying properties of the labile  
protons of GAG oligosaccharides by NMR 
31 
1.4.3.1. Temperature coefficients 31 
1.4.3.2. Line-shape analysis and the quantification of 
energy barriers associated with exchange 
31 
1.4.3.3. Exchange spectroscopy for the direct  
measurement of proton exchange rates 
32 
1.5. Conclusions 33 
 ix 
1.6. References 35 
  
2. CHAPTER TWO. Chemical Modification of GAGs 47 
2.1. Introduction 48 
2.2 Experimental Section 50 
2.2.1. Materials and Reagents 50 
2.2.2. Chemical modification of GAGs by solvolytic de-N-sulfation 51 
2.2.3. Chemical modification of GAGs by chemoselective  
N-acetylation 
53 
2.2.4. Chemical modification of GAGs by reduction with  
sodium borohydride 
53 
2.2.5. Solution preparation and ESI-MS measurements 55 
2.2.6. Solution preparation and NMR measurements 55 
2.2.6.1. Carbon-bound proton resonance assignments 55 
2.2.6.2. Amino proton resonance assignment 57 
2.3. Results and Discussion 58 
2.3.1. Solvolytic de-N-sulfation 58 
2.3.2. Chemoselective N-acetylation 64 
2.3.3. Reduction with sodium borohydride 66 
2.3.4. Structure elucidation of de-N-sulfated ArixtraTM 71 
2.3.4.1. Electrospray ionization – mass spectrometry 71 
2.3.4.2. Nuclear magnetic resonance spectroscopy 73 
2.3.4.2.1. One-dimensional proton NMR spectra 75 
2.3.4.2.2. Homonuclear two-dimensional proton  
NMR spectroscopy 
76 
2.4. Conclusions 87 
2.5. References 89 
  
 x 
3. CHAPTER THREE. Probing Salt Bridges in GAGs: A Structural 
Role for 3-O-Sulfated Glucosamine in a Model HS Oligosaccharide 
95 
3.1. Introduction 96 
3.2. Experimental Section 100 
3.2.1. Materials and Reagents 100 
3.2.2. Preparation of chemically modified oligosaccharides 101 
3.2.3. Solution preparation and NMR measurements 101 
3.2.3.1. Carbon-bound proton resonance assignments 101 
3.2.3.2.  Amino proton resonance assignment 101 
3.2.3.3.  Rates of chemical exchange and temperature 
  coefficient measurements 
102 
  3.2.3.4. pKa determination 103 
3.2.4. MD simulation parameters 105 
3.3. Results and Discussion 106 
3.3.1. Chemical shifts dependence on N-substitution in ArixtraTM 108 
3.3.2. Temperature coefficients, Δδ/ΔT 112 
3.3.3. Measurements of solvent exchange rates 118 
3.3.4. Comparison of pKa values 123 
3.3.5. Comparison of coupling constants 130 
3.3.6. MD simulations 132 
3.4. Conclusions 136 
3.5. References 137 
  
4. CHAPTER FOUR. Investigation of Amide Proton Solvent 
 Exchange Properties in GAG Oligosaccharides 
144 
4.1. Introduction 145 
4.2. Experimental Section 148 
4.2.1. Materials and Reagents 148 
 xi 
4.2.2. Partial digestion of bovine trachea chondroitin sulfate A with 
 Chondroitinase ABC from Proteus vulgaris 
149 
4.2.3. Digestion of hyaluronic acid with Hyaluronidase from 
 Streptomyces hyalurolyticus 
150 
4.2.4. Size-exclusion chromatography of chondroitin sulfate A 
 digested oligosaccharides 
151 
4.2.5. Size-exclusion chromatography of hyaluronic acid digested 
 oligosaccharides 
151 
4.2.6. Reduction of oligosaccharides with sodium borohydride 154 
4.2.7. Strong anion-exchange high-performance liquid  
chromatography 
155 
4.2.8. Chemoselective N-acetylation of dNSA and 3-O-sulfated 
 glucosamine 
156 
4.2.9. ESI-MS measurements 156 
4.2.10. NMR measurements 157 
4.2.10.1. Carbon-bound proton resonance assignments 157 
4.2.10.2. Amide proton resonance assignments 159 
4.2.10.3. Temperature experiments 161 
4.2.10.4. pH titrations 163 
4.2.11. Molecular dynamics simulations 164 
4.3. Results and Discussion 165 
4.3.1. Amide proton temperature coefficients 166 
4.3.2. Line-shape analysis and energy barriers 176 
4.3.3. Effects of pH on labile proton resonance line widths 181 
4.4. Molecular dynamics simulations 186 
4.4. Conclusions 190 
4.5. References 192 
  
 
 
 
 
 
 
 xii 
5. CHAPTER FIVE. Conclusions and Future Directions 195 
5.1. Conclusions 195 
5.2. Future directions 200 
5.3. References 203 
  
APPENDIX 205 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiii 
List of Figures 
 
 
Figure 1.1.  
Haworth projections of the disaccharide repeat units characterizing the 
members of the GAG family. (A) Hyaluronic acid is the only unsulfated GAG. 
(B) Chondroitin sulfate is subclassified based on sulfate positions as chondroitin 
sulfate A, chondroitin sulfate C, chondroitin sulfate D, and chondroitin sulfate 
E. Disaccharides containing 4-O-sulfated GalNAc residues are chondroitin 
sulfate A, 6-O-sulfated GalNAc residues are chondroitin sulfate C, 2-O-sulfated 
GlcA and 6-O-sulfated GlcNAc residues are chondroitin sulfate D, and 4,6-O-
sulfated GalNAc residues are chondroitin sulfate E. (C) Keratan sulfate is the 
only GAG without a uronic acid residue. (D) Dermatan sulfate. (E) Heparin and 
heparan sulfate 
 
 4 
Figure 1.2.  
Haworth projection of the synthetic antithrombic drug ArixtraTM (Fondaparinux 
Sodium), a potent inhibitor of activated Factor Xa. The numbering of the 
oligosaccharide residues in this dissertation is from right to left, in other words, 
numbering starts at oligosaccharide reducing end residue and terminates at non-
reducing end residue. 
 
 13 
Figure 1.3.  
Schematic showing the eliminative cleavage of a chondroitin sulfate A 
polysaccharide by Chondroitinase ABC from Proteus vulgaris. The enzyme is 
not specific to chondroitin sulfate A and also lyses the glycosidic linkage 
between GalNAc and the uronic acid residues in chondroitin sulfate C and 
dermatan sulfate. As a result of this cleavage, a double bond is incorporated into 
the uronic acid residue of the non-reducing end between carbons 4 and 5 (Δ4,5-
unsaturated), while the new reducing end GlcNAc residue exists as α/β 
anomers. 
 
 15 
Figure 1.4.  
Monitoring the partial enzymatic digestion of chondroitin sulfate A by 1H NMR. 
An aliquot of the digestion mixture containing the chondroitin sulfate A 
polysaccharide and Chondroitinase ABC was transferred into an NMR tube and 
placed in the magnet for incubation at 310.2 K. 1H NMR spectra were acquired 
at intervals during digestion period. The resonance of hydrogen atom bound to 
fourth carbon of the modified uronic acid residue (H4) has a characteristic 
chemical shift between 5.8 - 6.0 ppm. As the digestion proceeds, the intensity 
of the H4 resonance increases. The resonance labeled with a red dot belongs to 
chondroitin sulfate A oligosaccharides and the resonance labeled with black star 
belongs to chondroitin sulfate C and/or dermatan sulfate oligosaccharides 
 16 
 xiv 
(Section 1.2.2.2). Plotting the integrated resonance as function of time generates 
a digestion progress graph. 
 
Figure 1.5.  
Size-exclusion chromatograms of (A) chondroitin sulfate A and (B) hyaluronic 
acid. Each data point represents individual 4.5 mL or 3.5 mL size-uniform 
fractions collected for chondroitin sulfate A or hyaluronic acid, respectively. 
The peak labeling corresponds to oligosaccharide size: mono- (dp 1), di- (dp 2), 
tri- (dp 3), tetra-(dp 4), penta-(dp 5), hexa-(dp 6), hepta-(dp 7), octa-(dp 8), 
deca-(dp 10), and dodecasaccharides (dp 12) where dp refers to 
depolymerization product. 
 
 18 
Figure 1.6.  
Strong anion-exchange -HPLC chromatogram of the pooled chondroitin sulfate 
A tetrasaccharide fractions obtained by size-exclusion chromatography. 
Components of the mixture are separated by differences in charge. The 
chondroitin sulfate A tetrasaccharide  and  anomer peaks are resolved 
indicating that their mutorotation is slow on the separation time scale. The 
remaining peaks are due to impurities or minor structural variants present in 
original chondroitin sulfate A polysaccharide sample. 
 
 21 
Figure 1.7.  
The effects of chemical exchange between two equally populated cis- and trans- 
dimethylamino groups in the simulated 1H NMR spectra of dimethylformamide. 
The rate of the rotation of the dimethylamino group about the single bond 
joining nitrogen and carbon is temperature dependent. As the temperature 
increases, individual methyl resonances assigned as νA and νB, become broader 
and shift toward each other until they coalesce. Chemical exchange rates in the 
intermediate regime can be determined from the NMR spectral parameters. 
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Figure 1.8. 
Exchange reaction of labile protons with water is temperature and pH 
dependent. The asterisk in the exchange reaction denotes a proton transferred 
during the exchange. 
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Figure 2.1. 
Schematic of the SN2 mechanism proposed for the solvolytic de-N-sulfation 
reaction of ArixtraTM.  
 
 60 
Figure 2.2. 
1H NMR spectra of ArixtraTM acquired through the stages of its structural 
modification. (A) Spectrum of original N-sulfated pentasaccharide ArixtraTM 
acquired at 278.2 K in 90% H2O/10% D2O solution at pH 8.14. Doublets of the 
 62 
 xv 
sulfamate group proton resonances are found in the region 5.5 - 6.0 ppm. (B) 
Spectrum of de-N-sulfated ArixtraTM acquired at 259.1 K in 85% H2O/15% 
acetone-d6 solution at pH 1.54 adjusted before acetone addition. Singlets of the 
amino group protons resonate downfield in the region 8.0 - 8.5 ppm. (C) 
Spectrum of N-acetylated ArixtraTM acquired at 298.2 K in 90% H2O/10% D2O 
solution with pH 7.4. The amide group doublets are observed in the region 7.8 
- 8.2 ppm. Additionally, three characteristic amide group methyl proton singlets 
were observed around 2.0 ppm. The resonances arising from impurities are 
indicated by an asterisk. 
 
Figure 2.3.  
Schematic mechanism proposed for the selective N-acetylation of dNSA. The 
reaction is catalyzed by acetic acid. 
 
 65 
Figure 2.4. 
Schematic depiction of the cyclization of the reducing end monosaccharide 
residue of a chondroitin sulfate A tetrasaccharide. The acyclic form of the 
reducing end sugar is converted to a cyclic form by intramolecular reaction of 
the -OH group at C5 and the aldehyde group at C1. Red dashed circular 
arrows show rotation of groups attached to C4. Depending on the position of 
these groups, either an α or β anomer will be formed. 
 
 67 
Figure 2.5.  
1H NMR spectra of 4-O-sulfated chondroitin sulfate oligosaccharides before 
(A1 and B1) and after (A2 and B2) reduction with sodium borohydride. A1 and 
A2 are spectra of the tetrasaccharide in Figure 2.4. B1 and B2 are spectra of the 
hexasaccharide (ΔUA-GalNAc4S-GlcA-GalNAc4S-GlcA-GalNAc4S). Due to 
mutarotation at the anomeric carbon, in A1 and B1 two sets of chemical shifts 
are observable in the NMR spectra for the α and β configurations of each 
oligosaccharide. The insets show the effect of mutarotation and reduction on 
the resonances of amide group methyl protons. Reduction of the reducing end 
monosaccharide converts the α and β aldose configurations to an alditol and 
only one set of chemical shifts is present in NMR spectra A2 and B2.  
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Figure 2.6.  
Reduction of the chondroitin sulfate A tetrasaccharide with sodium 
borohydride. The reducing end aldose is converted to alditol form eliminating 
the α and β anomers. 
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Figure 2.7. 
Mass spectrum of dNSA obtained using an ESI Q-TOF mass spectrometer 
operating in negative ionization mode. The loss of sulfate and the presence of 
sodium adducts is common in analysis of GAG oligosaccharides by ESI-MS. 
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The expected mass of dNSA in 1267.08 U was confirmed by mass 
spectrometry. 
 
Figure 2.8. 
(A) The Haworth projection of de-N-sulfated ArixtraTM (dNSA) with labeled 
residues and numbered carbon-bound protons within each residue. For example, 
the carbon labeled with number 1 in the following sections is referred to as C1, 
the proton bound to this carbon is referred to as H1, and so on. (B) The 1H NMR 
spectrum of dNSA acquired in D2O. 
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Figure 2.9.  
(A) 1H-1H TOCSY and (B) 1H-1H COSY spectra of dNSA acquired in D2O. 
Five spin systems of dNSA were identified through TOCSY cross-peaks 
aligned along the F2 dimension. Assignment of the individual resonances of 
each monosaccharide spin system was performed using the COSY cross-peaks 
as illustrated for the GlcN6S(V) residue. The one-dimensional 1H NMR 
spectrum is included along both dimensions of the contour plot. 
 
 79 
Figure 2.10.  
The 1H-1H ROESY spectrum of dNSA acquired in D2O. Cross-peaks in the 
ROESY spectrum correlate protons coupled through the space within about 5 
Å. Identification of the inter-residue cross-peaks between sequential residues 
GlcN6S(V) H1-H4 GlcA(IV), GlcA(IV) H1-H4 GlcN3S6S(III), GlcN3S6S(III) 
H1-H4 IdoA2S(II), IdoA2S(II) H1-H4 GlcN6S(I), and GlcN6S(I) H1- CH3 
confirms the sequence and completes the resonance assignment process. The 
one-dimensional 1H NMR spectrum is included along both dimensions of the 
contour plot. 
 
 82 
Figure 2.11.  
Homonuclear (A) TOCSY and (B) COSY spectra of dNSA acquired in 85% 
H2O/15% acetone-d6 at 259.1 K. Through the cross-peak linkages the amino 
proton resonances were assigned to corresponding glucosamine residues. The 
one-dimensional 1H NMR spectrum is included along both dimensions of the 
contour plot. 
 
 86 
Figure 3.1.  
Haworth projections of the oligosaccharides: (A) ArixtraTM, (B) de-N-sulfated 
ArixtraTM (dNSA), (C) N-acetylated ArixtraTM (NAcArixtra), (D) heparin 
tetrasaccharide, (E) de-N-sulfated heparin tetrasaccharide (dNSt). Abbreviated 
residue names with their relative numbers in an oligosaccharide sequence are 
shown under each sugar ring. An example of carbon-bound proton numbering 
order across each residue is shown for dNSA and highlighted in red. 
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Figure 3.2.  
Graphical depiction of chemical shifts listed in Table 3.1. Chemical shifts of the 
ArixtraTM carbon-bound protons for are marked by circles, those of dNSA are 
marked by diamonds, and for NAcArixtra are marked by triangles. 
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Figure 3.3.  
(A) The region of the 
1
H NMR spectrum of dNSA showing the temperature 
dependence of the amino proton resonances at pH 1.6 and 4.1. Amino 
resonances are labeled according to residue number (Figure 3.1). (B) 
Comparison of the amino protons resonance linewidths at pH 1.6 and 4.1 and 
259.7 K. 
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Figure 3.4.  
Temperature coefficient plots of amino proton chemical shifts measured at pH 
1.6 and 4.1 for dNSA (A and B), and dNSt (C and D), respectively. Chemical 
shifts were plotted as a function of the calibrated temperature and the absolute 
value of the slope represents the temperature coefficient. 
 
 116 
Figure 3.5.  
Example of EXSY spectra of (A) dNSA and (B) dNSt measured at pH 1.6. 
Selected spectra with mixing times 6 ms, 18 ms, and 36 ms show differences in 
the exchange cross-peak intensity for each amino group. Traces through the 
exchange cross-peaks at the water chemical shift (≈ 5.2 ppm along the F1 
dimension) are plotted at the top of each contour map. Notably higher intensity 
is observed for the GlcN3S6S(III) amino group exchange cross-peak 
(highlighted in red) relative to other amino groups containing residues confined 
in the dNSA and dNSt oligosaccharides. 
 
 120 
Figure 3.6.  
EXSY build-up curves for the solvent exchange of the amino protons of dNSA 
and dNSt measured at (A) pH 1.6 and (B) 4.1 in 85% H2O/15% acetone-d6.  
 
 121 
Figure 3.7.  
pD titration of the dNSA in deuterated 10 mM phosphate buffer. 1H NMR 
spectra acquired as a function of pD reflect the effect of solution pD on the 
chemical shifts of carbon-bound protons in dNSA. Resonances are labeled 
according to the dNSA residue number with the subscript indicating the 
corresponding proton number within a given residue (see Figure 3.1B). The 
sequential deprotonation of ionizable groups induces chemical shifts changes. 
The most highly affected proton resonances were those in close spatial 
proximity to ionizable groups. 
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Figure 3.8.  
pD titration curves obtained through TOCSY experiments for (A) H2 protons 
in amino containing residues and (B and C) H5 protons for carboxylate 
containing residues. H2 protons in GlcN3S6S (III) and GlcN6S(V) residues 
showed sensitivity to changes in ionization state of carboxylates. Reciprocally, 
the H5 protons of GlcA(II) and IdoA2S(IV) were sensitive to changes in the 
ionization states of the amino groups. 
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Figure 3.9.  
Representative structure of dNSA taken from one step of the 300 ns MD. (A) 
Intramolecular hydrogen bonds predicted from MD are labeled by black dashed 
lines. Only hydrogen bonds with occupancies greater than 20% are shown. (B) 
Interatomic distances were calculated by averaging the shortest distances 
separating oxygens from nitrogen atoms. Residues are labeled with 
corresponding residue numbers. 
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Figure 4.1.  
Size-exclusion chromatograms of hyaluronic acid digested by Hyaluronidase 
from Streptomyces hyalurolyticus in batch #1. (A) The poor separation of the 
mixture of hyaluronic acid oligosaccharides was due to column performance. 
Peaks labeled #1 and #2 were further separated at atmospheric pressure on a 1.6 
x 70 cm column packed with Bio-Rad Bio-Gel P-6 fine polyacrylamide resin. 
(B) Peak #1 contains tri- and tetrasaccharides. (C) Peak #2 contains penta- and 
hexasaccharides. (D) Unresolved peaks from (A) were combined and separated 
again on a 3.0 x 200 cm column repacked with Bio-Gel P-10 fine resin and 
yielding improved chromatographic resolution.  
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Figure 4.2.  
Library of amide-containing saccharides. For oligosaccharide descriptions refer 
to Table 4.1. Oligosaccharide residue numbering order is from right to the left. 
The corresponding residue number is indicated in brackets by Roman numerals. 
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Figure 4.3.  
Graphical depiction of the data of the amide proton temperature coefficients 
presented in Table 4.2. The graph does not include the temperature coefficient 
of β conformers. The 3-O-sulfated residues are indicated by solid black circles 
and 4-O-sulfated GalNAc residue is highlighted by a solid grey circle. 
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Figure 4.4.  
(A) Example of amide proton resonance peak fitting to extract the line widths 
at half height for a GlcNAc α and β anomer measured at 293.2 K using 
MestReNova-12.0.1 software. Experimentally measured spectrum is plotted in 
black, simulated spectrum in blue, fitted spectrum in purple with residuals 
 177 
 xix 
shown in red. (B) Example plot for the determination of activation energy 
barriers, ΔG
‡
, for GlcNAc α anomer. Each red data point corresponds to amide 
proton resonance line width measured at half height as function of calibrated 
temperature. Blue line is an exponential fit of the data to the Eyring-Polanyi 
equation (Eq. 1.1.). (C) Residual line widths (difference between measured and 
fitted line widths) for plot shown in (B). 
 
Figure 4.5.  
Graphical depiction of the amide proton ΔG
‡
 results from Table 4.3 with the β 
conformers omitted. The saccharide order is the same as in Figure 4.3. 3-O-
sulfated GlcNAc residues are highlighted with solid black diamonds and the 4-
O-sulfated GalNAc residue is indicated with a solid grey diamond.  
 
 180 
Figure 4.6.  
pH titration of GalNAc, GlcNAc, chitin disaccharide, GlcNAc6S, GlcNAc3S, 
and NAcArixtra. Line widths of the amide resonances were measured as 
function of solution pH at 298.2 K.  
 
 182 
Figure 4.7.  
pH titration of N-sulfo glucosamine monosaccharides: D-glucosamine-2-N-
sulfate (GlcNS), D-glucoamine-2-N,3-O-disulfate (GlcNS3S), D-glucosamine-
2-N,3-O- and 6-O-trisulfate (GlcNS3S6S), and D-glucosamine-2-N,6-O-
disulfate (GlcNS3S6S). Line widths of the sulfamate resonances were measured 
as function of solution pH at 298.2 K. 
 
 184 
Figure 4.8.  
3D representations of the mono- and disaccharides in the α conformation. (A) 
GlcNAc, (B) GlcNAc3S, (C) GlcNAc6S, (D) GlcNS3S6S, (E) ΔUA-
GalNAc4S, and (F) ΔUA-GalNAc6S. For convenience, each carbon of the 
sugar ring is labeled according to its position relative to anomeric carbon (C1). 
Measured average distances separating amide/sulfamate proton and the O-sulfo 
groups are shown. 
 
 187 
Figure 4.9.  
3D representation of the penta- and hexasaccharides (A) N-acetylated ArixtraTM 
(NAcArixtra), (B) unsaturated HA hexasaccharide, and (C) unsaturated 4-O-
sulfated chondroitin sulfate hexasaccharide. In addition to the shortest averaged 
distances separating the amide protons from oxygens of the O-sulfo groups, the 
distances separating amide protons from the uronic acid carboxylate oxygens 
are also reported, and hydrogen bonds, shown by striped bars, with occupancies 
greater than 25% are indicated. 
 189 
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Table 3.4.  
Averaged torsion angles measured in dNSA. Atoms used to assign torsion 
angles in dNSA are shown in Figure 3.9A. 
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Table 4.1. 
Description of oligosaccharide structures shown in Figure 4.2.  
 
 169 
Table 4.2.  
Amide proton temperature coefficients in ppb/K measured at pH 7.40. 
Subdivision of the residues in column I distinguishes temperature coefficients 
measured for the reducing end sugar in the α (I-α) or β (I-β) conformation, or in 
a single conformation such as NAcArixtra, unsaturated reduced CS-A tetra- and 
hexasaccharides, and unsaturated reduced HA hexasaccharide (I). 
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 xxi 
Table 4.3.  
Calculated activation energy barriers, ΔG
‡
 (in kcal/mol) associated with amide 
proton solvent exchange. Errors were calculated through a numerical estimate 
of the covariance matrix and corresponded to ± 2.48 times the standard error for 
each parameter in this two-parameter fit. To compensate for systematic errors, 
the calculated errors for each measurement were rounded up to ± 0.1 kcal/mol. 
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CHAPTER ONE 
Introduction 
 
The aims of the research presented in this dissertation are the development of new 
analytical approaches for the structural analysis of glycosaminoglycans (GAGs). Emphasis 
is placed on the chemical modification and isolation of oligosaccharides with unique 
structures. Structural elements including the identity of the uronic acid residue, nature of 
the glycosidic linkage, sulfation position and the nitrogen substitution are all explored. The 
primary structures of oligosaccharides are elucidated using mass spectrometry (MS) and 
nuclear magnetic resonance (NMR) spectroscopy and the impacts of unique elements of 
primary structure, such as glucosamine 3-O sulfation, on secondary structure in aqueous 
solution are determined using NMR. 
The analysis of intact GAG polysaccharides can represent a significant challenge 
due to the structural complexity and microheterogeneity introduced during their non-
template driven biosynthesis.1-4 Characterization and structural studies of these 
biopolymers proceed through a bottom-up approach that employs depolymerization 
followed by chromatographic isolation of individual oligosaccharides based on size and 
charge.5-11 However, isolation of sufficient quantities of oligosaccharides with rare 
structural elements is not always feasible, therefore, this work relied on the synthetic 
modification of several isolated and chemically synthesized oligosaccharides.  
Research of the former lab members Dr. Consuelo Beecher and Dr. Derek 
Langeslay established the foundation for this research. They identified conditions suitable 
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for detection of labile protons in hydroxyl, amino, and sulfamate groups, and detected 
persistent intramolecular hydrogen bonds involving sulfamate and hydroxyl groups in 
synthetic antithrombotic drug ArixtraTM. In desire to expand our knowledge of physico-
chemical properties of GAGs in aqueous solutions, the objectives of this thesis are outlined 
below. 
 
Objective 1:  Develop and optimize chemical modifications of GAG oligosaccharides. 
Through the selective chemical modifications of suitable abundantly available precursors, 
rare elements of biopolymer structure can be introduced via chemical means to enable 
structural studies of unusual oligosaccharides.  
 
Objective 2:  Establish methods for identification of intramolecular salt bridges involving 
the amino groups of GAG oligosaccharides and determine the structural elements that 
promote salt bridge formation in aqueous solution.  
 
Objective 3:  Evaluate the effect of GAG structure on amide proton exchange rates at 
physiological pH to gain insights into the hydration, hydrogen bonding, and structural 
flexibility of GAG oligosaccharides. 
 
Objective 4:  Predict and confirm the presence of hydrogen bonds and salt bridges through 
molecular dynamic simulations of GAG oligosaccharides.  
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1.1. Glycosaminoglycans 
The glycosaminoglycan (GAG) family is comprised of heparin, heparan sulfate, 
chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. The GAGs are 
unbranched and highly anionic polysaccharides. Varying in size, composition, 
glycosylation linkage, and substitution, GAGs are classified based on their major 
disaccharide repeat subunits, in which a hexose residue is linked through the glycosidic 
bond to a hexosamine residue. The generalized representation of disaccharide repeat units 
of each GAG are shown in Figure 1.1.  
1.1.1. Structural variability and complexity. The structures of GAG 
polysaccharides range from relatively simple to highly complex. For instance, hyaluronic 
acid, the only GAG that is not biosynthesized as a proteoglycan and is ubiquitously 
expressed in the extracellular matrix of mammals, is comprised of only β-D-glucuronic 
acid (GlcA) and N-acetylglucosamine (GlcNAc) disaccharide repeat units (Figure 1.1A). 
Though they are derived from a similar GlcA-GlcNAc backbone linked by (1→4) 
glycosidic bonds as a result of enzymatic transformations during biosynthesis, heparin and 
heparan sulfate are more complex, heterogeneous, polydisperse, and highly negatively 
charged.3 The uronic acid residue in heparin and heparan sulfate can exist in one of two 
epimeric forms, β-D-glucuronic acid (GlcA) or α-L-iduronic acid (IdoA), while the 
nitrogen of the GlcN residue can be N-sulfated (GlcNS), N-acetylated (GlcNAc), or 
unsubstituted as the free amine (GlcN) (Figure 1E).3, 12, 13 Additionally, the uronic acid 
residues can be 2-O-sulfated or unsulfated and glucosamine residues can be 3-O- and/or 6-
O-sulfated.12, 13  
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Figure 1.1. Haworth projections of the disaccharide repeat units characterizing the 
members of the GAG family. (A) Hyaluronic acid is the only unsulfated GAG. (B) 
Chondroitin sulfate is subclassified based on sulfate positions as chondroitin sulfate A, 
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chondroitin sulfate C, chondroitin sulfate D, and chondroitin sulfate E. Disaccharides 
containing 4-O-sulfated GalNAc residues are chondroitin sulfate A, 6-O-sulfated GalNAc 
residues are chondroitin sulfate C, 2-O-sulfated GlcA and 6-O-sulfated GlcNAc residues 
are chondroitin sulfate D, and 4,6-O-sulfated GalNAc residues are chondroitin sulfate E. 
(C) Keratan sulfate is the only GAG without a uronic acid residue. (D) Dermatan sulfate. 
(E) Heparin and heparan sulfate.  
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Table 1.1. Abbreviations of monosaccharides used throughout this dissertation with their 
corresponding full names. 
Abbreviation Full name 
GlcN glucosamine 
GlcNS N-sulfated glucosamine 
GlcNS3S N-,3-O-disulfated glucosamine 
GlcNS6S N-,6-O-disulfated glucosamine 
GlcNS3S6S N-,3,6-O-trisulfated glucosamine 
GlcN3S 3-O-sulfated glucosamine 
GlcN3S6S 3,6-O-disulfated glucosamine 
GlcNAc N-acetylglucosamine 
GlcNAc3S 3-O-sulfated N-acetylglucosamine 
GlcNAc6S 6-O-sulfated N-acetylglucosamine 
Gal galactose 
Gal6S 6-O-sulfated galactose 
GalNAc N-acetylgalactosamine 
GalNAc4S 4-O-sulfated N-acetylgalactosamine 
GalNAc6S 6-O-sulfated N-acetylgalactosamine 
UA uronic acid 
UA2S 2-O-sulfated uronic acid 
ΔUA unsaturated uronic acid 
ΔUA2S 2-O-sulfated unsaturated uronic acid 
GlcA glucuronic acid 
GlcA2S 2-O-sulfated glucuronic acid 
IdoA iduronic acid 
IdoA2S 2-O-sulfated iduronic acid 
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Structurally heparin and heparan sulfate are distinguished from each other based on 
the content of the major disaccharide repeat units and the ratio of sulfate groups per 
disaccharide unit (the sulfate/hexosamine ratio). In heparin, the tri-sulfated IdoA2S - 
GlcNS6S disaccharide comprises over 70% of the polysaccharide and heparin has on 
average 1.8 - 2.6 sulfate groups per disaccharide unit.13, 14 In contrast, the major 
disaccharide repeating unit of heparan sulfate is GlcNAc - GlcA comprising about 40 - 
60% of the polymer and a 0.8 - 1.8 sulfate/hexosamine ratio.12, 13 Additionally, heparan 
sulfate contains highly sulfated heparin-like regions with other regions where there is a 
greater structural variability at the disaccharide level.15 The structural complexity of 
heparin and heparan sulfate is introduced during biosynthetic chain elongation during 
which a variety of enzymes act on specific locations of the growing polysaccharide 
backbone.3, 16 For instance, the variability of N-/O-sulfo group substitution is introduced 
by sulfotransferase enzymes, while inversion of GlcA to IdoA is performed by an 
epimerase.3, 17, 18  
Similar non-template driven polysaccharide backbone modifications account for 
the polydisperse and heterogeneous nature of the chondroitin sulfate, dermatan sulfate, and 
keratan sulfate polysaccharides. The chondroitin sulfate disaccharide repeat unit is 
comprised of a GlcA residue linked through a β(1→3) glycosidic bond to N-
acetylgalactosamine (GalNAc). The GlcA residue can be sulfated at the 2-O position and 
the GalNAc residue can be sulfated at the 4-O and 6-O positions. The dermatan sulfate 
polysaccharide resembles chondroitin sulfate, except that uronic acid residue exists 
exclusively as IdoA. The keratan sulfate structure differs from all other GAGs in that 
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hexose residue of the disaccharide repeat sequence is a Gal or Gal6S residue linked by a 
β(1→4) linkage to GlcNAc or GlcNAc6S hexosamine residues.4 Keratan sulfate is only 
GAG doesn’t containing uronic acid residues. 
1.1.2. Significance of GAG structure to physiological processes and interactions 
with proteins. GAGs are the most abundant heteropolysaccharides in the body and they are 
important components in many life-essential physiological processes. The unsulfated 
polysaccharide hyaluronic acid, the only GAG not covalently attached to a protein core, is 
an important component in maintenance of the elastoviscosity of liquid connective tissues, 
control of  tissue hydration and water transport, numerous receptor-mediated roles in cell 
detachment, mitosis, migration, tumor development and metastasis, inflammation, and the 
supramolecular assembly of proteoglycans in the extracellular matrix.19-22 Hyaluronic acid 
is widely used in regenerative medicine and cosmetics.23-26 Chondroitin sulfate and 
dermatan sulfate are major components of the extracellular matrix and are found in many 
connective tissues such as bone, cartilage, skin, ligaments and tendons.27, 28 Chondroitin 
sulfate and dermatan sulfate can specifically interact with variety of heparin-binding 
proteins.29 They are an important components for central nervous system development, 
wound repair, infection, growth factor signaling, morphogenesis and cell division.30, 31 
Chondroitin sulfate is also well known for its potential function in the treatment of 
osteoarthritis.32 Keratan sulfate, originally identified as the major GAG of the cornea, is 
also found in cartilage and aggrecan.33 Keratan sulfate is known for its ability to bind and 
modify proteins including fibromodulin, PRELP, and osteoadherin.34-36 Heparin and 
heparan sulfate, interact with a wide variety of proteins and participate in a range of 
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important biological activities including cell development,37, 38 proliferation,39-41 
differentiation,42 adhesion,3, 43 inflammation, 44-47 angiogenesis,48 viral49-51 and microbial 
infections, 52 and in the pathological conditions of tumor growth. 3, 53-55 
Countless number of interactions between GAGs and proteins mediate diverse 
physiological effects including hemostasis, lipid transport and absorption, cell growth and 
migration, and development. Binding to GAGs can immobilize proteins at their sites of 
production and in the extracellular matrix, regulate enzyme activity, binding of ligands to 
their receptors, and protect proteins against degradation.1 While charge is a major 
component of protein binding, the microheterogeneity of GAGs allows specific recognition 
of proteins through different structural motifs that include various patterns of uronic acid 
and glucosamine O-sulfation, glucosamine N-substitutions (acetyl, sulfo or free amino 
groups), uronic acid C-5 epimerization (α-L-iduronic acid or β-D-glucuronic acid) etc. 
These interactions are critically dependent on particular arrangements of saccharides with 
specific structural elements localized within the polysaccharide chain.  
One of the best studied GAG-protein interactions is the binding of heparin to the 
serine protease inhibitor antithrombin-III which is driven by the interactions of the 
negatively charged sulfate and carboxyl groups of heparin with the positively charged 
amino acids of protein. High affinity binding to antithrombin-III, which is critical for 
triggering downstream coagulation-cascade proteases, requires a pentasaccharide that 
includes a -GlcA-GlcNS3S6S-IdoA2S- motif as the minimum binding sequence. This 
pentasaccharide motif is also present in synthetic antithrombotic drug ArixtraTM 
(Fondaparinux sodium) shown in Figure 1.2. The relatively rare 3-O-sulfate modification 
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in the trisulfated glucosamine residue GlcNS3S6S is found in roughly 5% of heparin 
disaccharides56 and is critical for high affinity binding. Removal of this 3-O-sulfo group 
decreases the antithrombin-III binding affinity of an oligosaccharide by 1000-fold.57 A 
recent study by Langeslay et al. revealed the involvement of this 3-O-sulfo group in a 
persistent intramolecular hydrogen bond with the adjacent N-sulfo proton of GlcNS3S6S 
in ArixtraTM.58 This hydrogen bond may be correlated with the “kink” observed in the 
crystal structure of oligosaccharides bound to antithrombin-III.59, 60 Additional studies of 
ArixtraTM identified hydrogen bonds involving hydroxyl protons and revealed the 
flexibility of IdoA2S residue.61 The specific hydrogen bonds involving IdoA2S residue 
depend on the presence of the 3-O-sulfo group in GlcNS residue, suggesting that IdoA2S 
residue may contribute to stability of the pentasaccharide secondary structure. 
Consequently, not only do electrostatic interactions play an important role in GAG-protein 
interactions, structural elements that promote intramolecular hydrogen bonds may help 
pre-organize the oligosaccharide secondary structure to facilitate protein binding.  
The importance of 3-O-sulfated GlcN motifs is not limited to heparin-antithrombin-
III binding. Multiple studies suggest that incorporation of 3-O-sulfated glucosamine 
(GlcN3S) residues into the polysaccharide sequence is critical for heparan sulfate activity 
in many biological processes. For example, the entry of herpes simplex virus type 162, 63 
into cells begins through the non-specific binding of viral glycoproteins B and C (gB and 
gC, respectively) to an heparan sulfate proteoglycan polysaccharide chain localized on the 
cell surface.64-66 However, this interaction alone is insufficient for cell entry and infection, 
which requires fusion between the viral envelop and the cell membrane. Specific binding 
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of the viral glycoprotein D (gD) with a sequence that includes a 3-O-sulfated glucosamine 
residue leads to fusion between the viral envelop and the cell membrane.64-66 Moreover, 
the heparan sulfate disaccharides IdoA2S-GlcN3S and IdoA2S-GlcN3S6S are reported to 
be possible mediators of herpes simplex virus type 1 entry.67 Besides the interaction with 
gD,49, 50 different heparan sulfate oligosaccharides containing GlcN3S or GlcNS3S6S 
residues are known to bind to a number of important proteins mediating critical biological 
functions. For example, cyclophilin B (CyPB) binding to a heparan sulfate sequence 
containing GlcN3S promotes lymphocyte adhesion and migration,68 while binding of a 
different oligosaccharide with 3-O-sulfated glucosamine residues to stabilin-1 and 2 
enhance the clearance of circulating heparin.69, 70 3-O-sulfated GlcNS3S and GlcNS3S6S 
residues are also a critical part of the binding motif for FGF and FGF receptors affecting 
cell growth.71, 72 Binding specificity may be related to the relative rarity of 3-O-sulfated 
content in heparan sulfate (only 1 - 6%).73-75 Clearly the heparan sulfate 3-O-sulfo group 
in GlcN3S is biologically important, but it’s structural role in heparan sulfate remains 
unclear. In Chapter 3 the identification of a salt bridge involving the negatively charged 
GlcN3S 3-O-sulfo group with the adjacent positively charged amino is described for the 
first time. This non-covalent interaction could be an important element of heparan sulfate 
secondary structure and contribute to its specific interactions with proteins.  
 
1.2. Challenges in structural studies of GAGs: The bottom-up approach 
Structural studies and the investigation of the physico-chemical properties of GAGs 
are complicated by their polydisperse nature in addition to their flexibility in aqueous 
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solutions. Unlike genomics, proteomics and transcriptomics, the non-template driven chain 
elongation process of GAG biosynthesis does not allow the use of omics approaches or 
knowledge bases for their analysis. To overcome problems associated with polysaccharide 
complexity, the bottom-up approach is widely utilized in GAG studies. This approach 
initially involves depolymerization of the GAG polysaccharide followed by 
chromatographic isolation of uniformly fractionated oligosaccharides based on size and 
charge. Finally, the oligosaccharide is isolated in sufficient quantities for structure 
elucidation by MS and NMR and ideally, characterization of its biological properties. 
1.2.1. Polysaccharide depolymerization. The depolymerization strategy employed 
usually depends on the final application and the need to obtain oligosaccharides with 
certain degree of polymerization. Generally, two methods are utilized to depolymerize 
GAG polysaccharides: 1) enzymatic digestion and 2) chemical depolymerization. In both 
methods, the specificity and degree of depolymerization can be controlled by selecting 
appropriate reaction conditions.  
1.2.1.1. Enzymatic digestion. One of the greatest advantages of employing enzymes 
for GAG depolymerization is their ability to cleave glycosidic bonds at only specific 
locations of the polysaccharides. There are wide variety of enzymes are available to 
accommodate selective or non-selective GAG depolymerization reactions. For instance, 
depolymerization of chondroitin sulfate A can be performed by using Chondroitin ABC 
lyase (Chondroitinase ABC) derived from Proteus vulgaris bacteria.5, 76 This enzyme is 
nonspecific, cleaving the glycosidic bond between GalNAc and uronic acid residues in 
chondroitin sulfate A (4-O-sulfated), chondroitin sulfate C (6-O-sulfated) and   
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Figure 1.2. Haworth projection of the synthetic antithrombic drug ArixtraTM 
(Fondaparinux Sodium), a potent inhibitor of activated Factor Xa. The numbering of the 
oligosaccharide residues in this dissertation is from right to left, in other words, numbering 
starts at oligosaccharide reducing end residue and terminates at non-reducing end residue. 
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dermatan sulfate (Figure 1.3.). Enzymatic cleavage of the glycosidic bond introduces a 
Δ4,5-unsaturated residue at the non-reducing end of the oligosaccharide. This double bond 
provides a unique analytical handle absorbing UV light at 232 nm and producing a 
characteristic 1H NMR resonance. The depolymerization reaction can be performed as an 
exhaustive digestion reducing the polysaccharide to its constituent disaccharide building 
blocks, or when larger oligosaccharides are desired for structural or protein binding 
experiments, the degree of depolymerization can be conveniently controlled and stopped 
at a partial digestion by monitoring the progress of the enzymatic reaction by 1H NMR 
(Figure 1.4). 
1.2.1.2. Chemical depolymerization. A variety of chemical reactions have been 
developed for GAG depolymerization including oxidative cleavage, β-elimination, and 
reductive deamination. Oxidative depolymerization proceeds through reaction of the 
polysaccharide with hydrogen peroxide and the divalent ions copper or iron.6, 77 The 
reaction is highly specific to unsubstituted uronic acid (GlcA or IdoA) residues and yields 
an oxidized fragments of the hexuronic acid. The β-elimination reaction proceeds through 
the two steps. First, the carbon of the uronic acid carboxylate group reacts with benzyl 
halide to form an ester. Then treatment with strong base abstracts the proton from the fifth 
carbon of the uronic acid to form a double bond between fourth and fifth carbons of the 
uronic acid. Reductive deamination reaction proceeds through treatment of the 
polysaccharide with nitrous acid below pH 1.5. Cleavage occurs at N-unsubstituted GlcN 
residues to form a 2,5-anhydro-D-mannose residue at the reducing end of depolymerized  
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Figure 1.3. Schematic showing the eliminative cleavage of a chondroitin sulfate A 
polysaccharide by Chondroitinase ABC from Proteus vulgaris. The enzyme is not specific 
to chondroitin sulfate A and also lyses the glycosidic linkage between GalNAc and the 
uronic acid residues in chondroitin sulfate C and dermatan sulfate. As a result of this 
cleavage, a double bond is incorporated into the uronic acid residue of the non-reducing 
end between carbons 4 and 5 (Δ4,5-unsaturated), while the new reducing end GlcNAc 
residue exists as α/β anomers.   
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Figure 1.4. Monitoring the partial enzymatic digestion of chondroitin sulfate A by 1H 
NMR. An aliquot of the digestion mixture containing the chondroitin sulfate A 
polysaccharide and Chondroitinase ABC was transferred into an NMR tube and placed in 
the magnet for incubation at 310.2 K. 1H NMR spectra were acquired at intervals during 
digestion period. The resonance of hydrogen atom bound to fourth carbon of the modified 
uronic acid residue (H4) has a characteristic chemical shift between 5.8 - 6.0 ppm. As the 
digestion proceeds, the intensity of the H4 resonance increases. The resonance labeled with 
a red dot belongs to chondroitin sulfate A oligosaccharides and the resonance labeled with 
black star belongs to chondroitin sulfate C and/or dermatan sulfate oligosaccharides 
(Section 1.2.2.2). Plotting the integrated resonance as function of time generates a digestion 
progress graph.   
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oligosaccharide. This reaction can also be applied to any GalNAc containing 
polysaccharide, but requires preliminary de-N-acetylation, and yields 2,5-anhydro-D-
talose residues at the oligosaccharide reducing end.78  
1.2.2. Isolation of depolymerized oligosaccharides. Solutions of depolymerized 
GAGs contain multicomponent mixtures of oligosaccharides. The composition of the 
mixture can be directly analyzed by mass spectrometry, either through direct infusion or in 
conjunction with a mass spectrometry-compatible separation.79-82 However, the 
investigation of the structure, physico-chemical properties, and biological activities of 
GAG oligosaccharides demands sufficient quantities (typically milligrams) of pure 
oligosaccharides and therefore, requires isolation of individual oligosaccharides from the 
mixture through chromatographic approaches.  
1.2.2.1. Size-exclusion chromatography. Size-exclusion chromatography is 
typically the first step in oligosaccharide separations. The partially depolymerized GAG is 
loaded onto the chromatographic column and eluted with appropriate mobile phase. The 
choice of stationary and mobile phases is selected for the particular application and the 
separation can be performed at the analytical or preparative scale. Size-exclusion 
chromatography resolves similarly-sized oligosaccharides into separate bands that can be 
collected for subsequent separation based on charge. Figure 1.5 shows the representative 
preparative size-exclusion chromatographic profiles obtained for 905 mg of chondroitin 
sulfate A partially digested with Chondroitinase ABC and 50 mg of hyaluronic acid 
digested with Hyaluronic acid lyase derived from Streptomyces hyalurolyticus.   
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Figure 1.5. Size-exclusion chromatograms of (A) chondroitin sulfate A and (B) hyaluronic 
acid. Each data point represents individual 4.5 mL or 3.5 mL size-uniform fractions 
collected for chondroitin sulfate A or hyaluronic acid, respectively. The peak labeling 
corresponds to oligosaccharide size: mono- (dp 1), di- (dp 2), tri- (dp 3), tetra-(dp 4), penta-
(dp 5), hexa-(dp 6), hepta-(dp 7), octa-(dp 8), deca-(dp 10), and dodecasaccharides (dp 12) 
where dp refers to depolymerization product.   
19 
The separations were performed at atmospheric pressure using a preparative size-
exclusion chromatography column (3 × 200 cm) packed with Bio-Gel P10 fine gel. Though 
preparative scale chromatography requires a much longer time (on the order of days) to 
complete the separation, its advantage over analytical HPLC-size-exclusion 
chromatography is the capacity of the column to resolve large amounts of material in one 
separation. For the size-exclusion chromatograms shown in Figure 1.5, the eluent was 
collected in individual fractions and the progress of the separation monitored offline by 
measurement of the UV absorbance at 232 nm. Because of the structural differences of the 
polysaccharides and the specificity of enzymes used in these digestions, the size-exclusion 
chromatograms reflect structural differences in the depolymerized chondroitin sulfate A 
and hyaluronic acid. For instance, the digested chondroitin sulfate A contains oligomers 
comprised of both odd and even numbers of monosaccharides, while the mixture of 
digested hyaluronic acid contains only even-numbered oligosaccharides with major 
products consisting of tetra-, hexa-, and octasaccharides. Finally, to remove mobile phase 
constituents from the isolated oligosaccharides, the pooled size-uniform fractions were 
lyophilized and desalted using a 1.6 × 70 cm desalting column packed with GE Sephadex 
G-10 superfine resin and using ultrapure deionized water as the mobile phase. The fractions 
containing the desalted oligosaccharides were lyophilized and stored at -80 ºC for further 
analysis.  
1.2.2.2. Strong anion-exchange chromatography. The size-uniform fractions 
isolated by size-exclusion chromatography are heterogeneous mixtures of oligosaccharides 
with a distribution of structures and charges, therefore, strong anion-exchange-HPLC UV-
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Vis chromatography is used for the isolation of pure oligosaccharides derived from GAG 
digestions. Figure 1.6 shows the strong anion-exchange chromatogram of the chondroitin 
sulfate A tetrasaccharides fraction isolated by size-exclusion chromatography. Because the 
chondroitin sulfate A starting material used for this digestion was 70% pure and contains 
significant amounts of chondroitin sulfate C and dermatan sulfate, the size uniform 
fractions obtained by size-exclusion chromatography contain oligosaccharides that are 
variously sulfated and differ in IdoA/GlcA content. The strong anion-exchange separation 
was performed using a Waters Spherisorb semi-preparative column packed with 5µm 
silica-based particles with a quaternary ammonium bonded sorbent. Though, semi-
preparative columns provide lower resolution and require longer equilibration times 
compared to analytical columns, this disadvantage is compensated by their capacity to 
separate larger amounts of material. The eluted strong anion-exchange chromatography 
peaks are collected over multiple injections, and the fractions containing each 
oligosaccharide are combined, lyophilized, desalted and lyophilized again for long-term 
storage at -80 ºC. These purified oligosaccharides are now ready for structure elucidation. 
 
1.3. Structure elucidation 
The complete structure elucidation of isolated GAG oligosaccharides is 
accomplished using two of the most powerful analytical techniques: MS and NMR 
spectroscopy.  
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Figure 1.6. Strong anion-exchange -HPLC chromatogram of the pooled chondroitin sulfate 
A tetrasaccharide fractions obtained by size-exclusion chromatography. Components of 
the mixture are separated by differences in charge. The chondroitin sulfate A 
tetrasaccharide  and  anomer peaks are resolved indicating that their mutorotation is 
slow on the separation time scale. The remaining peaks are due to impurities or minor 
structural variants present in original chondroitin sulfate A polysaccharide sample.  
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1.3.1. Mass spectrometry. Destructive in nature but highly sensitive, MS identifies 
the oligosaccharide composition including molecular weight, extent of sulfation and 
acetylation and, through fragmentation, can often elucidate the sequence of the 
monosaccharide residues.83-85 Electrospray ionization mass spectrometry (ESI-MS) is 
typically used in negative mode and provides effective ionization of the negatively charged 
oligosaccharides. However, when direct infusion is used, the ESI mass spectra can be 
complicated by the presence of sodium or/and potassium adducts and the presence of 
multicharged molecular ions associated with sulfate loss. While adduct ions can be reduced 
by thoughtful sample preparation (e.g. careful desalting and use of ammonium buffers80) 
or by incorporating a reversed-phase ion pairing HPLC separation,86-90 the loss of sulfate 
during the ionization process is much harder to control. Sulfate loss can be reduced by 
careful tuning of the ionization and ion-extraction voltage parameters of the ionization 
source, but complete elimination of sulfate loss is a challenge. In cases where additional 
structural information is required, tandem mass spectrometry can elucidate the 
oligosaccharide sequence.85, 91-93 The ion activation technique electron detachment 
dissociation along with tandem mass spectrometry is even able to distinguish the uronic 
acid epimers GlcA and IdoA.94  
1.3.2. Solution state NMR. NMR spectroscopy is an invaluable analytical tool for 
the study of GAGs,95-97 protein-GAG interactions,98 and oligosaccharide secondary 
structure.15, 58, 61, 99-104 NMR is also used in structure elucidation to confirm the structures 
postulated by mass spectrometry, and is particularly helpful when advanced techniques like 
electron detachment dissociation  are not readily accessible. NMR is non-destructive and 
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therefore allows full recovery of the precious and limited amounts of sample isolated 
through the painstaking processes described in Section 1.2. However, NMR struggles with 
fundamental issues of low sensitivity especially compared with mass spectrometry. This 
disadvantage can be partially overcome using more concentrated samples, reduced volume 
NMR tubes, and by performing the measurements at the highest available magnetic field 
using probes and preamplifiers that are cryogenically cooled to reduce Johnson noise in the 
detected signals.105 
One-dimensional (1D) and multi-dimensional (2D, 3D) NMR experiments 
employing 1H, 13C  and 15N are among most successful approaches for the characterization 
of GAG oligosaccharides.97, 106-108 Because of the limited dispersion of the 1H NMR 
resonances of carbohydrates, resonance overlap can make it challenging to assign the NMR 
spectra of even medium-sized oligosaccharides.5, 109, 110 The use of higher field magnets 
and, when feasible, GAG isotopic labeling in cell cultures97 can improve peak resolution 
and sensitivity.  
The standard arsenal of 2D homonuclear NMR experiments COSY, TOCSY, and 
ROESY are invaluable for oligosaccharide spectral assignments by connecting 1H 
resonances through cross peaks that reflect through bond or through space interactions.111-
116 The greater dispersion of [1H,13C] HSQC spectra can make it useful for resonance 
assignments, and this experiment has even been used to characterize the components of the 
anticoagulant drug Enoxaparin, a complex mixtures of oligosaccharides produced by the 
chemical depolymerization of heparin.106, 107 Indirect detection of the 15N nuclei found in 
every other monosaccharide residue in GAGs can provide important structural information.  
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The detection and characterization of the amide groups in hyaluronic acid oligosaccharides 
up to decamers has been successfully accomplished through [1H,15N] HSQC NMR,95 in 
contrast to 13C NMR where only a hyaluronic acid hexamer’s internal acetyl groups could 
be resolved. Major advances in the application of [1H,15N] HSQC for GAG analysis were 
made by Langeslay et al. and Beecher et al. who identified experimental conditions that 
minimize the exchange rates of the GAG sulfamate and amine protons. Langeslay et al. 
also used the [1H,15N] HSQC spectra of Enoxaparin to demonstrate the sensitivity of the 
sulfamate group 1H and 15N chemical shifts to subtle structure differences.9  
Much of the work in this dissertation relies on NMR spectroscopy. In Chapter 2, 
the detailed structure characterization of chemically modified oligosaccharides is 
presented. In Chapters 3 and 4, NMR is used to study the properties of the labile nitrogen-
bound protons of the GAG acetyl and amino groups, and this topic is briefly introduced in 
the following section. 
 
1.4. The examination of labile protons in the study of GAG secondary structure 
Hydrogen bonds and salt bridges play very important roles in many chemical and 
biochemical processes.117-119 They are responsible for determining the conformation and 
complexation of large and small chemical and biochemical molecules and systems. For 
instance, structure of DNA is crucially dependent on the strength of the hydrogen bonds 
between the base pairs. Similarly, the strength of the cellulose, a polysaccharide composed 
of glucose units, is fully dependent on intermolecular hydrogen bonding.120, 121 Because 
elements of secondary structure like hydrogen bonds or salt bridges may help stabilize the 
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conformation of an oligosaccharide in an orientation that facilitates protein binding, the 
exploration of the  intramolecular properties of oligosaccharides in aqueous solution could 
help advance our understanding of specific GAG-protein interactions.  
NMR methods and approaches to study oligosaccharide solution structure and 
dynamics continue to advance. For instance, the investigation of the dynamics of 
hyaluronic acid oligosaccharides in aqueous solution through 1H and 15N NMR 
spectroscopy revealed the absence of amide-carboxylate hydrogen bonds which were 
previously believed to be responsible for the stiffening of the hyaluronic acid polymer by 
forming inter-residue hydrogen bonds.122 This discovery provided a new view on the 
secondary and tertiary structures of the hyaluronic acid biopolymer in aqueous solution. 
More recently, Langeslay et al. reported that the 3-O-sulfo group of the center 
GlcNS3S(III) residue in synthetic pentasaccharide ArixtraTM (Figure 1.2) is involved in a 
hydrogen bond with the nitrogen-bound proton of the adjacent sulfamate group.58 Beecher 
et al. complemented these findings by identifying two additional intramolecular hydrogen 
bonds involving the ArixtraTM  hydroxyl protons. Chapter 3 discusses the identification of 
salt bridge in a model heparan sulfate pentasaccharide involving the 3-O-sulfated 
glucosamine (GlcN3S) amine group and adjacent 3-O-sulfo group. In each of these 
examples, the intermolecular interactions were identified (or in the case of hyaluronic acid 
disproved) by exploration of the dynamics and chemical exchange properties of labile 
protons in aqueous solution using NMR spectroscopy.  
1.4.1. Chemical exchange and the NMR time scale. In NMR, the term chemical 
exchange refers to the process by which a nucleus relocates from one chemical 
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environment to another and is simultaneously replaced by another nucleus maintaining the 
chemical equilibrium of the system.123 It should be noted that chemical exchange doesn’t 
perturb chemical equilibrium and is observable only in NMR spectra, providing that the 
rate of exchange is in the appropriate regime. The NMR chemical shift time scale is defined 
by the difference in chemical shift in Hz of the nuclei in the two environments. Because 
this chemical shift difference depends linearly on magnetic field strength, it can be helpful 
to acquire spectra at more than one magnetic field. 
Using simulated spectra, Figure 1.7 shows an example of the effect of chemical 
exchange between the cis- (A) and trans- (B) methyl groups of dimethylformamide on the 
1H NMR spectrum. In this case, the exchange is governed by first order kinetics and the 
populations of the exchanging groups are equal, though this need not be the case. The 
different chemical environments of the cis- and trans- methyl groups cause their protons 
to resonate at two different frequencies, νA and νB, and it is the difference in chemical shift 
(νA - νB) that defines the NMR time-scale for this system. Because of the partial double 
bond character of the amide N-C bond, rotation about this bond is slow enough to be 
observed in the 1H NMR spectrum. At low temperature, the rate of rotation about the N-C 
bond is sufficiently slow that during the acquisition of the free induction decay, exchange 
is not observed and the exchange rate constant, k, is very much less than the difference in 
chemical shift (νA - νB). In this slow exchange regime, the cis- and trans- methyl protons 
produce narrow resonances at their characteristic frequencies (νA and νB).  Gradual heating 
increases the rate of rotation and the effects of chemical exchange can be observed in the 
NMR spectrum as the methyl proton resonances broaden and their chemical shifts move  
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Figure 1.7. The effects of chemical exchange between two equally populated cis- and 
trans- dimethylamino groups in the simulated 1H NMR spectra of dimethylformamide. The 
rate of the rotation of the dimethylamino group about the single bond joining nitrogen and 
carbon is temperature dependent. As the temperature increases, individual methyl 
resonances assigned as νA and νB, become broader and shift toward each other until they 
coalesce. Chemical exchange rates in the intermediate regime can be determined from the 
NMR spectral parameters.  
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environments. Eventually the two resonances coalesce at the average chemical shift, (νA + 
νB)/2, and then sharpen as the fast exchange regime is reached. In this fast exchange regime, 
the rate of exchange is much larger than frequency difference separating two 
dimethylformamide methyl proton resonances. It is important to note that when the 
populations of the exchanging protons are much different, as with chemical exchange 
between the labile protons of a GAG oligosaccharide (~1 mM) and the protons of water 
(~110 M), the coalescence frequency is the population weighted average and therefore 
appears essentially at the water resonance frequency.  
1.4.2. Chemical exchange and the labile protons of GAGs. The labile GAG 
protons observable by 1H NMR in aqueous solution include the amide (NHCOCH3), amino 
(NH3
+
), sulfamate (NHSO3
- 
), and hydroxyl (OH) protons. Figure 1.8 shows the generalized 
chemical exchange reaction between an amino sugar residue (R) containing labile protons 
of different types and the protons of water. The rate of proton exchange is temperature-
dependent and hence follows the Eyring-Polanyi equation (Eq. 1.1) which describes the 
relationship between the chemical exchange rate constant (k), temperature (T), and the 
energy barrier associated with exchange (ΔG
‡
). 
k = 
𝑘𝐵T
𝜋ℎ
𝑒
ΔG‡
RT                                                   (Eq. 1.1) 
Eq. 1.1 indicates that exchange rates are directly proportional to the solution 
temperature, and consequently slower exchange occurs at reduced temperatures. In 
aqueous solutions of sugars, it is possible to lower the temperature below the freezing point   
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Figure 1.8. Exchange reaction of labile protons with water is temperature and pH 
dependent. The asterisk in the exchange reaction denotes a proton transferred during the 
exchange.   
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of water by adding 10 - 15% of the minimally-perturbing solvent deuteroacetone, which 
can also serve as the spectrometer lock.61, 124 The solution pH is another important 
experimental parameter because the chemical exchange reaction between the labile protons 
and water is catalyzed by H3O
+
 and OH
-
 ions. Because exchange process occurs in aqueous 
solution with a large excess of the water, the proton exchange reaction is governed by the 
pseudo first-order kinetics as described by Eq. 1.2.125  
kobs = kH+[H
+
] + kOH-[OH
-
]                                         (Eq. 1.2) 
According to Eq. 1.2, the overall rate constant (kobs) of the proton exchange reaction 
is the sum of two terms, kH3O+[H3O
+
] and kOH-[OH
-
], representing the exchange rate of the 
base and acid catalyzed reactions, respectively. Because the exchange rate constants for 
the acid (kH3O+) and base (kOH-) catalyzed reactions are not equal and depend on the 
chemical system, the solution pH that produces the slowest exchange is also system 
dependent. 
Among the four GAG functional groups with observable labile protons, the rate of 
solvent exchange with the amide protons is slowest and their resonances can be easy 
detected at room temperature over a wide pH range, with an optimum around pH 6.0.126 
The sulfamate protons exchange with solvent more rapidly than amide protons, but slower 
than the protons of hydroxyl and amine groups. Though, sulfamate protons are detectable 
at room temperature, the pH range over which they can be detected is much narrower than 
for amides, with an optimum solution pH between 7.5 and 8.5.58, 127 Detection of hydroxyl 
and amine group proton resonances is more challenging and requires temperatures below 
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0 °C. The optimum pH for detection of hydroxyls is around 7.8 - 8.8 and that for aminos is 
around 3.2 - 4.2.61, 124 Furthermore, the optimum pH to detect the labile protons of a 
particular oligosaccharide depends on factors that including the size and extent of sulfation.  
1.4.3. Experimental approaches for studying properties of the labile protons of 
GAG oligosaccharides by NMR. A variety of NMR approaches originally developed to 
study hydrogen bonding, salt bridge formation, and proton-solvent exchange in aqueous 
solutions of peptides and oligonucleotides can also be used to characterize the properties 
of labile protons in solutions of GAG oligosaccharides.99, 104, 128-130  
1.4.3.1. Temperature coefficients. Temperature coefficients, Δδ/ΔT, are measured 
by observing changes in the 1H NMR resonance frequency as a function of temperature, 
and are one of the most powerful indicators of hydrogen bonds in proteins, peptides, and 
carbohydrates.128, 129, 131, 132 The overall effect is that the change in resonance frequency as 
function of temperature for a labile proton involved in a hydrogen bond will be less than 
for a proton that does not participate in a hydrogen bond. The value of Δδ/ΔT is obtained 
by taking the absolute value of the slope of the line obtained by plotting the chemical shift 
of the exchangeable proton as function of temperature, and a low temperature coefficient 
can indicate participation of a proton in a hydrogen bond.130  
1.4.3.2. Line shape analysis and the quantification of energy barriers associated 
with exchange. 1H NMR spectra acquired for the determination of temperature coefficients 
can also provide insights into the kinetics of the exchange of labile protons with water.  For 
the more slowly exchanging protons of the amide and sulfamate groups, the resonance line 
width measured at half of the peak height is proportional to the exchange rate constant (k). 
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Resonance line widths measured as function of temperature can be fit using the Eyring-
Polanyi equation (Eq. 1.1), allowing the extraction of the energy barrier (or activation 
energy), ΔG
‡
, associated with proton exchange as it will be discussed in Chapter 4. Protons 
with a significantly greater energy barrier compared to other structurally similar protons 
may be protected from exchange with solvent, for example by participating in an 
intramolecular hydrogen bond.58, 133-135  
1.4.3.3. Exchange spectroscopy for the direct measurement of proton exchange 
rates. Due to limits on how low a temperature can be reached in aqueous solution, the more 
rapid exchange of the amino and hydroxyl group protons with water precludes the accurate 
measurement of their exchange rate constants through line shape analysis. Luckily, the 
faster solvent exchange rates of the amino and hydroxyl protons put them in an exchange 
regime accessible by 2D exchange spectroscopy (EXSY). EXSY utilizes the NOESY pulse 
and detects the magnetization transfer between exchanging protons.115 The intensity of the 
EXSY cross peaks depends on the exchange rate, mixing time, and the longitudinal (T1) 
relaxation times of the exchanging nuclei. Plotting the EXSY cross peak volumes as 
function of mixing time generates a build-up curve from which exchange rates can be 
extracted by fitting to the Bloch equation modified to account for contributions of radiation 
damping to the longitudinal relaxation rate of the hydroxyl and amino protons.61 
Comparison of the exchange rates of similar protons can indicate participation in a 
hydrogen bond and/or a salt bridge (Chapter 3) 
 
 
33 
1.5. Conclusions 
The purpose of the research presented in this dissertation is the development of new 
methods and approaches for the structural characterization of GAGs in aqueous solution 
using NMR. The major focus of the work discussed in Chapter 2 is the preparation of 
unique GAG structures by enzymatic and chemical modifications. Mechanisms are 
proposed for the reactions used for modification of saccharides and an example of the 
process of structure elucidation of modified oligosaccharides by MS and NMR is also 
presented.  
The methods of chemical modification used in this research provided access to 
heparan sulfate oligosaccharides containing rare, unique, and important 3-O-sulfated 
glucosamine residues. In Chapter 3, temperature coefficients, exchange rates and pKa 
values for de-N-sulfated ArixtraTM are used to evaluate possibility of a salt bridge between 
the 3-O-sulfate and adjacent amino group of the central glucosamine residue.  
Chapter 4 explores the amide proton exchange properties of N-acetylated residues 
in GAG oligosaccharides. The dependence on oligosaccharide size, extent of sulfation, 
position of sulfation, glycosidic linkage, and type of sugar (GalNAc/GlcNAc and 
IdoA/GlcA) were investigated by employing temperature experiments and pH titrations. 
The chemically modified N-acetylated ArixtraTM  and N-acetylated GlcN3S facilitated this 
study and helped discern the effect of charge repulsion of hydroxyl ions by nearby 
negatively charged groups in the catalysis of amide proton solvent exchange. All 
experimental findings were further complemented by molecular dynamics simulations 
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using GLYCAM 06g force fields. Chapter 5 summarizes the work presented in this 
dissertation and provides an outlook for future research in GAG structural analysis. 
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CHAPTER TWO 
Chemical Modifications of GAGs 
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Abstract: In vivo, the enzymatic modification of heparan sulfate and heparin can introduce 
rare structural elements, for example 3-O-sulfated glucosamine residues. Understanding 
the way that these unique elements impact GAG structure and biological function are 
among the great challenges facing the fields of biology and chemistry. For example, the 
low abundance of these elements in GAG polysaccharides can make it challenging for 
researchers to obtain pure material from natural sources in the quantities necessary for 
structural and biological studies. The development of approaches to synthesize or modify 
GAG oligosaccharides can open up new avenues for the investigation of novel compounds. 
This chapter discusses methods for the chemical modification of GAG oligosaccharides. 
The investigations of the physico-chemical properties of the modified oligosaccharides 
through the properties of labile protons in amino and amide groups are presented in Chapter 
3 and 4, respectively. The solvolytic selective de-N-sulfation, chemoselective N-
acetylation, and reduction of oligosaccharides with sodium borohydride were successfully 
applied. Proposed reaction mechanisms with optimized conditions for unique chemical 
modifications are presented. The assessment of chemically modified oligosaccharide 
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structures was accomplished using ESI-MS and 1H NMR, and a detailed example of the 
structure elucidation process is provided. 
 
2.1. Introduction 
The enzymatic or chemical depolymerization of GAGs in conjunction with 
isolation strategies is an important approach for obtaining oligosaccharides from natural 
sources. For example, heparin is well known for its role as an anticoagulant in the 
antithrombotic physiological process, where it binds to the protease inhibitor antithrombin-
III.1-3 Naturally occurring unfractionated heparin (UFH) and its derivative low molecular 
weight (LMWH) heparin are two widely prescribed pharmaceuticals to treat thrombosis-
related medical conditions.4-7 Although these important drugs provide benefits for human 
health, both UHF and LMWH heparins can also cause adverse side effects.8 One of the 
life-threatening conditions associated with the administration of heparin is heparin-induced 
thrombocytopenia (HIT), caused by binding large polysaccharide chains to platelet factor 
4 (PF4).9-11 The undesired binding affinity of heparin to PF4 can be minimized by reduction 
of polysaccharide size.12 Consequently, LMWH obtained by enzymatic or chemical 
depolymerization of UFH has significantly reduced affinity to PF4.12 Unfortunately, the 
complete elimination of the problems associated with heparins binding to PF4 was not 
achieved using heparins from natural sources. Furthermore, additional problems with 
natural heparins arose from difficulties in controlling their purity and structural uniformity 
due to their size, polydispersity, and heterogeneity. In 2008, these problems were 
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exasperated by the heparin contamination crisis, caused by the adulteration of UFH with 
over-sulfated chondroitin sulfate.13-15  
Advances in synthesis of carbohydrates have offered an alternative way to generate 
a synthetic version of heparin.16, 17 In response to problems associated with natural 
heparins, a fully synthetic version of a biologically active heparin oligosaccharide was 
prepared and marketed as the pharmaceutical drug ArixtraTM. The structure of ArixtraTM 
mimics heparin’s pentasaccharide sequence required for high affinity antithrombin-III 
binding.18-20 Lacking long heterogeneous and polydispersed polysaccharide chains, the 
ArixtraTM pentasaccharide exclusively and selectively binds to antithrombin-III and 
deactivates factor Xa. The inhibited factor Xa interrupts the blood coagulation cascade and 
thus inhibits thrombin formation and thrombus development.19 Importantly, synthetic 
ArixtraTM completely eliminates problems associated with PF4 binding and HIT 
development.21, 22 Furthermore, the synthetic nature and small size of ArixtraTM  provides 
a great advantage in drug quality control. Its structure can be readily elucidated by MS and 
NMR, which is not the case with UFH and LMWH. As the ArixtraTM example 
demonstrates, difficulties associated with GAGs from natural sources can be resolved 
through the development of synthetic analogs of oligosaccharides with desired structural 
features. Furthermore, the design, synthesis, and chemical modifications of GAGs can be 
tailored for applications where selective binding is necessary.23-26 
Specific GAG-protein interactions are heavily reliant on the protein amino acid 
sequence and conformation as well as the microstructure of the GAG binding region. 
Therefore, investigation of the physico-chemical properties of GAGs is essential to 
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advancing our understanding of the structure-function relationship. Beyond the naturally 
occurring GAG motifs, chemical modifications of GAGs can impart changes in their 
physico-chemical and biological properties. In this Chapter, methods for the chemical 
modification of GAG oligosaccharides are discussed for the purpose of providing 
experimental access to structural elements that are rare in GAGs or are not found in nature. 
The physico-chemical properties of these modified oligosaccharides were investigated in 
aqueous solutions using NMR, with results discussed in detail in Chapters 3 and 4. 
Furthermore, because the modification of oligosaccharides involves chemical reactions, 
structure elucidation is essential to ascertain whether the modified structure is what was 
intended. An example highlighting the structure elucidation process for a modified GAG 
oligosaccharide is presented in this Chapter. 
 
2.2. Experimental Section 
2.2.1. Materials and Reagents. ArixtraTM (Fondaparinux sodium), formulated as 
prefilled syringes for clinical use, was obtained from the University Pharmacy and 
Department of Pharmacy Administration of Semmelweis University (Budapest, Hungary). 
Heparin tetrasaccharide (ΔUA2S-GlcNS6S-IdoA2S-GlcNS6S) ammonium salt (Catalog 
No. HO04) was purchased from Iduron Ltd. (Manchester, UK). Size-uniform fractions of 
chondroitin sulfate tetra- and hexasaccharides were isolated from a mixture of 
enzymatically depolymerized chondroitin sulfate A (see details in Sections 4.2.2. - 4.2.5). 
3-O-sulfated glucosamine (GlcN3S), cation exchange resin Dowex 50WX8 hydrogen form 
(50-100 mesh), 3-(trimethylsilyl)-1-propanesulfonic acid-d6 sodium salt (DSS-d6, 98% D), 
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35 wt% deuterated hydrochloric acid (DCl, 99% D), and 99.5% acetic anhydride were 
purchased from Sigma-Aldrich (St. Louis, MO). Methanol HPLC grade, pyridine, 12.1 N 
hydrochloric acid, 50% w/w sodium hydroxide solution, glacial acetic acid, and sodium 
borohydride were purchased from Thermo Fisher Scientific (Bellefonte, PA). Deuterated 
acetone (acetone-d6, 99.9% D), deuterium oxide (D2O, 99.9% D), 40% w/w sodium 
deuteroxide (NaOD, 99.5% D), deuterated dimethyl sulfoxide (DMSO-d6, 99.9% D), and 
the low temperature methanol standard were purchased from Cambridge Isotope 
Laboratories (Andover, MA). Ultrapure deionized water (18 MΩ/cm) was prepared using 
a Simplicity UV water purification system from Millipore (Billerica, MA). The pH meter 
calibration buffers 2.00, 4.00, 7.00, and 10.00 were purchased from Fisher Scientific 
(Nazareth, PA). All pH measurements were performed at room temperature using an AB 
15 Accumet Basic pH meter and a 9110DJWP double-junction Ag/AgCl micro pH 
electrode, both from Thermo Scientific (Chelmsford, MA). NMR tubes (NE-H5/3-Br) 
were purchased from New Era Enterprises (New Era Enterprises Vineland, NJ). Eppendorf 
1.5 mL safe-lock tubes were purchased from Eppendorf (Thermo Fisher Scientific). Size-
exclusion chromatography resin Sephadex G-10 was purchased from GE Healthcare - Bio 
Sciences (Pittsburgh, PA). 
2.2.2. Chemical modification of GAGs by solvolytic de-N-sulfation. The de-N-
sulfated oligosaccharides were prepared by a selective solvolytic de-N-sulfation reaction.27, 
28 All operations were performed in a cold room at 4 °C with materials pre-equilibrated to 
this temperature. A cation exchange column was prepared by packing Dowex 50 WX8 
cation exchange resin into a 1 cc plastic cartridge. The resin was converted to the hydrogen 
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form with 3 mL of 1M hydrochloric acid followed by conditioning with 3 mL of methanol 
and 5 mL of deionized water. About 6.0 mg of ArixtraTM sodium salt was dissolved in 200 
µL of deionized water and introduced onto the cartridge. The protonated form of ArixtraTM  
was eluted by washing three times with 1 mL aliquots of deionized water. The effluent was 
then neutralized with pyridine and freeze dried. The resultant light-brown ArixtraTM  
pyridinium salt was reconstituted in 400 µL of DMSO-d6 containing 5% deionized water 
and incubated at 50°C and 350 rpm for 90 min in Eppendorf ThermoMixer C (Thermo 
Fisher Scientific, Asheville, NC). The reaction was quenched by addition of 400 µL of 
deionized water followed by pH adjustment to 9.3 with 0.1 M sodium hydroxide. Volatile 
organic components of the mixture were removed by speed vacuum using Speedvac Savant 
SC 110 equipped with a refrigerator vapor trap RVT400 (Thermo Fisher Scientific, 
Asheville, NC) at medium heat for 3 h. The residual solution was diluted with 300 µL of 
deionized water and speed vacuumed for an additional 3 h and the remaining solution was 
lyophilized. The sample was purified by dissolving the solid in 400 µL of deionized water 
and passing it through a 1.6 x 70 cm desalting column packed with Sephadex G-10 
superfine resin using deionized degassed water as a mobile phase at a flow rate of 0.15 
mL/min. As a result, about 2.7 mg of dNSA sodium salt was recovered as a white powder, 
a 45% yield. This procedure was repeated to produce a second batch of dNSA with 2.6 mg 
recovered from the reaction of 5.8 mg of ArixtraTM.  Similarly, this reaction was used to 
de-N-sulfated 5.0 mg of heparin tetrasaccharide (ΔUA2S-GlcNS6S-IdoA2S-GlcNS6S) 
yielding 3.8 mg of de-N-sulfated heparin tetrasaccharide (dNSt, ΔUA2S-GlcN6S-IdoA2S-
GlcN6S), a 76% yield.  
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2.2.3. Chemical modification of GAGs by chemoselective N-acetylation. The N-
acetylated ArixtraTM  was prepared from the previously de-N-sulfated ArixtraTM sodium 
salt. The reaction procedure was developed and optimized starting with approaches 
elaborated by Danishefsky et al.29, Naik et al.30, Roseman et al.31 and Trombotto et al.32 
About 2.0 mg of dNSA was dissolved in 0.2 mL of 10% acetic acid, the pH of the solution 
was adjusted to 4.6 with 1M NaOH solution. Aliquots of 1.0 mL of MeOH and 14 µL of 
99.5% acetic anhydride were added into the solution. The resultant solution mixture was 
agitated, followed by overnight incubation at room temperature. The next morning, the 
mixture was placed into a speed vacuum at medium heat for 3 h to remove volatile 
components of the mixture. The residual solution after speed vacuum was diluted with 0.1 
mL of deionized water and lyophilized. The product was dissolved in 400 µL of deionized 
water and purified by passing the solution through a 1.6 x 70 cm desalting column packed 
with Sephadex G-10 superfine resin using deionized degassed water as a mobile phase at 
a flow rate of 0.15 mL/min. Finally, the collected fractions containing N-acetylated 
ArixtraTM  were combined and lyophilized. About 1.8 mg of white dry powder was 
recovered, a 90% yield. Using the same method was also prepared N-acetylated 3-O-
sulfated glucosamine (GlcNAc3S) from 1.75 mg of 3-O-sulfated glucosamine (GlcN3S).  
2.2.4. Chemical modification of GAGs by reduction with sodium borohydride. 
Chondroitin sulfate A tetra- and hexasaccharides were reduced with sodium borohydride. 
Approximately 77.0 mg of tetrasaccharide (ΔUA-GalNAc4S-GlcA-GalNAc4S) isolated 
from the enzymatic depolymerization reaction (Sections 1.2.1.1. and 4.2.2.) was dissolved 
in 1.5 mL of solution containing 1M sodium borohydride in 100 mM sodium hydroxide. 
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The resultant mixture was incubated overnight in Eppendorf ThermoMixer C at 50 °C. The 
reaction was quenched through the careful and slow addition of 40 µL of glacial acetic acid 
to avoid excessive effervescence from decomposing borohydride. The excess of 
borohydride and any reaction by-products were removed by cation exchange 
chromatography. The column was prepared by packing Dowex 50WX8 cation exchange 
resin into a 1 cc plastic cartridge and converting it to the hydrogen form with 3 mL of 1M 
hydrochloric acid followed by conditioning with 3 mL of methanol and 5 mL of deionized 
water. The sample was introduced onto the cartridge and the tetrasaccharide was eluted by 
washing three times with 1 mL aliquots of deionized water. The effluent was then 
neutralized with 1M NaOH solution and lyophilized. The final purification step was 
performed by dissolving the lyophilized solid in 400 µL of deionized water and passing it 
through a 1.6 x 70 cm desalting column packed with Sephadex G-10 superfine resin using 
deionized degassed water as a mobile phase at a flow rate of 0.15 mL/min. The collected 
fractions containing reduced tetrasaccharide were combined and lyophilized, yielding 64.5 
mg of lyophilized product. Similarly, 74.4 mg of an isolated chondroitin sulfate A 
hexasaccharide (ΔUA-GalNAc4S-GlcA-GalNAc4S-GlcA-GalNAc4S) was reduced by 
this procedure to yield 68.5 mg of lyophilized product. Additionally, the hyaluronic acid 
hexasaccharide (ΔUA-GlcNAc-GlcA-GlcNAc-GlcA-GlcNAc) was converted to the 
alditol by similar reduction reaction with sodium borohydride. 2.0 mg sample of the 
hyaluronic acid hexasaccharide was dissolved in 0.1 mL of solution containing 1M sodium 
borohydride in 100 mM sodium hydroxide. However, due to the problems with reduction 
of non-sulfated hyaluronic acid hexasaccharides leading to oligosaccharide degradation, 
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all steps of hyaluronic acid hexasaccharide reduction were performed in presence of 10 
mM phosphate buffer. After desalting, fractions containing hyaluronic acid 
hexasaccharides were combined and buffered with 10 mM phosphate followed by 
lyophilization to yielded 1.7 mg of product. Freeze dried samples then were stored at -80 
°C for future use. 
2.2.5. Solution preparation and ESI-MS measurements. About 2.7 mg of desalted 
de-N-sulfated ArixtraTM (dNSA) was dissolved in 500 µL of deionized water. An aliquot 
of 30 µL was transferred into a 1.5 mL Eppendorf safe-lock tube and diluted with 200 µL 
of solution composed of 30% methanol and 70% water, the remainder of the solution was 
lyophilized for subsequent NMR experiments. The sample solution was infused into a 
Micromass/Waters ESI quadrupole time-of-flight (Q-Tof micro) mass spectrometer 
(Waters Corporation, Millford, MA) at a flow rate of 10 µL/min. Data acquisition was 
performed using Masslynx 4.1 software and the mass spectrum was obtained in negative 
mode using the following instrumental parameters: capillary voltage, 3 kV; cone voltage, 
25 V; extractor voltage, 1 V; source temperature, 120 °C; desolvation temperature, 275 °C; 
interscan delay, 0.1 s and m/z range, 150 - 1000.  
2.2.6. Solution preparation and NMR measurements.  
2.2.6.1. Carbon-bound proton resonance assignments. About 2.6 mg of dNSA was 
dissolved in 1.5 mL of 10 mM phosphate buffer containing 6 µL of 100 mM DSS-d6 as a 
chemical shift reference (0.00 ppm) and freeze dried. To reduce the residual HOD peak, 
the sample was twice re-dissolved in 300 µL of 99.9% D2O and freeze dried. The resultant 
solid was dissolved in 1.5 mL of 99.9% D2O for NMR measurements. Aliquots of 300 µL 
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were transferred to three 1.5 mL Eppendorf tubes. The pD was of the solutions were 
adjusted to 1.77, 6.67, and 11.27 with 10 mM and 100 mM solutions of NaOD and DCl 
(prepared from concentrated solutions by dilution with appropriate volume of D2O). 
Solution pD values were calculated from pH meter readings measured in deuterated 
solvents (pH*) using Eq. 3.233, 34 (pD = pH* + 0.4). The pD-adjusted solutions were 
transferred to NE-H5/3-Br NMR tubes and 
1
H, 
1
H-
1
H COSY, 
1
H-
1
H TOCSY, and 
1
H-
1
H 
ROESY spectra were acquired using a Bruker Avance 600 MHz spectrometer operating at 
599.52 MHz and equipped with a BBI probe at 298.2 K. All spectra were acquired using a 
90° pulse of 9.10 - 9.27 µs with solvent suppression of the residual HOD resonance 
provided by presaturation at a power of 59 dB and relaxation delay of 2.0 s. All spectra 
were referenced to the 
1
H resonance of DSS-d6 (0.00 ppm). One-dimensional 
1
H NMR 
spectra were acquired using a spectral window of 6361 Hz and 112 scans coadded into 
42,014 complex points. These spectra were processed in 65,536 points using an exponential 
multiplication window function and 0.4 Hz line broadening. Phase-sensitive two-
dimensional COSY, TOCSY, and ROESY spectra were acquired in States-TPPI with a 
spectral window of 3597 Hz in both dimensions. COSY spectra were acquired into 2048 
complex points using 64 experiments, each with 416 coadded scans. TOCSY spectra were 
acquired using a mixing time of 120 ms with a 36 µs spinlock pulse at a power of 8.20 dB 
into 2048 complex points using 56 experiments, each with 416 coadded scans. ROESY 
spectra were acquired into 2048 complex points using 48 experiments, each with 512 
coadded scans. All two-dimensional spectra were zero filled to 4096 × 1024 data points 
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and apodized using a cos2 window function. All spectra were analyzed using Bruker 
TopSpin 3.2 software.  
2.2.6.2. Amino proton resonance assignment. The dNSA solution lyophilized after 
the ESI-MS measurements (Section 2.2.5.) was dissolved in 249 µL of deionized water and 
6 µL of 100 mM DSS-d6 solution added as a chemical shift reference (0.00 ppm). The pH 
of the solution was adjusted to 3.4 with 0.1 M HCl according to previously identified 
conditions suitable for amino proton detection.35 A 45 µL aliquot of acetone-d6  was added 
to provide a lock-signal and reduce the freezing point giving a final volume of 300 µL with 
a solvent composition of 85% H2O/15% acetone-d6. The solution was transferred into a 
NE-H5/3-Br NMR tube and 
1
H, 
1
H-
1
H TOCSY, and 
1
H-
1
H COSY spectra were acquired 
using the Bruker Avance spectrometer operating at 600.01 MHz equipped with a 5 mm 
TBI probe. All spectra were acquired at 259.1 K using a 90° pulse of 9.65 µs at a power 
level of -4.00 dB with solvent suppression provided by excitation sculpting. The one-
dimensional 
1
H NMR spectrum was recorded using a spectral window of 7788 Hz and a 
relaxation delay of 1.5 s with 256 scans coadded into 32,768 complex points.  The free 
induction decay (FID) was zero-filled to 65,536 points and apodized by multiplication with 
an exponential function equivalent to 0.5 Hz line broadening prior to Fourier 
transformation. Phase-sensitive COSY and TOCSY spectra were acquired into 2048 
complex points over 256 increments using States-TPPI using a 2.0 s relaxation delay and 
a spectral window of 8389 Hz in both dimensions. The COSY spectrum was recorded by 
coaddition of 128 scans while 88 scans were coadded for the TOCSY spectrum. The 
TOCSY spectrum was acquired using a mixing time of 120 ms with a 38 µs spinlock pulse 
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at a power of 6.77 dB. The COSY and TOCSY spectra were zero-filled to 4096 × 1024 
data points and apodized using a cos2 window function. 
 
2.3. Results and Discussion 
In this Chapter, we performed a series of chemical modification of oligosaccharides 
to provide experimental access to structural elements that are rare in GAGs or are not found 
in nature. In Chapters 3 and 4 these chemically modified structures will be investigated in 
aqueous solutions using NMR. Herein we describe chemical modifications of 
oligosaccharides by solvolytic de-N-sulfation, chemoselective N-acetylation and reduction 
of oligosaccharides using the mild reducing agent sodium borohydride. The structures of 
the resultant chemically modified oligosaccharides are elucidated by MS and NMR, and a 
detailed example of structure elucidation process is provided for de-N-sulfated ArixtraTM. 
Structures of other oligosaccharides were elucidated similarly, and the results are presented 
in Appendix. 
2.3.1. Solvolytic de-N-sulfation. The goal of the de-N-sulfation reaction is the 
selective removal of N-sulfo groups without incorporation of any other structural 
modifications, including de-O-sulfation or oligosaccharide chain degradation. To perform 
this task, a reaction initially introduced in 1960 by Inoue et al. for the selective solvolytic 
N-desulfation of intact heparin was adapted.27 A successful de-N-sulfation reaction 
requires two general considerations. First, the oligosaccharide sodium salt must be 
completely converted to pyridinium salt. Second, incubation of oligosaccharide pyridinium 
salt must be in a solution containing the right proportion of water in dimethyl sulfoxide 
59 
(DMSO). A solution with too high of water content will result in non-selective loss of sulfo 
groups from both N- and O-substituted positions.36 However, a reaction with water content 
that is too low will not proceed to completion and the final product will contain partially 
de-N-sulfated oligosaccharides.  
To the best of our knowledge, there is no proposed mechanism describing solvolytic 
de-N-sulfation. Figure 2.1 shows a possible reaction mechanism for de-N-sulfation by 
treatment of the ArixtraTM  pyridinium salt with DMSO containing 5% of water. The first 
step of the reaction involves conversion of the ArixtraTM sodium salt to a pyridinium salt, 
a step that is important for the following reasons. First, pyridinium salts more easily react 
than inorganic salts and therefore give higher yields of final products.37 Second, pyridinium 
ions act as counter ions to sulfate and carboxylate groups. A charge balance is necessary 
to stabilize negatively charged groups and prevent oligosaccharide from degradation 
during de-N-sulfation reaction.38 Finally, the solubility of the ArixtraTM pyridinium salt in 
DMSO is much higher than that of sodium salt.  
The first step of the reaction is the conversion of the ArixtraTM  sodium salt to the 
protic form by passing it through an acidified cation exchange column. The resulting 
solution is neutralized with pyridine and lyophilized to yield the pyridinium salt. Removal 
of the ArixtraTM  N-sulfo groups occurs rapidly following dissolution of the pyridinium salt 
in 95% DMSO/5% H2O and incubating the reaction mixture at 50 °C. 
The de-N-sulfation reaction most likely occurs through a SN2 (bimolecular 
nucleophilic substitution) mechanism. As depicted in Figure 2.1, a DMSO molecule has 
two resonance structures. A negatively charged oxygen in one of the two resonance  
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Figure 2.1. Schematic of the SN2 mechanism proposed for the solvolytic de-N-sulfation 
reaction of ArixtraTM.  
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structures acts as a nucleophile and attacks the partially positively charged sulfur atom of 
the N-sulfo group. The bond connecting the sulfur and nitrogen is broken and the nitrogen 
atom abstracts a proton from a water molecule. The addition of water into the reaction 
mixture quenches the reaction because in aqueous solutions, molecules of DMSO form 
solvation complexes with water molecules39 and lose their nucleophilic properties. 
Adjustment to pH 9 with sodium hydroxide deprotonates pyridinium and replaces pyridine 
by sodium ions as the counterion to negatively charged groups of dNSA. Pyridine than was 
removed with other volatile compounds by speed vacuuming at medium heat for 3 h. 
Visual inspection of the 
1
H NMR spectra of ArixtraTM  and dNSA shown in Figure 
2.2A and B, respectively, reveals that the de-N-sulfation reaction was successful with 
essentially 100% yield, converting ArixtraTM  to a completely de-N-sulfated form. Figure 
2.2A shows the spectrum of ArixtraTM before the reaction, with the clearly observable 
proton resonances of the three N-sulfo groups found within the chemical shift region of 5.5 
- 6.0 ppm. The doublets of the protons of the sulfamate groups disappear after the reaction, 
with three new singlets of the amino groups appearing in the region from 8.0 - 8.5 ppm of 
the dNSA spectrum (Figure 2.2B). To confirm that only de-N-sulfation occurred without 
any additional sulfate losses or side reactions, the successful chemical modification of 
ArixtraTM by solvolytic de-N-sulfation was confirmed through the complete structure 
elucidation procedure described in following Section 2.3.4. In addition to de-N-sulfation 
of ArixtraTM  a de-N-sulfated heparin tetrasaccharide was prepared using the same reaction 
conditions yielding the structure shown in Figure 3.1E of Chapter 3.   
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Figure 2.2. 1H NMR spectra of ArixtraTM acquired through the stages of its structural 
modification. (A) Spectrum of original N-sulfated pentasaccharide ArixtraTM acquired at 
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278.2 K in 90% H2O/10% D2O solution at pH 8.14. Doublets of the sulfamate group proton 
resonances are found in the region 5.5 - 6.0 ppm. (B) Spectrum of de-N-sulfated ArixtraTM 
acquired at 259.1 K in 85% H2O/15% acetone-d6 solution at pH 1.54 adjusted before 
acetone addition. Singlets of the amino group protons resonate downfield in the region 8.0 
- 8.5 ppm. (C) Spectrum of N-acetylated ArixtraTM acquired at 298.2 K in 90% H2O/10% 
D2O solution with pH 7.4. The amide group doublets are observed in the region 7.8 - 8.2 
ppm. Additionally, three characteristic amide group methyl proton singlets were observed 
around 2.0 ppm. The resonances arising from impurities are indicated by an asterisk.   
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2.3.2. Chemoselective N-acetylation. The de-N-sulfated ArixtraTM provided not 
only an heparan sulfate mimic oligosaccharide containing rare GlcN3S and GlcN3S6S 
residues (discussed in Chapter 3), it also served as the starting material for the synthesis of 
a unique N-acetylated motif for the investigation of the physico-chemical properties of the 
labile protons of amide groups (Chapter 4). Herein, a reaction for the chemoselective N-
acetylation of de-N-sulfated ArixtraTM was developed and optimized.29, 30 The reaction is 
driven by acetic acid that acts as catalyst for the bonding of acetyl groups to the free amines. 
An important component of the reaction is the opposite charges of the amino group and 
acetic acid. Therefore, the deprotonated acetic acid carboxylate and protonated amino 
promote fast and complete N-acetylation. For example, we observed that reactions 
performed at a solution pH lower than the acetic acid pKa drastically reduce the yields of 
N-acetylated products (by about 98%).  
The proposed reaction mechanism for the N-acetylation of dNSA is schematically 
depicted in Figure 2.3. The reaction is initiated by abstraction of a proton from the 
positively charged amino group by the deprotonated acetic acid. Simultaneously, the lone 
pair of the amine group nitrogen forms a bond with the carbonyl carbon of acetic anhydride, 
which in turn breaks the bond to the adjacent oxygen. The broken bond in acetic acid 
anhydride leaves the second part of the molecule, deprotonated acetic acid, with a negative 
charge on the oxygen atom. Extraction of the proton from the amide by the deprotonated 
acetic acid stabilizes the amide group. Chemoselective N-acetylation of oligosaccharides 
with free amino groups is preferred over other available methods for amine acetylation.40-
44 Reaction is simple and utilizes a green chemistry approach and therefore does not   
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Figure 2.3. Schematic mechanism proposed for the selective N-acetylation of dNSA. The 
reaction is catalyzed by acetic acid.   
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generate harmful waste. Furthermore, acetic acid, methanol, and unreacted acetic 
anhydride are volatile compounds and therefore can be easily removed through 
vaporization, facilitating the isolation of relatively pure end products.  
In Figure 2.2B and C show, respectively, the 1H NMR spectra of dNSA and the 
final product N-acetylated ArixtraTM  (NAcArixtra). Three amino proton singlets of dNSA 
appear in the 8.0 - 8.5 ppm in spectrum B. The spectrum recorded after the N-acetylation 
reaction (Figure 2.2C) shows three doublets belonging to the three-amide groups, 
resonating further upfield in the region 7.8 - 8.2 ppm. In addition, three characteristic 
singlet resonances of the amide group methyl protons are introduced in spectrum 2.2C 
around 2.0 ppm. The absence of additional methyl singlets confirms that O-acetylation of 
the hydroxyl groups, a possible side reaction, was avoided.  
2.3.3. Reduction with sodium borohydride. The reduction of monosaccharides 
with sodium borohydride is often applied in studies of polysaccharide structure.45 The 
reaction is designed to convert the aldose form of the reducing end monosaccharide to an 
alditol. Figure 2.4 shows the structure of a representative tetrasaccharide isolated after 
enzymatic digestion of chondroitin sulfate A with Chondroitinase ABC. In solution, the 
tetrasaccharide has two anomeric configurations, α and β, due to mutarotation at carbon 1 
(C1) of the reducing end residue. The α and β configurations result from cyclization of the 
acyclic form of the sugar (depicted using a Fisher projection formula) as shown in Figure 
2.4. Hemiacetals (depicted with a Haworth projection) are formed through an 
intramolecular interaction of the hydroxyl group at carbon 5 (C5) with the aldehyde group.  
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Figure 2.4. Schematic depiction of the cyclization of the reducing end monosaccharide 
residue of a chondroitin sulfate A tetrasaccharide. The acyclic form of the reducing end 
sugar is converted to a cyclic form by intramolecular reaction of the -OH group at C5 and 
the aldehyde group at C1. Red dashed circular arrows show rotation of groups attached to 
C4. Depending on the position of these groups, either an α or β anomer will be formed.   
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This cyclization creates a new chirality center at C1, the anomeric carbon. Depending on 
the position of the group attached to C4 (shown with red dashed arrows), two diastereomers 
can be formed.  
Configurations at C1 are not static, but are in constant dynamic equilibrium in 
aqueous solution, therefore, both configurations are observed simultaneously in the NMR 
spectrum.  In Figure 2.5, A1 is the NMR spectrum of the 4-O-sulfated tetrasaccharide with 
the sequence given in Figure 2.4. The inset of Figure 2.5 A1 shows the effect of the α and 
β anomeric carbon configurations on the amide methyl resonances. Though there is a 
minimal effect on the internal residues, the amide group methyl protons of the reducing 
end residue resonate at two frequencies, producing partially overlapped singlet resonances. 
The resonances of the other carbon-bound protons are severely overlapped in the region of 
the 1H NMR spectrum from 3.6-4.6 ppm complicating the identification of individual 
resonances. With increasing oligosaccharide size, the 1H NMR spectra become even more 
complex as observed in Figure 2.5 B1 for the 4-O-sulfated chondroitin sulfate 
hexasaccharide.  
One way to improve the quality of an oligosaccharide NMR spectrum is to “lock” 
the reducing end residue in one configuration by reduction of the aldose to an alditol using 
sodium borohydride, a relatively mild reducing agent. Under typical conditions, sodium 
borohydride does not reduce amides and carboxylic acids, which is important for GAGs. 
Mechanistically, the sodium borohydride reduction reaction proceeds through the two steps 
schematically depicted in Figure 2.6. In the first step, a nucleophilic hydride ion (H-) is 
transferred from borohydride to the electrophilic aldehyde carbon of the aldose forming an  
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Figure 2.5. 1H NMR spectra of 4-O-sulfated chondroitin sulfate oligosaccharides before 
(A1 and B1) and after (A2 and B2) reduction with sodium borohydride. A1 and A2 are 
spectra of the tetrasaccharide in Figure 2.4. B1 and B2 are spectra of the hexasaccharide 
(ΔUA-GalNAc4S-GlcA-GalNAc4S-GlcA-GalNAc4S). Due to mutarotation at the 
anomeric carbon, in A1 and B1 two sets of chemical shifts are observable in the NMR 
spectra for the α and β configurations of each oligosaccharide. The insets show the effect 
of mutarotation and reduction on the resonances of amide group methyl protons. Reduction 
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of the reducing end monosaccharide converts the α and β aldose configurations to an alditol 
and only one set of chemical shifts is present in NMR spectra A2 and B2.  
*- denotes resonances arising from impurities present in solution  
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alkoxide salt and borane. Then the basic alkoxide is protonated by acetic acid to form the 
alcohol. As the 1H NMR spectrum of the reduced 4-O-sulfated tetrasaccharide (Figure 2.5, 
A2) illustrates, elimination of the α and β anomers simplifies the NMR spectrum allowing 
easier identification of the resonances of each sugar residue. For example, the insets of 
Figure 2.5 A2 and B2 show that the amide group methyl resonances are converted to a 
single peak because there is only one possible configuration of the alditol. 
Although the sodium borohydride reduction also worked well for the chondroitin 
sulfate hexasaccharide (Haworth projection shown in Figure 4.1T, Chapter 4), extra care 
was required for the reduction of oligosaccharides derived from hyaluronic acid. As 
hyaluronic acid oligosaccharides do not have large sulfo groups capable of stabilizing 
negative charge, we found the reduced hyaluronic acid oligosaccharides to be less stable. 
The use of phosphate buffer in the reaction mixture during the reduction reaction and in all 
post-reaction steps was found to help stabilize the hyaluronic acid oligosaccharides.  
2.3.4. Structure elucidation of de-N-sulfated ArixtraTM. The successful outcome 
of a chemical reaction can only be reported after elucidation of the complete structure of 
the product. In this section, the structure elucidation process is illustrated for de-N-sulfated 
ArixtraTM. This general approach was applied to all the isolated and chemically modified 
oligosaccharides used in this dissertation. For those compounds not discussed explicitly in 
Chapters 2-4, tables with the resonance assignments are provided in the Appendix. 
2.3.4.1. Electrospray ionization – mass spectrometry. Electrospray ionization – 
mass spectrometry (ESI-MS) is commonly used at the initial stages of the oligosaccharide 
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Figure 2.6. Reduction of the chondroitin sulfate A tetrasaccharide with sodium 
borohydride. The reducing end aldose is converted to alditol form eliminating the α and β 
anomers.   
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structure elucidation process. This soft ionization source produces molecular ions with 
little fragmentation while the MS analyzer produces a spectrum showing ion abundance as 
a function of mass-to-charge ratio (m/z). The mass spectrum provides rapid determination 
of the molecular weight, degree of sulfation, and possible acetylation of oligosaccharides.  
Figure 2.7 shows the ESI mass spectrum of dNSA with the peak assignments. The 
calculated expected mass of dNSA is 1267.08 U. The doubly (m/z 632.54), triply (m/z 
421.40), and quadruply (m/z 315.84) charged molecular ions were observed, and as 
expected, the higher charged molecular ions were more prone to sulfate loss (-80 Da). For 
example, loss of a sulfate group from the triply charged molecular ion corresponds to a m/z 
difference of 26.66 producing the peak at m/z 394.78. Similarly, m/z 19.99 separates 
quadruply charged ion peaks with (m/z 295.85) and without (m/z 315.84) sulfate loss. 
Because dNSA was prepared as the sodium salt and the sample was infused directly into 
the ESI-MS, molecular ions were also accompanied by sodium adducts. Analysis of the 
mass spectrum revealed that chemical modification of ArixtraTM  did not affect the carbon 
backbone of pentasaccharide and that only sulfate groups were released during the reaction. 
ESI-MS results for the de-N-sulfated heparin tetrasaccharide (Figure A1) and NAcArixtra 
(Figure A2) can be found in Appendix. 
2.3.4.2. Nuclear magnetic resonance spectroscopy. Though the MS is critical for 
confirming the basic structure of oligosaccharides, nuclear magnetic resonance (NMR) 
provides complementary information about oligosaccharide structure and structure-
function relationships, physicochemical properties and dynamics. 1H NMR is an essential  
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Figure 2.7. Mass spectrum of dNSA obtained using an ESI Q-TOF mass spectrometer 
operating in negative ionization mode. The loss of sulfate and the presence of sodium 
adducts is common in analysis of GAG oligosaccharides by ESI-MS. The expected mass 
of dNSA in 1267.08 U was confirmed by mass spectrometry.   
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tool for GAG characterization due to its high natural abundance and gyromagnetic ratio, 
and spin of ½. Furthermore, hydrogen is one of the most abundant elements in GAGs and 
proton NMR chemical shifts, coupling constants and resonance line widths can report on 
small changes in GAG structure and conformation, especially at high magnetic fields.  
2.3.4.2.1. One-dimensional proton NMR spectra. The process of GAG structure 
elucidation typically begins with acquisition of the one-dimensional (1D) 1H NMR 
spectrum of negatively charged GAG oligosaccharides, typically measured in phosphate 
buffer at neutral pH to ensure that all the carboxylates have been deprotonated and chemical 
shifts are stable. Additionally, EDTA-d16 is often added to remove the line broadening 
associated with the presence of trace paramagnetic species in solution.34, 46, 47 
The 1H NMR spectra of GAGs have several common characteristics associated with 
specific elements of structure. For example, the singlet resonances between 1.8 and 2.2 
ppm are characteristic of the N-acetyl methyl protons, as observed in Figure 2.3C and 
Figure 2.5. Most of the protons of the sugar rings resonate in the region between 2.5 and 
4.6 ppm. Because of the limited chemical shift dispersion of sugars in this region, the 
resonances are highly overlapped and resolution of individual resonances is difficult for 
oligosaccharides of even modest length. Further downfield between about 4.6 and 6.0 ppm, 
the anomeric proton resonances are better resolved, as are the distinctive peaks of the H4 
protons of the unsaturated uronic acid residues (ΔUAs), along with the hydroxyl, and 
sulfamate group protons. Finally, the most downfield resonances are produced by the 
protons of amide and amino groups, which typically have chemical shifts between 6.8 ppm 
and 9.0 ppm. The labile protons of hydroxyl, sulfamate, amide, and amino groups require 
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special conditions for detection and are not observed in spectra acquired in D2O due to 
their exchange with deuterium. The assignment of the dNSA amino protons resonances 
will be discussed separately in the following sections.  
The 1D 1H NMR spectrum of dNSA (Figure 2.8B) was measured in D2O solution 
using phosphate buffer and referenced to zero ppm with a DSS-d6 internal standard. The 
spectrum was acquired using the presaturation pulse sequence to suppress the solvent 
resonance arising from residual protons of HOD.48 This pulse sequence is composed of 
only three major pulse components: a long selective pulse to saturate the solvent resonance, 
a non-selective pulse for excitation and the acquisition of FID. One of the problems with 
presaturation is that analyte resonances close to the solvent frequency are also attenuated, 
therefore, care should be used in selection of the presaturation power. Inspection of the 1H 
NMR spectrum of dNSA allows one to immediately identify the residual HOD resonance 
at 4.8 ppm and the methoxy group protons (-OCH3) at 3.41 ppm. Additionally, the 
spectrum reveals the resonances of low level impurities (labeled with an *). Although the 
600 MHz 1H NMR spectrum of dNSA contains multiple well-resolved resonances, the 
spectra still suffer from limited chemical shift dispersion in the region between 2.5 and 4.6 
ppm. Consequently, definitive resonance assignments require homonuclear two-
dimensional (2D) NMR experiments as described in the following section.49 
2.3.4.2.2. Homonuclear two-dimensional proton NMR spectroscopy. Fortunately, 
the overlapped peaks of the 1D spectrum can be readily assigned using a set of 2D 
homonuclear (1H-1H) NMR experiments. Three 2D experiments are generally used for the 
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Figure 2.8. (A) The Haworth projection of de-N-sulfated ArixtraTM (dNSA) with labeled 
residues and numbered carbon-bound protons within each residue. For example, the carbon 
labeled with number 1 in the following sections is referred to as C1, the proton bound to 
this carbon is referred to as H1, and so on. (B) The 1H NMR spectrum of dNSA acquired 
in D2O.  
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structure elucidation of oligosaccharides: the total correlation spectroscopy (TOCSY), 
correlation spectroscopy (COSY), and rotating-frame nuclear Overhauser effect 
spectroscopy (ROESY) experiments.50-53 Structure elucidation of GAG oligosaccharides 
by 1H-1H NMR usually begins with acquisition of the TOCSY and COSY spectra. The 
purpose of these experiments is to identify the individual monosaccharide subunits in the 
oligosaccharide chain using scalar couplings to provide through-bond connectivity.54 
Finally, dipolar coupling employed in the ROESY experiment completes the structure 
elucidation  process by establishing connectivity across the glycosidic linkage.  
Monosaccharides are the major constituents of oligosaccharides linked through a 
glycosidic bond. Consequently, each monosaccharide represents an individual isolated spin 
system that can be identified through the cross-peaks of a 1H-1H TOCSY spectrum.54 The 
length of the TOCSY mixing time should be sufficient for magnetization transfer from the 
anomeric proton (H1) to the furthest separated carbon-bound protons (H6) of a 
monosaccharide ring. In practice, 120 ms allows for transfer of magnetization throughout 
the spin system. The spin lock pulse length requires calibration and varies for each 
experiment, though typical values fall in the range of 35 - 45 µs for spectrometers operating 
at a 1H frequency of 600 MHz. 
In the 1H-1H TOCSY spectrum, the diagonal peaks running from the top right to 
the bottom left corner are the equivalent of the proton spectrum. The off-diagonal cross-
peaks correspond to the chemical shifts of the other protons within that spin system. Figure 
2.9A shows the TOCSY spectrum of dNSA in which the five spin systems of the individual 
monosaccharides of the dNSA sequence are identified. Identification of each residue starts   
79 
 
Figure 2.9. (A) 1H-1H TOCSY and (B) 1H-1H COSY spectra of dNSA acquired in D2O. 
Five spin systems of dNSA were identified through TOCSY cross-peaks aligned along the 
F2 dimension. Assignment of the individual resonances of each monosaccharide spin 
system was performed using the COSY cross-peaks as illustrated for the GlcN6S(V) 
residue. The one-dimensional 1H NMR spectrum is included along both dimensions of the 
contour plot.  
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with recognition of their well-resolved H1 resonances. Then, the cross-peaks are traced to 
other protons found within the same spin system. Monosaccharides belonging to the uronic 
acid (GlcA or IdoA2S) and GlcN residues (GlcN6S and GlcN3S6S) can be distinguished 
from each other based on the number of cross-peaks found in each spin system. For 
instance, GlcN residues contain 7 cross-peaks that correspond to 7 protons of this spin 
system. In contrast, GlcA and IdoA2S residues contain only 5 cross-peaks corresponding 
to 5 carbon-bound protons of their sugar rings.  
Once each type of monosaccharide residue has been identified, the structure 
elucidation process proceeds to determine the chemical shifts of the individual proton 
resonances found within the same spin system. The 1H-1H COSY experiment allows 
identification of protons coupled through 3-bonds (typically).55 Figure 2.9B shows a 1H-
1H COSY spectrum acquired in D2O by using a COSY pulse sequence with presaturation.  
Similarly to TOCSY, the COSY spectrum contains diagonal peaks running from the top 
right to the bottom left corners of the spectrum with cross-peaks relating coupled spins. 
Starting with an H1 chemical shift along the diagonal, the correlations are followed through 
the cross-peak to the coupled H2, which can then be traced similarly to the H3 cross-peak, 
and so on. The COSY spectrum shown in Figure 2.9B illustrates the cross-peak correlations 
for the protons within GlcN6S(V). Similarly, correlated protons are found for the spin 
systems of the other four monosaccharide residues. 
Using the TOCSY and COSY spectra the chemical shifts of all the protons of the 
dNSA monosaccharide rings were identified. However, complete structure elucidation 
requires determination of the monosaccharide sequence. This task can be accomplished  
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through execution of the NMR experiments that provide information about the spatial 
proximity of protons. The Homonuclear rotating frame Overhauser spectroscopy (1H-1H 
ROESY) is a good option, especially for medium-sized oligosaccharides like the dNSA 
pentasaccharide. ROESY is a variation of the nuclear Overhauser effect spectroscopy 
(NOESY) pulse sequence with both experiments utilizing the nuclear Overhauser effect 
(NOE), a phenomenon relying on dipolar relaxation of spins localized within about 5 Å.56 
In the NOESY spectrum, the sign of the NOE depends on the product of the spectrometer 
frequency, , and the rotational correlation time, c, which is related to the rate of molecular 
tumbling in solution.57 NOEs are positive for small, rapidly tumbling molecules and 
negative for large, slowly tumbling molecules. The NOE intensity passes through zero 
when the molecular reorientation lies between these two motional extremes.  Because the 
ROE evolves in the rotating frame of reference, all molecules give rise to positive ROE 
cross-peaks that are opposite in sign to the diagonal.56   
In the structure elucidation process, analysis of the ROESY spectrum builds on the 
assignments made using the TOCSY and COSY spectra. Figure 2.10 shows the ROESY 
spectrum of dNSA, where the diagonal peaks are shown in pale red and dipolar coupled 
protons in purple. Because protons coupled through 3 bonds are also close in space, there 
is some overlap between intramolecular ROESY cross-peaks and those observed in the 
COSY spectrum. By overlaying the two spectra, the inter-residue ROESY cross-peaks 
between the H1 and H4 protons across the glycosidic bond can be identified (Figure 2.10) 
and used to elucidate the oligosaccharide sequence. Table 2.1 provides the assigned 
chemical shifts of all the carbon-bound protons of dNSA.  
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Figure 2.10. The 1H-1H ROESY spectrum of dNSA acquired in D2O. Cross-peaks in the 
ROESY spectrum correlate protons coupled through the space within about 5 Å. 
Identification of the inter-residue cross-peaks between sequential residues GlcN6S(V) H1-
H4 GlcA(IV), GlcA(IV) H1-H4 GlcN3S6S(III), GlcN3S6S(III) H1-H4 IdoA2S(II), 
IdoA2S(II) H1-H4 GlcN6S(I), and GlcN6S(I) H1- CH3 confirms the sequence and 
completes the resonance assignment process. The one-dimensional 1H NMR spectrum is 
included along both dimensions of the contour plot.  
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Table 2.1. Proton assignments in dNSA. All protons chemical shifts were assigned using 
1D spectra, except those labeled with * which were assigned using COSY spectra. Carbon-
bound protons are assigned from NMR spectra acquired at 298.2 K in 10 mM phosphate 
buffer with pD 11.27. Amino proton chemical shifts are assigned from spectra acquired at 
259.1K in 85% H2O/15% acetone-d6 solution with solution pH 3.4 measured before 
acetone-d6 addition. 
Residue Proton 1H Chemical shift, ppm 
GlcN6S(I) 1 4.735 
 2 2.741 
 3 3.59* 
 4 3.63* 
 5 3.989 
 6 4.25* 
 6’ 4.37* 
 -CH3 3.411 
 -NH3
+ 8.393 
IdoA2S(II) 1 5.188 
 2 4.282 
 3 4.16* 
 4 4.07* 
 5 4.842 
GlcN3S6S(III) 1 5.083 
 2 2.932 
 3 4.34* 
 4 3.89* 
 5 4.06* 
 6 4.21* 
 6’ 4.499 
 -NH3
+ 8.054 
GlcA(IV) 1 4.588 
 2 3.39* 
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 3 3.741 
 4 3.815 
 5 3.74* 
GlcN6S(V) 1 5.436 
 2 2.689 
 3 3.545 
 4 3.472 
 5 3.88* 
 6 4.14* 
 6’ 4.36* 
 -NH3
+ 8.336 
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The resonance assignments of the purchased, isolated and chemically modified mono- and 
oligosaccharides used in this research were determined using a similar process and are 
reported in the Appendix.  
Unlike carbon-bound protons, the GAG amino, amide, sulfamate, and hydroxyl 
protons are in dynamic exchange with water. As described in Section 1.4.2. the detection 
of labile protons by NMR requires the use of solution conditions that minimize the 
exchange rate. The conditions for detection of the amino proton resonances have been 
previously reported and involve measurements in low pH aqueous solution at reduced 
temperature.35  
The assignment of the amino resonances builds on the assignments of the carbon-
bound protons and uses the information contained in the 1H, 1H-1H TOCSY, and 1H-1H 
COSY spectra. Through the TOCSY spectrum, the spin system to which amino proton 
belongs can be identified and the COSY spectrum confirms the amino proton scalar-
coupling to the adjacent carbon-bound proton H2. Figure 2.11 A and B show the TOCSY 
(A) and COSY (B) spectra of dNSA acquired in 85% H2O/15% acetone-d6 at 259.1K with 
the 1D 1H NMR spectrum drawn along each dimension of the contour plot. All spectra 
were acquired using excitation sculpting as the solvent suppression method.58 Excitation 
sculpting is preferred over presaturation for measurements of labile protons to avoid 
saturation of the resonances of interest via exchange with water. In addition, the use 
presaturation with aqueous solutions can produce baseline distortions in the resulting 
spectra. In contrast, with excitation sculpting, which utilizes pulsed field gradients and 
shaped selective pulses, much flatter baselines are obtained.   
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Figure 2.11. Homonuclear (A) TOCSY and (B) COSY spectra of dNSA acquired in 85% 
H2O/15% acetone-d6 at 259.1 K. Through the cross-peak linkages the amino proton 
resonances were assigned to corresponding glucosamine residues. The one-dimensional 1H 
NMR spectrum is included along both dimensions of the contour plot.  
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The chemical shifts of the amino proton resonances of dNSA are found in the region of the 
spectrum from 7.9 to 8.5 ppm and are summarized in Table 2.1. At this point, the structure 
of dNSA is completely elucidated and the carbon- and nitrogen-bound 1H NMR resonances 
have been assigned. A similar process was used for the resonance assignments of the 
purchased, isolated and modified mono- and oligosaccharides used in this research and 
tables containing the resonance assignments for the amino and amide proton resonances of 
each compound are given in the Appendix.  
 
2.4. Conclusions 
In this chapter, to provide access to rare but biologically important elements of 
structure in GAG polysaccharides, reactions for chemical modification of ArixtraTM and 
isolated GAG oligosaccharides were developed. Through the solvolytic de-N-sulfation of 
the synthetic ArixtraTM pentasaccharide, the unique structure of de-N-sulfated ArixtraTM 
(dNSA) was obtained mimicking the structure of rare heparan sulfate oligosaccharides 
containing a 3-O-sulfated glucosamine residue. This de-N-sulfated ArixtraTM is used in 
Chapter 3 to study the possibility of salt bridge formation involving the positively charged 
amino group and the adjacent negatively charged 3-O-sulfo group of the GlcN3S6S(III) 
residue. Furthermore, through the chemoselective N-acetylation reaction dNSA was further 
modified to an N-acetylated version of ArixtraTM (NAcArixtra). The comparison of the 
properties of ArixtraTM, dNSA and NAcArixtra in Chapter 3 provides insights into the role 
of primary structure in stabilizing the hydrogen bonds in ArixtraTM and a salt bridge in 
dNSA. NAcArixtra was also used in Chapter 4 to investigate the exchange properties of 
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the amide group protons in aqueous solution at the physiologically important pH 7.4. 
Importantly, we believe this to be the first report of the preparation and characterization of 
dNSA and NAcArixtra. 
Finally, the reaction of oligosaccharides with sodium borohydride converted the 
aldose form of the reducing end residue, which exists as α and β anomers to the alditol 
form simplifying the resulting NMR spectrum. Oligosaccharides derived from chondroitin 
sulfate A and hyaluronic acid were reduced using this method and the properties of their 
amide protons are discussed in Chapter 4. Proposed reaction mechanisms for the solvolytic 
de-N-sulfation, chemoselective N-acetylation, and reduction with borohydride were 
presented. Importantly, the structures of all chemically modified oligosaccharides were 
elucidated using ESI-MS and NMR. A detailed example of the structure elucidation 
process was provided for dNSA, and tables summarizing the chemical shifts of the 
purchased, isolated and modified mono- and oligosaccharides are summarized in Chapters 
3 and the Appendix.  
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CHAPTER THREE 
Probing Salt Bridges in GAGs: A Structural Role for 3-O-Sulfated Glucosamine in a 
Model HS Oligosaccharide 
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Abstract: Although 3-O-sulfated glucosamine residues are rare but important elements of 
heparan sulfate (HS), the functional and structural roles of this residue remain largely 
unexplored. In this chapter, a model HS oligosaccharide was synthesized by the selective 
chemical removal of the N-sulfo moieties from the ArixtraTM pentasaccharide to produce 
de-N-sulfated ArixtraTM (dNSA). The resultant zwitterionic dNSA can carry up to seven 
charges simultaneously and provides an excellent substrate to examine the potential for salt 
bridge formation in HS. Measurement of the amino proton temperature coefficients and 
exchange rates, in addition to comparison of the carboxylate and amino pKa values for 
ArixtraTM and dNSA, provided evidence of salt bridge existence between the positively 
charged amino group and adjacent negatively charged 3-O-sulfo group in the central 
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glucosamine residue of dNSA. Evidence is also presented that suggests a possible salt 
bridge with the carboxylate moiety of the 2-O-sulfo iduronic acid carboxylate group in its 
ionized form. The experimental findings were supported by 300 ns molecular dynamics 
(MD) simulation results. 
 
3.1. Introduction 
The glycosaminoglycan (GAG) heparan sulfate (HS) is a linear polysaccharide 
consisting of 1,4 - linked repeating disaccharide units with alternating α-D-glucosamine 
(GlcN) and uronic acid residues (β-D-glucuronic acid (GlcA) or α-L-iduronic acid 
(IdoA)).1 Structurally, HS is closely related to heparin but is distinguished by the 
composition of its major repeating disaccharide units and the ratio of sulfate groups per 
disaccharide unit (sulfate/hexosamine ratio).1-4 HS has a 0.8 - 1.8 sulfate/hexosamine ratio 
with GlcA-GlcNAc as the major repeating disaccharide unit comprising 40 - 60% of the 
polymer length, whereas heparin has 1.8 - 2.6 sulfate groups per disaccharide unit and the 
tri-sulfated IdoA2S-GlcNS6S comprises over 70% of the polysaccharide.1-4 Moreover, HS 
has greater variability with the regions of high and low sulfation.1, 5 A high degree of 
microheterogeneity is introduced into the HS structure by various enzyme complexes 
during biosynthetic polymeric chain elongation.1, 6-8 As a result, GlcN residues can be N-
acetylated (GlcNAc) or N-sulfated (GlcNS), while β-D-glucuronic acid (GlcA) can be 
epimerized to α-L-iduronic acid (IdoA). Furthermore, the activity of different classes of 
sulfotransferases makes HS even more complex and highly negatively charged by the 
insertion of sulfo groups at carbons 2, 3, and 6.1, 6-9 
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In organisms, HS is covalently attached to multiple core proteins (proteoglycans) 
and is localized on the cell membranes, in the extracellular matrix, and in secretory 
vesicles.1, 6, 10 HS is involved in the regulation of many essential life processes through its 
interactions with a variety of protein ligands.2, 6, 9-12 As mentioned in Chapter 1, the 
polysaccharide chains of the HS proteoglycan localized on the cell surface13-15 can non-
specifically bind to the herpes simplex virus type 1 (HSV-1) viral glycoproteins gB and 
gC.16, 17 However, for further entry of HSV-1 into the cell, fusion between the viral envelop 
and cell membrane is required, which can occur through specific binding of viral 
glycoprotein gD with a 3-O-sulfated glucosamine (GlcN3S) residue confined within the 
HS polysaccharide chain.13-15 For instance, HS polysaccharide chains containing 
disaccharides composed of IdoA2S-GlcN3S and IdoA2S-GlcN3S6S were reported as 
possible mediators of HSV-1 entry.18 
 Importantly, the glucosamine 3-O-sulfo group, which is critical for binding, is 
generated through the action of 3-O-sulfotransferase isoform 3 (3-OST-3), which inserts a 
sulfate at the 3-OH position of a N-unsubstituted glucosamine residue linked to a 2-O-
sulfated iduronic acid (IdoA2S). Multiple studies have reported that incorporation of 3-O-
sulfo groups in a polysaccharide sequence defines the activity of HS in many biological 
processes.19-24 
Because GlcN3S residues are rare elements in HS polysaccharides, their structural 
role is largely unknown.24 Nevertheless, there are at least seven isoforms of 3-O-
sulfotransferase (3-OST) complexes, including 3-OST-3 mentioned above, responsible for 
the addition of sulfates to the 3-OH position in glucosamine residues (including N-sulfated 
98 
glucosamines).6, 8, 9, 25 Only two of these isoforms are responsible for production of the 
antithrombin-binding sequence, whereas the remaining five isoforms generate sequences 
that facilitate ligand binding distinct from the antithrombin-binding motif.6, 9, 25  
From the best studied heparin-antithrombin complexes, it is known that the high 
affinity binding of heparin to antithrombin III is driven by a specific sequence of 
monosaccharide residues and sulfation patterns, including a required 3-O-sulfo group 
localized in the central N-sulfo glucosamine residue.26-28 However, only recent studies of 
the synthetic pentasaccharide ArixtraTM (fondaparinux sodium) revealed that a central N-
sulfated glucosamine sulfamate proton (-NHSO3
-
) is involved in a hydrogen bond with the 
adjacent 3-O-sulfo group,29 suggesting that such structural features of the polysaccharide 
may have an important role in pre-organizing the secondary structure for its interaction 
with protein ligands.  
Given this context, it is of great importance to continue exploring the structure-
function relationships of GAGs. In this chapter, the possibility of salt bridge formation 
between the negatively charged 3-O-sulfo group and the positively charged glucosamine 
amino group is examined. This non-covalent interaction might be important for pre-
organizing HS secondary structure for protein recognition. Moreover, understanding the 
conditions that promote salt bridge formation could provide insights into the role of 
GlcN3S in HS and in its interactions with proteins, especially as efforts for the in vitro 
synthesis of novel oligosaccharide structures continue to advance.30-33  
Previously, a report from our laboratory described an unsuccessful attempt to 
identify and characterize a possible salt bridge involving the amino group and adjacent 3-
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O-sulfo group in the 3-O-sulfated glucosamine (GlcN3S) monosaccharide.34 Nevertheless, 
this work laid the foundation for the current work. To the best of our knowledge, there have 
been no other previous studies to probe a salt bridge formation in GAG oligosaccharides. 
In an attempt to characterize the salt bridge involving the GlcN3S residue, we adapted the 
idea that the salt bridge can potentially resemble a combination of electrostatic attraction 
between a negatively charged 3-O-sulfo group and a positively charged amino group, on 
the one hand, and hydrogen bonding involving a 3-O-sulfo group oxygen and an amino 
group hydrogen, on the other. The difficulty of isolating a GlcN3S containing HS 
oligosaccharide in sufficient quantities for these experiments was overcome by chemical 
modification of the synthetic antithrombotic drug ArixtraTM. The lack of available 
reference data for salt bridges in GAGs was resolved by comparison with an N-sulfated 
heparin tetrasaccharide, which was chemically modified through a similar reaction as used 
for the de-N-sulfation of ArixtraTM. The heparin tetrasaccharide was selected because it has 
a structure similar to ArixtraTM but is lacking the 3-O-sulfo group. Therefore, it provided 
an excellent reference for the comparison of physico-chemical properties.  
In addition to the de-N-sulfation of ArixtraTM, ArixtraTM was also selectively N-
acetylated, as described in Chapter 2, converting the sulfamates to amides groups. The 
molecular stability of ArixtraTM allowed the preparation three structural analogs differing 
only in the substituents on the glucosamine nitrogen: the original N-sulfated ArixtraTM, de-
N-sulfated ArixtraTM, and N-acetylated ArixtraTM. These three structures provide a unique 
opportunity to investigate and compare the molecular properties of oligosaccharides 
differing only in their N-substituents. Importantly, work in this dissertation lays the 
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groundwork for many other opportunities offered by these pentasaccharides ranging from 
structural to biological studies.  
 
3.2. Experimental Section 
3.2.1. Materials and Reagents. Heparin tetrasaccharide ammonium salt (Catalog 
No HO04) was purchased from Iduron Ltd. (Manchester, UK). ArixtraTM (Fondaparinux 
sodium), formulated as prefilled syringes for clinical use, was obtained from the University 
Pharmacy and Department of Pharmacy Administration of Semmelweis University 
(Budapest, Hungary). Cation exchange resin Dowex 50WX8 hydrogen form (50 - 100 
mesh), 3-(trimethylsilyl)-1-propanesulfonic acid-d6 sodium salt (DSS-d6, 98% D), ACS 
grade dimethyl sulfoxide (DMSO), and 35 wt% deuterated hydrochloric acid (DCl, 99% 
D) were purchased from Sigma-Aldrich (St. Louis, MO). Methanol HPLC grade, pyridine, 
12.1 N hydrochloric acid, and 50% w/w sodium hydroxide solution were purchased from 
Thermo Fisher Scientific (Bellefonte, PA). The size-exclusion chromatography resin 
Sephadex G-10 was purchased from GE Healthcare - Bio Sciences (Pittsburgh, PA). 
Deuterated acetone (acetone-d6, 99.9% D), deuterium oxide (D2O, 99.9% D), 40% w/w 
sodium deuteroxide (NaOD, 99.5% D), and the low temperature methanol standard were 
purchased from Cambridge Isotope Laboratories (Andover, MA). The pH meter calibration 
buffers 2.00, 4.00, 7.00, and 10.00 were purchased from Fisher Scientific (Nazareth, PA). 
Ultrapure deionized water (18 MΩ/cm) was prepared by the Simplicity UV water 
purification system from Millipore (Billerica, MA). All pH measurements were performed 
at room temperature using an AB 15 Accumet Basic pH meter and 9110DJWP, a double-
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junction Ag/AgCl micro pH electrode, both from Thermo Scientific (Chelmsford, MA). 
NMR NE-H5/3-Br tubes were purchased from New Era Enterprises (New Era Enterprises 
Vineland, NJ). Eppendorf 1.5 mL safe-lock tubes were purchased from Eppendorf (Thermo 
Fisher Scientific). 
3.2.2. Preparation of chemically modified oligosaccharides. The de-N-sulfated 
ArixtraTM (dNSA) and de-N-sulfated heparin tetrasaccharide (dNSt) were prepared 
according to the procedure described in Section 2.2.2. Two batches, 2.7 mg and 2.6 mg, of 
dNSA were prepared from 6.0 mg and 5.8 mg of ArixtraTM, respectively. Additionally, 3.8 
mg of dNSt was prepared from 5.0 mg of the heparin tetrasaccharide.1.8 mg of N-
acetylated ArixtraTM (NAcArixtra) was prepared from 2.0 mg of dNSA according to the 
procedure described in Section 2.2.3. 
3.2.3. Solution preparation and NMR measurements 
3.2.3.1. Carbon-bound proton resonance assignments. The chemical shift 
assignments of the carbon-bound protons in dNSA were performed according to procedure 
described in Section 2.2.6.1. The carbon-bound proton chemical shifts of dNSt were 
assigned using a similar strategy, with the key difference being that the spectra of dNSt 
were acquired using a Bruker Avance spectrometer operating at 599.88 MHz and equipped 
with a 5 mm TBI probe. Chemical shifts assignments for NAcArixtra were performed 
according to procedure described in Section 4.2.10.1 
3.2.3.2. Amino proton resonance assignment. The chemical shift assignments of the 
amino protons of dNSA were performed according to the procedure described in Section 
2.2.6.2. Similarly, spectra of dNSt were acquired using a Bruker Avance spectrometer 
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operating at 599.88 MHz equipped with a 5 mm TBI probe. The solution pH was adjusted 
to 1.6 and the spectra were acquired at 259.5 K. 
3.2.3.3. Rates of chemical exchange and temperature coefficient measurements. 
The freeze-dried dNSA sample used for amino proton resonance assignments (Section 
2.2.6.2.) was dissolved in 600 µL of deionized water and split equally into two 1.5 mL 
Eppendorf tubes. At room temperature, the pH of the two samples was adjusted to 1.6 and 
4.1 using 10 mM solutions of HCl and NaOH. Next, a 255 µL aliquot of each pH-adjusted 
solution was diluted with 45 µL of acetone-d6 and transferred to an NMR tube for 
temperature and chemical exchange experiments. Due to the challenges of making 
reproducible pH measurements in unbuffered solutions, pH values are reported to two 
significant figures. Both the temperature and chemical exchange experiments were 
performed using a Bruker Avance spectrometer operating at 599.88 MHz and equipped 
with a 5 mm TBI probe. Similar conditions were applied to the sample of dNSt.  
Temperature experiments were performed over the range from 259.5 K to 286.9 K 
using one-dimensional 1H NMR. Spectra were acquired using a 90° pulse of 9.6 µs at a 
power level of -4.00 dB with solvent suppression provided by excitation sculpting. A total 
of 256 scans were coadded into 32,768 complex points for each spectrum. A spectral 
window of 7788 Hz and a relaxation delay of 1.5 s were used. Free induction decays (FIDs) 
were zero-filled to 65,536 points and apodized through multiplication by an exponential 
function equivalent to a 0.5 Hz line broadening prior to Fourier transformation. At least 7 
min was allowed for thermal equilibration of the sample. Sample temperatures were 
calibrated using the external low temperature methanol standard from Cambridge Isotope 
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Labs (Andover, MA) and calculated using the Van Geet equation.35 The spectra were 
referenced to the 1H resonance of DSS-d6 (0.00 ppm).  
Exchange spectroscopy (EXSY) was used to measure the chemical exchange rates 
of amino protons with water.34, 36, 37 The EXSY pulse sequence employed utilizes the basic 
NOESY pulse sequence incorporating excitation sculpting solvent suppression.38A total of 
twelve EXSY spectra were acquired for each solution. For the pH 1.6 sample, the mixing 
times ranged from 0 to 66 ms in 6 ms increments while for the pH 4.1 sample, the mixing 
times ranged from 0 to 44 ms in 4 ms increments. EXSY experiments were performed at 
259.7 K using a power level of -4.00 dB and a 90° pulse of 9.62 µs. The spectra were 
recorded using States-TPPI with 2048 complex points and 128 experiments, each with 32 
coadded scans. A spectral window of 7184 Hz was used in both dimensions with a 1.5 s 
relaxation delay. The EXSY spectra were zero-filled into 16,384 complex points in F2 and 
4096 complex points in F1 and apodized using a cos2 window function. Amino proton – 
water exchange cross-peaks and diagonal amino proton resonances were extracted into one 
dimensional spectra using TopSpin 3.2, followed by peak fitting and integration in 
MestReNova-12.0.1.  
3.2.3.4. pKa determination. The pKa values of the amino and carboxylate groups of 
dNSA and dNSt were determined in deuterated solution using 
1
H and 
1
H-
1
H TOCSY 
experiments to follow the chemical shifts of the H2 resonances of the glucosamine residues 
and the H5 resonances of the uronic acid residues as a function of pD. The calculated pKa 
values determined in the deuterated solvent were mathematically adjusted to pKa 
equivalents in water.36, 39, 40  
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Five 1.5 mL Eppendorf tubes each containing 300 µL of dNSA or dNSt solution, 
prepared as described in Sections 2.2.6.1. and 3.2.4.1, respectively, were individually 
adjusted to the desired pD using 1 mM, 10 mM, and 100 mM solutions of NaOD and DCl 
prepared from concentrated solutions by dilution with appropriate volumes of D2O (99.9% 
D). Aliquots of 280 µL at each pD were transferred to a clean and dry NMR tube for data 
acquisition. After the spectrum was recorded, the contents of the NMR tube were 
transferred back to the 1.5 mL Eppendorf tube and adjusted to a new pD value to continue 
the titration.  
1D 
1
H and TOCSY NMR spectra were acquired at each pD using a Bruker Avance 
spectrometer operating at 599.52 MHz and equipped with a BBI probe at 298.2 K. All 
spectra were acquired using a 90° pulse of 8.9 - 9.1 µs with solvent suppression of the 
residual HOD resonance by presaturation at a power of 59 dB. The resulting spectra were 
referenced to the 
1
H resonance of DSS-d6 (0.00 ppm).  
The 1D 
1
H NMR spectra were acquired using a spectral window of 6361 Hz, a 
relaxation delay of 2.0 s, and 56 scans coadded into 42,014 complex points. Spectra were 
zero-filled to 65,536 points and multiplied by an exponential window function equivalent 
to 0.4 Hz line broadening prior to Fourier transformation.  
Phase-sensitive TOCSY spectra were acquired into 2048 complex points over 416 
increments using States-TPPI, a 2.0 s relaxation delay, and a spectral window of 3597 Hz 
in both dimensions. The spectra were recorded by coaddition of 36 scans using a mixing 
time of 120 ms with a 36 µs spinlock pulse at a power of 8.2 dB. The FIDs were zero-filled 
to 4096 × 1024 data points and apodized using a cos2 window function.  
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The pKa values of the amino and carboxylate groups in dNSt were determined 
similarly, using the Bruker Avance spectrometer operating at 599.88 MHz and equipped 
with a 5 mm TBI probe.  
3.2.4. MD simulation parameters. Starting with ArixtraTM  in the conformation it 
adopts when bound to AT-S195A factor Xa,29, 36, 41 an AmberTools 16 xleap42 module was 
used to model the dNSA structure and to generate the parameter, topology, and coordinate 
files for the molecular dynamics simulation using a GLYCAM 06g force field.43 GlcN 
residues were prepared by replacement of each of the N-sulfo groups with two additional 
hydrogens. Partial charge adjustments of the nitrogen and hydrogens of the amino groups 
were performed based on CH3-NH3
+ calculated charges using GAUSSIAN B3LYP/6-31G, 
giving the amino group a +1 charge overall. The AmberTools 16 xleap module was used 
to add four sodium ions (ff99SB parameters) to dNSA to make the system’s overall charge 
neutral (addions function) and to construct a cubic water box with each face a distance 12 
Å from the solute (2333 TIP3P water molecules were added for dNSA).42-45  
Minimization, heating, equilibration, and a molecular dynamics simulation 
production run were performed using NAMD 2.11.46 To remove possible bad contacts, 
conjugate-gradient minimization was performed separately in the following order: solute, 
solvent, and the entire system. Periodic boundary conditions were applied throughout. The 
particle mesh Ewald algorithm was used to treat long range electrostatic interactions with 
the grid spacing set to 1 Å.47 Non-bonded interactions were cut off at 12 Å and a smooth 
switching function was applied to 10 Å. The VDW and electrostatic 1-4 scaling factors 
(SCNB and SCEE, respectively) were set to unity for consistency with the GLYCAM 06g 
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parameters.43 The SETTLE algorithm was used to hold rigid hydrogen-oxygen bonds 
within water molecules.48 Slow system heating from 0 K to 298 K was performed in 398 
ps, including a 100 ps hold at the 298 K using a constant-NVE ensemble. The constant-
NPT ensemble with a pressure of 1 atm and a temperature of 298 K were used for system 
equilibration and production run. Control over temperature was performed by using the 
Langevin thermostat with a damping coefficient of 5 ps-1, while control over pressure was 
performed by using NAMD’s Nosé-Hoover Langevin piston method.46 Trajectory output 
was saved every 500 fs with a time step of simulation integration in 1 fs. Monitoring of 
temperature, pressure, and energy, in addition to trajectory visualization, was performed in 
VMD 1.9.2.49 The hydrogen-bonding analysis, including a 3.5 Å heavy-atom cutoff 
distance and a 120° angle cutoff, was performed using the AmberTools 16 cpptraj 
module.42 
 
3.3. Results and Discussion 
Both the functional and structural roles of the GlcN3S residues of HS are largely 
unknown,24 as the challenges of obtaining sufficient amounts of HS or its oligosaccharides 
in pure form deters research. In this work, a model HS oligosaccharide was prepared by 
the de-N-sulfation of ArixtraTM (Figures 3.1A and B). The resulting dNSA has a partially 
zwitterionic structure at neutral pH and can potentially carry up to seven negative and three 
positive charges simultaneously. One and two-dimensional 
1
H NMR experiments were 
utilized to probe the presence of a salt bridge involving the negatively charged 3-O-sulfo 
group of GlcN3S with the adjacent positively charged amino group by the measurement of   
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Figure 3.1. Haworth projections of the oligosaccharides: (A) ArixtraTM, (B) de-N-sulfated 
ArixtraTM (dNSA), (C) N-acetylated ArixtraTM (NAcArixtra), (D) heparin tetrasaccharide, 
(E) de-N-sulfated heparin tetrasaccharide (dNSt). Abbreviated residue names with their 
relative numbers in an oligosaccharide sequence are shown under each sugar ring. An 
example of carbon-bound proton numbering order across each residue is shown for dNSA 
and highlighted in red.   
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the amino proton temperature coefficients, examination of the chemical exchange 
properties of the amino groups, and comparison of the pKa values of the ionizable 
carboxylate and amino groups. Finally, a complementary 300 ns MD simulation was 
carried out to provide a molecular perspective of dNSA’s structure in aqueous solution.  
3.3.1. Chemical shift dependence on N-substitution in ArixtraTM. Though the 
focus of current Chapter is the exploration of the properties of de-N-sulfated ArixtraTM in 
solution, he chemical shifts of carbon-bound protons in all three ArixtraTM based 
pentasaccharides are reported and compared herein (Figure 3.1A, B, and C): N-sulfated 
ArixtraTM (Figure 3.1A), unsubstituted ArixtraTM with free amino groups (Figure 3.1B), 
and N-acetylated ArixtraTM (Figure 3.1C). The unique opportunity, afforded by the 
chemical modification of ArixtraTM  allows us to explore the effect of N-substituents on the 
chemical shifts of the carbon-bound protons. Table 3.1 lists the measured chemical shifts 
of all the ArixtraTM, dNSA, and NAcArixtra protons. The order of proton numbering across 
each residue is shown in Figure 3.1B. Chemical shifts of overlapped resonances were 
assigned from COSY spectra and consequently are reported to two decimal places. For 
easier visualization of the effects of the N-substituents on chemical shifts, the data 
presented in Table 3.1 was transformed into the graph shown in Figure 3.2. In this graph, 
chemical shifts are plotted along x-axis and protons with corresponding numbers are 
plotted along y-axis. Dashed lines connect same proton chemical shifts assigned to 
ArixtraTM, dNSA, and NAcArixtra. Here we need to note that chemical shifts of protons in 
dNSA are especially sensitive to pH variation associated with the carboxylate and amino 
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Table 3.1. Chemical shifts of carbon-bound protons in ArixtraTM  (measured at 295.2 K in 
solution with pD 7.0),36 dNSA (measured at 298.2 K in solution with pD 7.5), and 
NAcArixtra (measured at 298.2 K in solution with pD 7.8) 
Residue Proton 
1H Chemical shift, ppm 
ArixtraTM dNSA NAcArixtra 
GlcNS6S (I) / 1 5.02 4.971 4.75 
GlcN6S (I)/ 2 3.28 3.305 3.954 
GlcNAc6S (I) 3 3.64 3.935 3.81 
 4 3.77 3.756 3.73 
 5 3.95 4.05 4.012 
 6 4.34 4.28 4.30 
 6’ 4.40 4.37 4.36 
 -CH3 3.41 3.447 3.38 
 amide -CH3 - - 2.023 
IdoA2S (II) 1 5.16 5.250 5.196 
 2 4.30 4.33 4.30 
 3 4.15 4.33 4.25 
 4 4.14 4.18 4.06 
 5 4.72 4.869 4.846 
GlcNS3S6S (III)/ 1 5.52 5.433 5.184 
GlcN3S6S (III)/ 2 3.44 3.618 4.212 
GlcNAc6S (III) 3 4.35 4.556 4.403 
 4 3.97 4.013 3.983 
 5 4.16 4.13 4.12 
 6 4.26 4.27 4.27 
 6’ 4.48 4.507 4.486 
 amide -CH3 - - 2.047 
GlcA (IV) 1 4.61 4.595 4.602 
 2 3.41 3.422 3.363 
 3 3.83 3.736 3.690 
 4 3.84 3.878 3.79 
 5 3.76 3.794 3.85 
GlcNS6S (V)/ 1 5.62 5.692 5.423 
GlcN6S (V)/ 2 3.25 3.287 3.90 
GlcNAc6S (V) 3 3.62 3.832 3.56 
 4 3.57 3.583 3.72 
 5 3.88 3.90 3.72 
 6 4.15 4.18 4.36 
 6’ 4.37 4.38 4.73 
 amide -CH3 - - 2.023 
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Figure 3.2. Graphical depiction of chemical shifts listed in Table 3.1. Chemical shifts of 
the ArixtraTM carbon-bound protons for are marked by circles, those of dNSA are marked 
by diamonds, and for NAcArixtra are marked by triangles.   
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group ionization states (further discussed in Section 3.3.3). Consequently, it is possible that 
the reported dNSA chemical shifts will include small deviations when compared to relevant 
chemical shifts in ArixtraTM (measured at pD 7.0) and NAcArixtra (measured at pD 7.8). 
Removal of the bulky N-sulfo groups from ArixtraTM  caused the H3 resonances in 
all GlcN residues to be shifted downfield. An interesting observation is made for H2 in 3-
O-sulfated GlcN3S6S(III) residue, the only H2 proton of the glucosamine residues 
significantly affected by de-N-sulfation. Its resonance is deshielded and appears downfield 
relative to the corresponding H2 of ArixtraTM.  
Introduction of the N-acetyl groups imparts large chemical shift changes in the H1, 
H2, and H3 proton resonances of the glucosamine residues relative to ArixtraTM  and 
dNSA. The anomeric protons (H1) of the NAcArixtra glucosamine residues more shielded 
than in ArixtraTM or dNSA. The H2 proton resonances were downfield shifted as a result 
of strong deshielding effect exerted by the adjacent N-acetyl groups. The H3 chemical 
shifts were less affected by N-acetylation. The H3 chemical shifts of GlcNAc6S(I) and 
GlcNAc3S6S(III) are found between the H3 resonances of ArixtraTM and dNSA and the 
H3 of GlcNAc6S(V) is slightly shielded compared to ArixtraTM and dNSA. Only in the 
GlcNAc6S(V) residue, chemical shifts of even numbered protons are deshielded, while the 
odd numbered protons are more shielded compared to ArixtraTM and dNSA. This trend 
may be explained by sugar ring conformational changes of the GlcNAc6S(V) residue, 
perhaps due to steric crowding between the reducing end O-CH3 and the N-acetyl group.  
Variations of the N-substituents of ArixtraTM imparted small chemical shift changes 
in the H3, H4 and H5 resonances of uronic acid residues may be associated with their closer 
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spatial proximity to the N-substituents. A similar, but inverse dependence is observed for 
H4-6 in first and third glucosamine residues, for H1 in GlcA(IV) and for H2 in IdoA2S(II). 
However, the unaffected chemical shift of H2 in IdoA2S(IV) can be attributed to its special 
chemical and magnetic environment due to adjacent 2-O-sulfo group. 
3.3.2. Temperature coefficients, Δδ/ΔT. Identification of hydrogen bonds in 
proteins, peptides, nuclei acids and carbohydrates is widely performed through NMR 
measurements of the temperature coefficients, Δδ/ΔT, of labile protons.29, 50-58 Because of 
their prevalence in proteins, temperature coefficients have been widely characterized for 
amide protons in peptides and proteins, and in this work we apply the same principles to 
oligosaccharide amino groups. The chemical shifts of labile protons, like those of amide or 
amino groups, are strongly temperature dependent. Gradual increases in temperature cause 
an increase in the thermal motion of atoms, which in turn forces the hydrogen bond length 
to stretch.  As the distance between the hydrogen bond acceptor and labile proton group 
donor increases, the deshielding effect exerted by the acceptor becomes less prominent. 
This effect can be observed in the 
1
H NMR spectrum by an upfield shift of the labile proton 
resonance. This temperature dependence is perhaps most notable for the water (or HOD) 
1H NMR resonance. The reason that temperature coefficients can be used to identify labile 
protons involved in hydrogen bonds is that average lengthening of an intermolecular 
hydrogen bond distance, for example for an amide proton with bulk water, is greater than 
for an intramolecular hydrogen bond.51 As a consequence, labile protons involved in an 
intramolecular hydrogen bond will have a significantly smaller change in chemical shift 
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with increasing temperature (a reduced temperature coefficient) than their non-hydrogen 
bonding counterparts.  
Because a salt bridge involving the dNSA amino and 3-O-sulfo groups could 
behave similarly to a hydrogen bond, its presence was probed through the measurement of 
temperature coefficients. To examine possible electrostatic interactions between the 
positively charged amino and negatively charged carboxylate groups, as well as the 
possibility that the GlcA(IV) and IdoA2S(II) carboxylate groups could polarize the amino 
N–H bonds through their nearby negative charge, temperature coefficients and solvent 
exchange rate measurements for the dNSA amino protons were performed at two pH 
values, 1.6 and 4.1. It is expected that at pH 1.6, the carboxylate groups are mostly 
protonated and therefore largely uncharged, and that at pH 4.1, they are mostly 
deprotonated and hence carry a negative charge. In contrast, the 3-O-sulfo group should be 
consistently negatively charged over this pH range. Lower and higher pH conditions were 
avoided because lower pH can affect the stability of the sugar and higher pH promotes 
faster amino protons solvent exchange rates that would cause problems detecting the amino 
resonances.34  
Figure 3.3A shows a portion of the 
1
H NMR spectrum of dNSA highlighting the 
effect of gradual temperature increase on the amino protons resonance at pH 1.6 and 4.1. 
The magnitude of the chemical shift change with temperature for the GlcN3S6S(III) is 
significantly less than is observed for the other amino groups at both pH values, suggesting 
possible involvement in a hydrogen bond with the adjacent 3-O-sulfo group. Figure 3.3B 
highlights reduced intensity of the GlcN3S6S(III) amino resonance at pH 4.1 in result of   
114 
 
Figure 3.3. (A) The region of the 
1
H NMR spectrum of dNSA showing the temperature 
dependence of the amino proton resonances at pH 1.6 and 4.1. Amino resonances are 
labeled according to residue number (Figure 3.1). (B) Comparison of the amino protons 
resonance linewidths at pH 1.6 and 4.1 and 259.7 K.  
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faster chemical exchange. Note that in Figure 3.3B the linewidth of amino proton in 
GlcN6S(I) is almost unaffected by the pH change, while resonance of amino proton in 
GlcN6S(V) broadens and shifts downfield at higher pH, suggesting dependence on the 
ionization state of the adjacent GlcA(II) carboxylate group.  
Quantitatively, the effect of temperature on the chemical shifts of labile protons is 
represented by temperature coefficients (Δδ/ΔT) calculated from the absolute value of the 
slope of the line obtained by plotting amino group proton chemical shift as a function of 
temperature (Figure 3.4). Calculated Δδ/ΔT values for the amino resonances of the de-N-
sulfated oligosaccharides are provided in Table 3.2. Significantly smaller Δδ/ΔT values 
were obtained for the dNSA amino resonance of GlcN3S6S(III) (1.22 ± 0.03 ppb/K and 
1.92 ± 0.05 ppb/K at pH 1.6 and 4.1, respectively) compared to all other amino groups. 
This small temperature coefficient suggests the involvement of the GlcN3S6S(III) amino 
protons in a hydrogen bond.29 Moreover, the small Δδ/ΔT values obtained at the lower pH 
limits support the hydrogen bonding and possible salt bridge formation with the GlcN3S6S 
3-O-sulfo group because at pH 1.6 the carboxylate groups are mostly protonated.  
The large temperature coefficients measured for dNSt further support a hydrogen 
bond in dNSA involving the GlcN3S6S(III) amino group. The amino temperature 
coefficients of the internal GlcN6S(III) residue in dNSt are 4.01 ppb/K and 4.33 ppb/K at 
pH 1.6 and 4.1, respectively, and are comparable to non-hydrogen bonded amino protons 
in dNSA. Note, in contrast to dNSA, dNSt has its anomeric carbon at the reducing end 
residue GlcN6S(I) and consequently two anomers are present in solution. However, the  
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Figure 3.4. Temperature coefficient plots of amino proton chemical shifts measured at pH 
1.6 and 4.1 for dNSA (A and B), and dNSt (C and D), respectively. Chemical shifts were 
plotted as a function of the calibrated temperature and the absolute value of the slope 
represents the temperature coefficient.   
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Table 3.2. Summary of the dNSA and dNSt temperature coefficients (Δδ/ΔT), exchange 
rate constants (kex) and pKa values. Exchange rates were measured at 259.7 K. pKa values 
were determined at 298.2 K. All pKa values measured in D2O are reported as their water 
equivalents.  
Oligosaccharide 
Δδ/ΔT, ppb/K kex, s-1 pKa 
pH 1.6 pH 4.1 pH 1.6 pH 4.1 de-N-sulfated N-sulfated 
dNSA       
GlcN6S(V) 3.69 ± 0.02 3.75 ± 0.04 4.1 ± 0.1 17.0 ± 0.1 8.36 ± 0.02  
GlcA(IV)     3.51 ± 0.02 3.49 ± 0.05a 
GlcN3S6S(III) 1.22 ± 0.03 1.92 ± 0.05 25.4 ± 0.2 34.3 ± 0.2 8.17 ± 0.01  
IdoA2S(II)     2.81 ± 0.04 3.40 ± 0.05a 
GlcN6 (I) 4.35 ± 0.03 4.36 ± 0.07 6.5 ± 0.1 8.8 ± 0.1 8.31 ± 0.02  
dNSt       
ΔUA2S(IV)     2.87 ± 0.02 2.98 ± 0.03 
GlcN6S(III) α 
4.01 ± 0.06 4.33 ± 0.04 
4.0 ± 0.1 
12.6 ± 0.1 8.30 ± 0.01 
 
GlcN6S(III) β 5.1 ± 0.1  
IdoA2S(II) α     3.03 ± 0.02 3.42 ± 0.02 
IdoA2S(II) β     2.98 ± 0.02 3.46 ± 0.02 
GlcN6S(I) α 2.60 ± 0.03 3.02 ± 0.05 4.2 ± 0.1 11.4 ± 0.1 8.59 ± 0.02  
GlcN6S(I) β 4.50 ± 0.06 5.20 ± 0.20 9.8 ± 0.1 17.4 ± 0.1 8.99 ± 0.02  
 
a pKa values of the ArixtraTM carboxylates were determined previously.36 
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temperature coefficients measured for GlcN6S(I-α) and GlcN6S(I-β) are not relevant to the 
internal residue of the oligosaccharide and consequently will be omitted from further 
discussion. 
In addition to reporting on the temperature dependence of the resonance chemical 
shift, Figure 3.3. also provides insights about the effects of temperature on resonance 
linewidths. As the temperature is increased, greater broadening is observed at both pH 
values for the amino resonance of GlcN3S6S(III) compared with the resonances of 
GlcN6S(V) and GlcN6S(I) residues. For labile protons, a greater resonance linewidth 
indicates faster chemical exchange with water. This result is strikingly different from the 
reduced linewidths, and therefore reduced exchange rates reported for amide, sulfamate, 
and hydroxyl protons involved in hydrogen bonds.29, 37, 54, 57-60 This result suggests that 
amino protons in close spatial proximity to negatively charged groups might experience an 
acceleration of the exchange rates, perhaps due to the presence of a salt bridge.61 
3.3.3. Measurements of solvent exchange rates. To verify the faster solvent 
exchange rates suggested by the greater degree of line broadening of the dNSA 
GlcN3S6S(III) amino resonance in Figure 3.3, exchange rates for the amino groups of 
dNSA and dNSt were measured using the EXSY pulse sequence.34, 36, 37 Though only one 
of the three glucosamine residues of dNSA contains a 3-O-sulfo group, the position of this 
amino in the center of the pentasaccharide raises the possibility the glucosamine residues 
at the reducing and non-reducing ends experience less line broadening with temperature 
simply because of their position in the oligosaccharide sequence. Performing similar 
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measurements for the de-N-sulfated heparin tetrasaccharide allows us to test this 
hypothesis.  
As shown in Figure 3.5, incrementally increasing the EXSY mixing time increases 
the intensities of the amino solvent exchange cross-peaks. Compared with the other dNSA 
and dNSt amino protons, the cross-peak intensity for the dNSA GlcN3S6S(III) amino 
(highlighted in red in Figure 3.5) appears to increase most rapidly with increased mixing 
time at both pH values studied. To quantitatively evaluate the differences between the 
amino groups, cross-peak intensities were extracted into one-dimensional spectra, 
integrated, and normalized to the intensity of the corresponding diagonal peak. The results 
were plotted as a function of mixing time generating the build-up curves shown in Figure 
3.6. These build-up curves further support the accelerated exchange of the amino protons 
of GlcN3S6S(III) relative to the other amino groups of dNSA as well as the dNSt internal 
GlcN6S(III) residue. Faster build-up for the amino protons in GlcN3S6S(III) is observed 
at both pH values. In contrast, the build-up rates of the dNSA GlcN6S(V) amino protons 
were significantly accelerated at pH 4.1 likely due to the spatial proximity of the 
carboxylate group of the adjacent GlcA(II) residue. Note that build-up rates of the amino 
protons in GlcN6S(I), GlcN6S(III), and GlcN6S(I-α/β) were relatively unaffected by the 
change in the ionization state of carboxylate groups. 
Exchange rates (kex) were quantitatively extracted from individual EXSY build-up 
curves by fitting with the nonlinear least squared equation derived earlier by Beecher et al. 
for the hydroxyl and amino protons (Eq. 3.1)34, 36, 53 using Mathematica61 and are 
summarized in Table 3.2.   
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Figure 3.5. Example of EXSY spectra of (A) dNSA and (B) dNSt measured at pH 1.6. 
Selected spectra with mixing times 6 ms, 18 ms, and 36 ms show differences in the 
exchange cross-peak intensity for each amino group. Traces through the exchange cross-
peaks at the water chemical shift (≈ 5.2 ppm along the F1 dimension) are plotted at the top 
of each contour map. Notably higher intensity is observed for the GlcN3S6S(III) amino 
group exchange cross-peak (highlighted in red) relative to other amino groups containing 
residues confined in the dNSA and dNSt oligosaccharides.  
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Figure 3.6. EXSY build-up curves for the solvent exchange of the amino protons of dNSA 
and dNSt measured at (A) pH 1.6 and (B) 4.1 in 85% H2O/15% acetone-d6.  
* Measurement of individual exchange rates of the dNSt amino protons of the GlcN6S(III) α and β anomers 
at pH 4.1 was not possible because of resonance overlap, therefore, only the average exchange rate is 
reported. 
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                      (Eq. 3.1) 
Notably, the amino proton exchange rates increase as the pH is raised from 1.6 to 
4.1. For instance, the largest increase in exchange rates was observed for GlcN6S(V) in 
dNSA which changed from 4.08 s-1 to 17.04 s-1 (Δkex = 12.96 s-1). Slightly lower increases 
in the exchange rate were observed for the dNSA GlcN3S6S(III) (Δkex = 8.90 s-1), and the 
GlcN6S(III α/β) (average Δkex = 8.2 s-1) and GlcN6S(I α/β) (average Δkex = 8.2 s-1) in dNSt. 
The smallest increase in exchange rates was observed for the GlcN6S(I) residue (Δkex = 
2.3 s-1) of dNSA. However, the pH dependence of the exchange rates  is expected 
accordingly to Eq. 1.2.62 This equation dictates that solvent exchange reaction (Figure 1.8) 
can be acid or base catalyzed. The rate constants for the acid (kH+) and base (kOH-) catalyzed 
reactions are not equal and depend on the nature of the labile proton functional group and 
its local environment. 
In terms of the overall magnitude of the exchange rate, the values of kex for dNSA 
GlcN3S6S(III) (kex = 25.4 s
-1 at pH 1.6 and 34.4 s-1 at pH 4.1) are significantly larger than 
the values for other amino groups at both pH values, and is likely due the close proximity 
of the 3-O-sulfo group, which remains deprotonated even at pH 1.6. A possible explanation 
for this effect is that the exchange driven by general-base catalysis promoted by the 
neighboring negatively charged sulfate, a mechanism that was proposed previously for 
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amino-carboxylate salt bridges in proteins.61 Another plausible explanation is the 
polarization of water molecules surrounding two oppositely charged groups, which in turn 
promotes accelerated exchange. In either case, the effect of nearby negatively charged 
moieties on the amino proton exchange rate should decrease as the distance separating the 
charged groups increases. Therefore, acceleration of exchange rates (in the absence of other 
factors, such as salt concentration, solution composition, temperature, etc.) indicates the 
possibility of charge-charge interaction and spatial proximity of the negatively charged 
group to the positively charged amino group. This also explains the observation made for 
the dNSA GlcN6S(V) that the exchange rate jumped from 4.08 s-1 to 17.04 s-1 (Δkex = 12.96 
s-1) as the nearby GlcA carboxylate group was deprotonated. The accelerated exchange 
rates promoted by the close spatial proximity of negatively charged groups and the 
possibility of electrostatic attraction with the positively charged amino group can be further 
evaluated through measurement of the pKa values of ionizable groups. 
3.3.4. Comparison of pKa values. The identification of salt bridges in proteins has 
been established through comparison of the pKa values of ionizable amine, guanidium and 
carboxylate groups of the amino acid side chains.61, 63-67 In proteins, the formation of a salt 
bridge alters the pKa values of the ionizable groups involved in the electrostatic interaction 
and a similar principle could be applied to GAG oligosaccharides. It is expected that if the 
amino group of a GlcN3S6S(III) residue is involved in a salt bridge with an adjacent 3-O-
sulfo group, the pKa of amino group would be altered relative to its normal values (e.g. in 
absence of a salt bridge). However, unlike proteins, where the difference in pKa of ionizable 
groups can be measured by the folding and unfolding of the protein,64 identification of pKa 
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differences in GAG oligosaccharides requires another approach. In this section the pKa 
values of the amino and carboxylate groups of dNSA and dNSt are compared based on the 
similarity of their residue composition, saccharide sequence order, and oligosaccharide 
length. The pKa of the GlcN3S6S(III) amino was compared to the pKa values for the aminos 
in 6-O-sulfated glucosamine residues lacking a 3-O-sulfo group, such as GlcN6S(I) and 
GlcN6S(V) in dNSA, and the internal GlcN6S(III) residue of dNSt. 
Experimentally, pKa values can be conveniently determined by monitoring the 
1
H 
NMR spectrum over the course of a pH titration.34, 36, 61, 63 The versatility of NMR spectra 
allows simultaneous determination of the pKas of all ionizable groups within an 
oligosaccharide. Moreover, due to the capability of NMR to detect small changes in the 
magnetic and chemical environments of the spin systems, direct detection of the amino and 
carboxylate group protons is unnecessary. The pKa can be determined by following the 
chemical shifts of the carbon-bound protons adjacent to the amino and carboxylate group, 
specifically (H2) for the amino containing glucosamine residues and (H5) for carboxylate 
containing uronic acid residues (numbering nomenclature is shown in Figure 3.1B). To 
reduce the interference from the water resonance, NMR spectra of the oligosaccharides 
were acquired in D2O and the solution pD adjusted using DCl and NaOD.
68 The 
relationship between the pH meter reading (pH
*
) of a D2O solution and pD is established 
by Eq. 3.2:36, 39  
pD = pH
* 
+ 0.40                                           (Eq. 3.2.) 
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Figure 3.7 shows the effect of pD on the proton chemical shifts of dNSA. In large 
molecules such as proteins, a change in ionization states of one group involved in a salt 
bridge affects the chemical shift of the other group allowing identification of the salt 
bridging pairs. However, because dNSA is a small flexible molecule, changes in the 
ionization state of the carboxylate and amino groups propagate through the oligosaccharide 
affecting nearly all dNSA’s protons and making identification of the potential salt bridge 
pairs by observation unfeasible. Though the one-dimensional 
1
H NMR spectrum provides 
insights into the resonance chemical shift dependence on pD, it suffers from low dispersity 
within the 3.3 – 4.5 ppm spectral window, which interferes with observation of the H5 in 
GlcA(IV) and H2 in GlcN3S6S(III) resonances for pKa determination. Consequently, 
chemical shifts were also determined using TOCSY spectra acquired in parallel with the 
one-dimensional spectra.  
Figure 3.8 shows the pD titration curves of the five ionizable groups of dNSA, highlighting 
the effect of the protonation state of the GlcA(IV) and IdoA2S(II) carboxylate groups on 
the chemical shifts of H2 protons of the GlcN6S(V) and GlcN3S6S(III) residues at low pD. 
Similarly, the deprotonation of the amino groups affected the chemical shifts of the H5 
protons of GlcA(IV) and IdoA2S(II) at higher pD. Notably, deprotonation of both 
carboxylates affected the chemical shifts of the GlcN6S(I) H2 resonance to a much smaller 
extent, but interestingly the exchange rates of the amino protons in the same residue 
experienced the smallest dependence on the ionization states of carboxylates (Δkex=2.3s-1). 
These observations suggest that the carboxylate in IdoA2S(II) and the amino group in 
GlcN6S(I) are separated from each other.  
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Figure 3.7. pD titration of the dNSA in deuterated 10 mM phosphate buffer. 1H NMR 
spectra acquired as a function of pD reflect the effect of solution pD on the chemical shifts 
of carbon-bound protons in dNSA. Resonances are labeled according to the dNSA residue 
number with the subscript indicating the corresponding proton number within a given 
residue (see Figure 3.1B). The sequential deprotonation of ionizable groups induces 
chemical shifts changes. The most highly affected proton resonances were those in close 
spatial proximity to ionizable groups.   
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Figure 3.8. pD titration curves obtained through TOCSY experiments for (A) H2 protons 
in amino containing residues and (B and C) H5 protons for carboxylate containing residues. 
H2 protons in GlcN3S6S (III) and GlcN6S(V) residues showed sensitivity to changes in 
ionization state of carboxylates. Reciprocally, the H5 protons of GlcA(II) and IdoA2S(IV) 
were sensitive to changes in the ionization states of the amino groups.  
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The pKa values in D2O were determined by plotting the observed chemical shifts 
(δobs) of the carbon-bound protons H5 and H2 as a function of pD (Figure 3.7), followed 
by fitting with Eq. 3.3 using Mathematica:69 
δobs = δu +
δp- δu
1+ 10n
(pKa-pH)
                                          (Eq. 3.3.) 
In Eq. 3.3, δp is the chemical shift of the protonated form (carboxylate -COOH or 
amino -NH
3
+
), δu is the chemical shift of the deprotonated form (carboxylate -COO
-
 and 
amine -NH
2
), and n is the Hill coefficient, which in our case is equal to 1.34, 70, 71 Conversion 
of the pKa (D2O) values to equivalent values in aqueous solution, pKa (H2O), was 
performed by using Eq. 3.4:36, 40 
pKa (H2O) = pKa (D2O) - 0.6                                    (Eq. 3.4.) 
Table 3.2 lists the pKa values determined for dNSA, dNSt, and heparin 
tetrasaccharide, as well as the literature pKa values for the carboxylates of Arixtra
TM.36 
Comparison of the carboxylate group pKas of the N-sulfated and de-N-sulfated forms of 
the same residue in dNSt reveals that the removal of N-sulfo group reduced the carboxylate 
pKa of the IdoA2S(II) residues by approximately 0.4 pH units. In dNSA, the pKa of the 
GlcA(IV) carboxylate was unaffected by de-N-sulfation, while carboxylate pKa of the 
IdoA2S(II) was reduced by 0.6 units from its relative value in ArixtraTM and is 0.2 units 
lower than pKa in IdoA2S(II) of the dNSt, suggesting its possible involvement in a salt 
bridge. Because the unsaturated uronic acid (UA2A) in dNSt is introduced by the 
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enzymatic depolymerization reaction and is not found in intact GAGs, it will be omitted 
from further discussion. 
Through the comparison of amino group pKa values in Table 3.2, it is apparent that 
the pKa (8.17) of dNSA GlcN3S6S(III) is smaller than the pKa values of the other aminos 
in dNSA and dNSt, which are around 8.3. Normally, a higher amino group pKa would be 
expected in the presence of a salt bridge, so at first glance this value is not consistent with 
the reduced temperature coefficient and enhanced exchange rates of the dNSA 
GlcN3S6S(III) amino protons, which both suggest salt bridge participation. However, 
because the reduced pKa measured for IdoA2S(II) suggests its involvement in a salt bridge, 
we raised the question about its possible interaction with amino group in adjacent 
GlcN3S6S(III) residue.  
Interpreting differences in the pKa of a carboxylate or amino group in isolation 
neglects that fact that it is the overall stabilization produced by ion pairing that must be 
considered. Changes in the pKa values of salt bridging pairs in proteins can be interpreted 
in terms of the free energy difference, ΔΔGu (kJ/mol), which can predict the contribution 
of the charged site (i) to the stability of the protein by following Eq. 3.5:  
ΔΔGui = 2.3RT(pKaU,i - pKaF,i)                              (Eq. 3.5.) 
where pKa
U,i and pKa
F,i are pKa values of i in unfolded and folded states, respectively.
64, 72 
This equation can be adapted to GAG oligosaccharides as follows: ΔΔGui = 2.3RT(pKano 
salt bridge,i - pKa
salt bridge,i), where pKa
no salt bridge,i and pKa
salt bridge,i are values measured for i 
without and with the salt bridge, respectively. Consequently, if a carboxylate group 
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participates in a salt bridge and contributes to the stability of the oligosaccharide, then 
ΔΔGu-COOH will be positive; if the amino group participates in a salt bridge and contributes 
to the stability of GAG, then ΔΔGu-NH3
+
 is expected to be negative.64 The approximate 
value for ΔΔGu-COOH for the carboxylate of IdoA2S(II) in dNSA was +1.37 kJ/mol (with 
pKa
no salt bridge = 3.00, and pKa
salt bridge = 2.81). Therefore, it is expected that this group 
stabilizes the GAG structure. However, an approximation of ΔΔGu-NH3
+
 for the amino 
group of GlcN3S6S(III) in dNSA in a salt bridge with the adjacent carboxylate group in 
IdoA2S(II) was +0.97 kJ/mol (with pKa
no salt bridge = 8.34 (an average pKa of GlcN6S(I) and 
GlcN6S(V)), and pKa
salt bridge = 8.17), which destabilizes the dNSA. However, this 
unfavorable effect of the charged group on dNSA structure does not completely cancel out 
overall stabilization estimated from the existence of the salt bridge. 
3.3.5. Comparison of coupling constants. Finally, one-dimensional spectra 
acquired at different pD values allow the measurement of three bond coupling constants 
which can reflect pH dependent conformational changes (Table 3.3). At low pD (1.77), the 
amino groups are positively charged and carboxylates mostly carry no charge; at 
intermediate pD (7.67), the amino groups and carboxylates are both charged; and at high 
pD (11.27), the amines are mostly neutral, and carboxylates are charged (Table 3.3). The 
three bond coupling constants for the dNSA GlcN3S6S(III) H1 and H2 (3JH1-H2) change 
consistently through these three molecular ionization states. At low pD, the 3JH1-H2 is 3.9 
Hz; at intermediate pD it is 3.7 Hz; and at high pD it is 3.5 Hz. Changes in the coupling 
constant of H1 are likely driven by changes in the molecular conformation associated with 
differences in charge-charge interactions resulting from deprotonation of the IdoA2S(II)  
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Table 3.3. 3JH-H constants of dNSA measured at 298.2 K 
Residue Proton 3JH-H 
pD 1.77 pD 6.67 pD 11.27 
δ, ppm 3JH-H, Hz δ, ppm 3JH-H, Hz δ, ppm 3JH-H, Hz 
GlcN6S(V)         
 IH1 3J1-2 5.610 3.7 5.701 3.7 5.436 3.7 
 IH2 3J1-2 3.377 3.7 3.336 3.7 2.690 3.8 
  3J2-3  n/ac  10.7  10.1 
GlcA(IV)         
 IIH1 3J1-2 4.631 7.9 4.594a 7.8a 4.587 8.0 
GlcN3S6S(III)         
 IIIH1 3J1-2 5.525 3.9 5.456b 3.7b 5.084 3.5 
 IIIH2 3J1-2 n/ac n/ac 3.664b 3.7b 2.932 3.5 
  3J2-3  n/ac  10.3b  10.2 
IdoA2S(II)         
 IVH5 3J4-5 5.228 1.7 4.873 1.7 4.842 2.0 
GlcN6S(I)         
 VH1 3J1-2 5.013 3.6 5.006 3.6 4.735 3.6 
 VH2 3J1-2 3.395 3.6 3.385 3.6 2.741 3.7 
  3J2-3  n/ac  10.5  9.8 
 
a Measured at pD 7.95. 
b Measured at pD 7.67. 
c Overlapped with other peak/peaks. 
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carboxylate group. For instance, 3JH1-H2 of H1 in GlcN6S(V) and GlcN6S(I) residues 
remained constant, at 3.7 Hz and 3.6 Hz, respectively, as the pH was increased.  
3.3.6. MD simulations. The experimentally identified hydrogen bond and possible 
two salt bridges in dNSA were reinforced by molecular dynamics (MD) simulations 
providing a molecular perspective. Examination of the structure of dNSA was initiated 
with ArixtraTM in the conformation it adopts when bound to AT-S195A factor Xa29, 36, 41 
by removal of N-sulfo groups, followed by charge adjustments. Figure 3.9 shows a 
perspective of the dNSA structure taken from one of the simulation frames with predicted 
hydrogen bonds and measured interatomic distances separating oppositely charged atoms. 
MD predicted a hydrogen bond (71%) involving GlcN3S6S(III) amino and 3-O-sulfo 
groups, which was experimentally confirmed by the reduced temperature coefficients 
determined for the amino group. Additionally, the simulation identified two other possible 
donor-acceptor pairs in dNSA: the 3-OH (a proton in the hydroxyl group bound to a third 
carbon) in GlcN6S(I) and the ring O in IdoA2S(II), and the 3-OH and 2-O-sulfo groups in 
IdoA2S(II). These hydrogen bonds were also previously predicted by MD for ArixtraTM 
and were further confirmed experimentally.29, 36 Nevertheless, removal of the N-sulfo 
groups from ArixtraTM disrupted strong hydrogen bonding between the N-sulfo group and 
3-OH,36 resulting in an overall conformation change of the pentasaccharide described in 
terms differences in torsion angles between the ArixtraTM and dNSA (Figure 3.9 and Table 
3.4).73 Measured interatomic distance in 2.96 Å separating negatively charged oxygens in 
the 3-O-sulfo group with positively charged nitrogen of the amino group is favorable for 
the electrostatic attraction of a salt bridge pair and is consistent with the accelerated  
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Figure 3.9. Representative structure of dNSA taken from one step of the 300 ns MD. (A) 
Intramolecular hydrogen bonds predicted from MD are labeled by black dashed lines. Only 
hydrogen bonds with occupancies greater than 20% are shown. (B) Interatomic distances 
were calculated by averaging the shortest distances separating oxygens from nitrogen 
atoms. Residues are labeled with corresponding residue numbers. 
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Table 3.4. Averaged torsion angles measured in dNSA. Atoms used to assign torsion 
angles in dNSA are shown in Figure 3.9A 
Torsion Angles Degrees, ° 
τ(O11-C11-O1-C24) 75.1 
τ(C11-O1-C24-C25) -143.3 
τ(O21-C21-O2-C34) -101.0 
τ(C21-O2-C34-C35) -128.5 
τ(O31-C31-O3-C44) 71.6 
τ(C31-O3-C44-C24) -123.8 
τ(O41-C41-O4-C54) -83.4 
τ(C41-O4-C54-C55) -138.6 
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solvent exchange rate of the GlcN3S6S(III) amino protons. Moreover, estimated distances 
separating the carboxylate oxygens and the amino group nitrogen explains the reduced pKa 
value of the IdoA2S(II) carboxylate and the acceleration of the amino proton exchange 
rates observed for the GlcN6S(V) and GlcN3S6S(III) residues as the solution pH is raised 
from 1.6 to 4.1. The 5.04 Å between the electrostatically interacting carboxylate of 
IdoA2S(II) and the amino of GlcN3S6S(III) places it within the range of weak salt bridge, 
consistent with our experimental observations. In contrast, the charge separation of 5.40 Å 
between the amino in GlcN6S (V) and carboxylate in GlcA (IV) was insufficient for salt 
bridge formation, however, it was sufficient to promote acceleration of the solvent 
exchange rate of the GlcN6S (V) amino group. Further, the 6.89 Å separation of the 
GlcN6S(I) amino from the nearby IdoA2S(II) carboxylate explains why the amino protons 
do not experience an observable influence from the negatively charged carboxylate group. 
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3.4. Conclusions 
In this chapter, dNSA was synthesized from synthetic pentasaccharide ArixtraTM 
for the purpose of mimicking rare 3-O-sulfated glucosamine residues found in HS. Through 
the comparison of exchange rates and pKa values, an electrostatic interaction involving the 
GlcN3S6S positively charged amino group with possibly two negatively charged groups - 
the adjacent 3-O-sulfo group and the IdoA2S(II) carboxylate group - was identified for the 
first time. Furthermore, salt bridges accompanied by hydrogen bonds, as is the case for the 
amino group in the dNSA GlcN3S6S(III), are identifiable through small temperature 
coefficients. These results suggest that reduced temperature coefficients and highly 
accelerated amino group proton solvent exchange rates are potential markers for screening 
for salt bridge formation in aqueous solutions of GAGs. Taken together this new 
information related to structure further contributes to our knowledge of the possible 
function of 3-O-sulfo groups in HS, and to the ability of elements of primary structure to 
impact the secondary structure and, in turn, the spatial organization of functional groups 
involved in protein recognition and binding. 
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CHAPTER FOUR 
Investigation of Amide Proton Solvent Exchange Properties in GAG 
Oligosaccharides
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Abstract: In this chapter, we conducted one-dimensional proton NMR experiments for the 
determination of temperature coefficients and activation energy barriers, and to evaluate 
the effect of pH on the solvent exchange properties of the amide protons of GAG 
oligosaccharides. A library of saccharides was prepared by enzymatic depolymerization of 
amide-containing polysaccharides and by chemical modification of heparin and heparan 
sulfate (HS) saccharides including members that contain a 3-O-sulfated glucosamine 
residue. The systematic evaluation of this saccharide library facilitated the assessment of 
145 
the effects of structural characteristics, such as size, sulfation number and site, and 
glycosidic linkage, on amide proton solvent exchange. Charge repulsion by neighboring 
negatively charged sulfate and carboxylate groups was found to have a significant impact 
on the catalysis of amide proton solvent exchange by hydroxyl ions. This observation led 
to the conclusion that significantly reduced solvent exchange rates do not conclusively 
establish the involvement of a labile proton in a hydrogen bond, as previously proposed, 
and additional supporting experimental evidence, for example reduced temperature 
coefficients, is required.  
 
4.1. Introduction 
In Chapter 1 it was noted that hydrogen bonds play an important role in many 
chemical and biological processes, therefore, the development of reliable methods for the 
identification of hydrogen bonds in saccharides is critically important. Variable 
temperature experiments have been used in studies of GAG oligosaccharides to probe the 
involvement of labile protons in hydrogen bonds and to the investigate kinetics and 
thermodynamics of solvent exchange in aqueous solutions.1-4 As discussed in Chapter 3, 
reduced temperature coefficients (Δδ/ΔT) in the range of 2 - 4 ppb/K can identify labile 
protons involved in hydrogen bonds.1-4  In addition, the in-depth analysis of NMR spectra 
acquired at different temperatures can provide additional insights into the solvent exchange 
properties of labile protons. For example, Langeslay et al. used line-shape analysis of  the 
sulfamate (N-sulfo group) 1H NMR resonances to complement temperature coefficient 
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results and identify a hydrogen bond between the sulfamate group and the adjacent 3-O-
sulfo group of the internal GlcNS3S6S residue of ArixtraTM.1  
For the more slowly exchanging sulfamate and amide protons, 1H NMR resonance 
line widths are related to the rate constant (kex) of the solvent exchange reaction. 
Consequently, resonance line widths measured as a function of temperature can be fit with 
the Eyring-Polanyi equation (Eq. 1.1, Chapter 1), followed by calculation of the energy 
barrier (ΔG
‡
 in kcal/mol) associated with solvent exchange.5-7 In prior work, protons with 
a comparatively high energy barrier (2 - 3 kcal/mol or more) were proposed to be protected 
from exchange through involvement in a hydrogen bond. For example, Langeslay et al. 
used the ΔG
‡
 of the ArixtraTM GlcNS3S6A(III) sulfamate proton (ΔG
‡
 = 18.1 kcal/mol) as 
evidence for participation in the hydrogen bond as it is about 3.0 kcal/mol larger than the 
values of the other ArixtraTM sulfamate protons (ΔG
‡
 = 15.1 – 15.7 kcal/mol).1  
Though line-shape analysis is suitable for the sulfamate and amide protons, it is not 
feasible for the characterization of the hydroxyl and amino protons under the conditions of 
our experiments because their faster rates of solvent exchange and the freezing point of the 
solution limit the temperature range over which measurements can be performed. 
Fortunately, there is another approach to access exchange rates and test susceptibility to 
exchange: the 2D 1H NMR exchange spectroscopy (EXSY) experiment.2, 3, 8, 9 The EXSY 
experiment, which uses the NOESY pulse sequence, is well-suited to characterize more 
rapidly exchanging protons and is one of the most popular NMR methods for measuring 
exchanging rates. The EXSY cross-peak intensity depends on the exchange rates and spin 
relaxation properties of the detected nuclei. Therefore, by integrating the cross-peak 
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volumes or, as demonstrated in Chapter 3, using the areas from 1D spectra extracted from 
the EXSY contour plots, a build-up curve can be generated by plotting cross peak intensity 
as a function of the EXSY mixing time. Exchange rates are extracted by fitting the build-
up curve with the Bloch equation modified to account for contributions from radiation 
damping to the longitudinal relaxation rate (Section 3.3.3.).1, 10, 11  
Using EXSY results, Beecher et al. reported three hydrogen bonds involving  the 
ArixtraTM hydroxyl protons.2 Importantly, there was agreement between the reduced 
temperature coefficients and decreased exchange rates for only of the two hydroxyl 
protons. The protons of the hydroxyl group attached to the third carbon of IdoA2S residue 
(OH3) behaved inconsistently, having a reduced exchange rate but large temperature 
coefficients. In other words, the exchange rate suggested a hydrogen bond involving the 
IdoA2S OH3, but the temperature coefficient did not support its presence.  
Because temperature coefficients are a well-established indicator of hydrogen 
bonds in carbohydrates, proteins and peptides,1, 2, 12-15 we questioned the identification of a 
hydrogen bond by faster exchange rates alone without support from the temperature 
coefficient results. This work also raised questions about the factors affecting the solvent 
exchange rate including the size, sulfo group position, type of glycosidic linkage, and other 
elements of the structure of the monosaccharide residue. As discussed in Chapter 3, in 
addition to the expected exchange rate dependence on general acid-base catalysis (Eq. 1.2), 
the spatial proximity of negatively charged groups can catalyze the solvent exchange of 
amino protons.  
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In this Chapter, the solvent exchange properties of the labile amide protons in a 
variety of GAG oligosaccharides are examined and discussed as they relate to hydrogen 
bond participation. Additionally, the polyelectrolyte character of selected oligosaccharides 
is explored at physiological pH.  
 
4.2. Experimental Section 
4.2.1. Materials and Reagents. ArixtraTM (Fondaparinux sodium), formulated as 
prefilled syringes for clinical use, was obtained from the University Pharmacy and 
Department of Pharmacy Administration of Semmelweis University (Budapest, Hungary). 
The cation exchange resin Dowex 50WX8 hydrogen form (50 - 100 mesh); 3-
(trimethylsilyl)-1-propanesulfonic acid-d6 sodium salt (DSS-d6, 98% D); 99.5% acetic 
anhydride; chondroitin sulfate A sodium salt from bovine trachea; enzymes Chondroitinase 
ABC from Proteus vulgaris and Hyaluronidase from Streptomyces hyalurolyticus; 
monosaccharides N-acetyl-D-glucosamine (GlcNAc), N-acetyl-D-glucosamine-6-O-
sulfate (GlcNAc6S), N-acetyl-D-galactosamine (GalNAc), D-glucosamine-3-O-sulfate 
(GlcN3S), and D-glucosamine-2-N-sulfate (GlcNS); ammonium bicarbonate (NH4HCO3); 
Tris-HCl; and 35 wt% deuterated hydrochloric acid (DCl, 99% D) were purchased from 
Sigma-Aldrich (St. Louis, MO). HPLC grade methanol, 12.1 N hydrochloric acid (HCl), 
50% w/w sodium hydroxide solution (NaOH), glacial acetic acid, sodium borohydride 
(NaBH4), disodium orthophosphate heptahydrate (Na2HPO4•7H2O), monobasic sodium 
phosphate ACS grade (NaH2PO4•H2O), sodium chloride (NaCl), bovine serum albumin 
(BSA) lyophilized powder, and sodium acetate trihydrate (CH3COONa•3H2O) were 
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purchased from Thermo Fisher Scientific (Bellefonte, PA). The disaccharides ΔUA-
GalNAc, ΔUA-GalNAc6S, and ΔUA-GalNAc4S were purchased from Iduron Ltd. 
(Manchester, UK). The disaccharides ΔUA2S-GlcNAc; ΔUA2S-GlcNAc6S; ΔUA-
GlcNAc6S; and ΔUA-GlcNAc and monosaccharides D-glucosamine-2-N, 3-O-disulfate 
(GlcNS3S); D-glucosamine-2-N, 6-O-disulfate (GlcNS6S); and D-glucoamine-2-N, 3-O, 
6-O-trisulfate (GlcNS3S6S) were purchased from Dextra Laboratories Ltd. (Reading, UK). 
Sodium hyaluronate was purchased from Spectrum Chemical MFG Corp. (New 
Brunswick, NJ). Chitin disaccharide (N-acetyl-glucosamine)2 was purchased from 
Qingdao BZ Oligos Biotech Co., LTD (Qingdao, China). Koptec Pure Ethanol (200 proof) 
was purchased from Decon Labs, Inc. (King of Prussia, PA). Deuterium oxide (D2O, 99.9% 
D), 40% w/w sodium deuteroxide (NaOD, 99.5% D), and the low temperature methanol 
standard were purchased from Cambridge Isotope Laboratories (Andover, MA). The pH 
meter calibration buffers 2.00, 4.00, 7.00, and 10.00 were purchased from Fisher Scientific 
(Nazareth, PA). Ultrapure deionized water (18 MΩ/cm) was prepared by Simplicity UV 
water purification system from Millipore (Billerica, MA). All pH measurements were 
performed at room temperature using an AB 15 Accumet Basic pH meter and a 9110DJWP 
double-junction Ag/AgCl micro pH electrode, both from Thermo Scientific (Chelmsford, 
MA). All pH values measured in deuterated solutions were reported with correction for the 
deuterium isotope effect (pD). NMR NE-H5/3-Br tubes were purchased from New Era 
Enterprises (Vineland, NJ).  
4.2.2. Partial digestion of bovine trachea chondroitin sulfate A with 
Chondroitinase ABC from Proteus vulgaris.16 A 0.90 g sample of bovine trachea 
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chondroitin sulfate A sodium salt was dissolved in 35 mL of 50 mM Tris buffer pH 8.0 
with 150 mM sodium acetate and 5 mg of BSA was added. Chondroitinase ABC equivalent 
to 2.5 IU was added to the room temperature solution and carefully mixed. An aliquot of 
524 µL taken from the digestion mixture was combined with 60 µL of D2O and 16 µL of 
a 100 mM DSS-d6 solution and transferred to a 5 mm NMR tube to monitor digestion 
progress as described in Chapter 1, Section 1.2.1.1. Both samples were incubated at 37 °C 
for 2 h 50 min at which point both solutions were combined and the reaction quenched by 
placing the solution in boiling water for 15 min. 
4.2.3. Digestion of hyaluronic acid with Hyaluronidase from Streptomyces 
hyalurolyticus.17-19 Two batches of hyaluronic acid oligosaccharides were prepared at 
different times using the same amounts, concentrations, and proportions of the starting 
reagents. Vials of Hyaluronidase from Streptomyces hyalurolyticus were received at 
different times and came from different lots. The digestions were carried out using a 50 mg 
sample of sodium hyaluronate dissolved in 15 mL of 200 mM sodium acetate buffer at pH 
5.1 with 0.15 M sodium chloride stored overnight in a refrigerator at 4 °C. Hyaluronidase 
equivalent to 900 IU was dissolved in 1 mL of 200 mM acetate buffer at pH 5.1 containing 
0.15 M sodium chloride and added to the hyaluronic acid solution pre-equilibrated to 37 
°C. The resulting digestion mixture was carefully but thoroughly agitated and an aliquot of 
540 µL was combined with 60 µL D2O and 10 µL of 100 mM DSS-d6 solution and 
transferred to a 5 mm NMR for reaction progress monitoring. Both samples were incubated 
for 10 h 5 min at 37 °C after which the samples were recombined and the reaction quenched 
by placing the solution in boiling water for 10 min.  
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4.2.4. Size-exclusion chromatography of chondroitin sulfate A digested 
oligosaccharides.16 The mixture of chondroitin sulfate A oligosaccharides prepared by 
enzymatic depolymerization was separated by size-exclusion chromatography using a 
mobile phase of 1 M sodium chloride with 10% of ethanol at a flow rate of 0.07 mL/min 
and a 3.0 x 200 cm atmospheric pressure chromatographic column packed with Bio-Rad 
Bio-Gel P-10 fine polyacrylamide resin (Bio-Rad Laboratories Hercules, CA). The eluted 
oligosaccharides were collected in separate 4.5 mL fractions and the separation monitored 
offline at 232 nm using a Thermo Scientific NanoDrop 2000 UV-Vis spectrophotometer 
(Wilmington, DE). The size-uniform fractions were pooled, lyophilized and desalted using 
deionized water on a 1.6 x 70 cm column packed with Sephadex G10 resin (GE Healthcare, 
Pittsburgh, PA). After desalting, the isolated oligosaccharide samples were lyophilized and 
stored at -80 °C for future use. A representative size-exclusion chromatogram is shown in 
Figure 1.5A of Chapter 1. 
4.2.5. Size-exclusion chromatography of hyaluronic acid digested 
oligosaccharides.18 Batch #1. A mixture of hyaluronic acid oligosaccharides prepared by 
enzymatic depolymerization was separated by size-exclusion chromatography using a 50 
mM ammonium bicarbonate solution at an average flow rate of 0.124 mL/min using a 3.0 
x 200 cm atmospheric pressure chromatographic column packed with Bio-Rad Bio-Gel P-
10 fine polyacrylamide resin. Eluted oligosaccharides were collected in separate 3.5 mL 
fractions. The separation was monitored offline at 232 nm using a Thermo Scientific 
NanoDrop 2000 UV-Vis spectrophotometer. The resulting size-exclusion chromatogram 
is shown in Figure 4.1A.   
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Figure 4.1. Size-exclusion chromatograms of hyaluronic acid digested by Hyaluronidase 
from Streptomyces hyalurolyticus in batch #1. (A) The poor separation of the mixture of 
hyaluronic acid oligosaccharides was due to column performance. Peaks labeled #1 and #2 
were further separated at atmospheric pressure on a 1.6 x 70 cm column packed with Bio-
Rad Bio-Gel P-6 fine polyacrylamide resin. (B) Peak #1 contains tri- and tetrasaccharides. 
(C) Peak #2 contains penta- and hexasaccharides. (D) Unresolved peaks from (A) were 
combined and separated again on a 3.0 x 200 cm column repacked with Bio-Gel P-10 fine 
resin and yielding improved chromatographic resolution.  
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An unstable flow rate and poor column packing resulted in suboptimal resolution 
of different sized hyaluronic acid oligosaccharides in the chromatogram in Figure 4.1A. 
Screening of isolated fractions by ESI-MS revealed the presence of odd-numbered 
oligosaccharides, which was inconsistent with the expected specificity of the enzyme used 
in this digestion. Major products of enzymatic depolymerization of hyaluronic acid by 
Hyaluronidase from Streptomyces hyalurolyticus are expected to be even-numbered 
oligosaccharides.19 The  fractions constituting the chromatographic peak labeled #1 in 
Figure 4.1A were pooled and lyophilized before being subjected to an additional size-
exclusion chromatography using the same mobile phase at a flow rate of 0.15 mL/min on 
a 1.6 x 70 cm atmospheric pressure column packed with Bio-Rad Bio-Gel P-6 fine 
polyacrylamide resin (Bio-Rad Laboratories Hercules, CA). Eluents were collected in 
separate 0.85 mL tubes and monitored offline at 232 nm by using a Thermo Scientific 
NanoDrop 2000 UV-Vis spectrophotometer. A size-exclusion chromatogram of this 
separation is shown in Figure 4.1B, where it can be observed that peak #1 was indeed 
composed of two unresolved tri- and tetrasaccharides (labeled as dp 3 and dp 4, 
respectively). Similarly, but only part of peak #2 was resolved on a 1.6 x 70 cm size-
exclusion chromatography column, yielding the penta- and hexasaccharides labeled dp 5 
and dp 6, respectively, shown in Figure 4.1C.  
Because of the poor separation achieved in Figure 4.1A, the 3.0 x 200 cm 
atmospheric pressure chromatographic column was repacked with Bio-Rad Bio-Gel P-10 
fine polyacrylamide resin and the collected fractions including the second part of peak #2, 
were pooled, lyophilized and reconstituted in 15 mL of 50 mM ammonium bicarbonate 
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buffer and the size-exclusion chromatography carried out at a stable flow rate of 0.08 
mL/min. The result of this separation is shown in Figure 4.1D. As with before, the isolated 
fractions were identified by ESI-MS, which clearly indicated that the digestion mixture 
was composed of even- and odd-numbered oligosaccharides. Fractions constituting each 
peak were combined, lyophilized, and stored at -80 °C for future use.  
Batch #2. A second batch of hyaluronic acid oligosaccharides were prepared by 
enzymatic depolymerization with Hyaluronidase (from a different lot) and separated by 
size using a 50 mM ammonium bicarbonate solution at a flow rate of 0.07 mL/min on a 3.0 
x 200 cm atmospheric pressure chromatographic column packed with Bio-Rad Bio-Gel P-
10 fine polyacrylamide resin. The eluted oligosaccharides were collected in separate 3.5 
mL fractions and the separation monitored offline at 232 nm by using a Thermo Scientific 
NanoDrop 2000 UV-Vis spectrophotometer. The chromatogram for this separation is 
shown in Figure 1.5B (Chapter 1) and revealed good resolution of the depolymerization 
products. This digestion with Hyaluronidase from Streptomyces hyalurolyticus yielded 
even-numbered oligosaccharides, as expected. Size-uniform fractions were pooled, 
lyophilized, desalted using deionized water on a 1.6 x 70 cm column packed with Sephadex 
G10 resin (GE Healthcare, Pittsburgh, PA), lyophilized again and stored at -80 °C for future 
use. 
4.2.6. Reduction of oligosaccharides with sodium borohydride.20 About 77.0 mg 
of chondroitin sulfate A tetrasaccharide, 74.4 mg of chondroitin sulfate A hexasaccharide, 
and 2 mg of hyaluronic acid hexasaccharide were converted to alditols by reaction of the 
reducing end residues with sodium borohydride as discussed in Chapter 2, Section 2.3.3. 
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Due to the problems encountered with degradation of the unsulfated hyaluronic acid 
hexasaccharides, all steps of the hyaluronic acid hexasaccharide reduction reaction were 
performed in the presence of 10 mM phosphate buffer, which improved the stability of the 
reaction products. After desalting, the size-uniform fractions containing the hyaluronic acid 
hexasaccharides were combined and buffered with 10 mM phosphate, followed by 
lyophilization and storage at -80 °C.  
4.2.7. Strong anion-exchange high-performance liquid chromatography. The 
fractions of the bovine trachea chondroitin sulfate A digestion labeled dp 4 
(tetrasaccharide) and dp 6 (hexasaccharide) in the size-exclusion chromatogram shown 
Figure 1.5A (Chapter 1) were reduced according to the procedure previously described in 
Chapter 2, Section 2.2.4. and separated by strong anion-exchange high-performance liquid 
chromatography using a Waters Spherisorb 5 µm (Milford, MA) semi-preparative column 
(10 x 250 mm) on a Dionex 500 ion chromatography system equipped with a GP40 gradient 
pump and AD20 UV-Vis detector. The size-exclusion chromatography fractions of the 
reduced tetra- and hexasaccharides were individually dissolved in purified deionized 
degassed water and introduced onto the strong-anion exchange column in 500 µL injections 
at a flow rate of 3.0 mL/min. The oligosaccharides were separated using a 20 mM sodium 
acetate buffer at pH 3.9 as mobile phase A, and 1.0 M sodium chloride in a 20 mM sodium 
acetate buffer at pH 3.9, as mobile phase B. The following gradient profile was employed 
to separate the tetrasaccharides: 0 min, 100% A and 0% B; 1 min, 89% A and 11% B; and 
23 min, 70% A and 30% B. The following gradient profile was used for the hexasaccharide 
separation: 0 min, 100% A and 0% B; 3 min, 85% A and 15% B; and 27 min, 65% A and 
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35% B. Each run was followed by a washing step of 100% B for 10 min and column 
equilibration with 100% A for 20 min. The eluted chromatographic peaks were collected 
separately over multiple consecutive injections. Each sample was lyophilized and 
reconstituted in the minimum amount of degassed deionized water for desalting on a 1.6 x 
70 cm column packed with Sephadex G10 resin. Deionized water sonicated for 25 min was 
used as the mobile phase at a flow rate of 0.14 mL/min with the eluent collected in 1.0 mL 
fractions. The collected fractions were monitored offline using a NanoDrop 2000 UV-Vis 
spectrophotometer at 232 nm. Fractions containing the desalted oligosaccharides were 
combined, lyophilized, and stored at -80 °C for future use. 
4.2.8. Chemoselective N-acetylation of dNSA and 3-O-sulfated glucosamine. The 
chemoselective N-acetylation reaction of dNSA and 3-O-sulfated glucosamine (GlcN3S) 
are discussed in detail in Section 2.2.3, Chapter 2. 
4.2.9. ESI-MS measurements. About 1.0 mg of each desalted oligosaccharide: N-
acetylated ArixtraTM (NAcArixtra), reduced chondroitin sulfate A tetra- and 
hexasaccharides after strong anion-exchange chromatography, and size-exclusion 
chromatography separated tri-, tetra-, penta-, and hexasaccharides of hyaluronic acid - were 
individually dissolved in separate 500 µL aliquots of deionized water. An aliquot of 30 µL 
of each solution was transferred to a 1.5 mL Eppendorf safe-lock tube and diluted with 200 
µL of solution composed of 30% methanol and 70% water. These samples were infused 
into a Micromass/Waters ESI quadrupole time-of-flight (Q-Tof micro) mass spectrometer 
(Waters Corporation, Millford, MA) at a flow rate of 10 µL/min. Data acquisition was 
performed using Masslynx 4.1 software. The mass spectrum was obtained in negative 
157 
mode using the following instrumental parameters: capillary voltage, 2800-3000 kV; cone 
voltage, 25-35 V; extractor voltage, 1-3 V; source temperature, 120 °C; desolvation 
temperature, 275 °C; interscan delay, 0.1 s; and m/z range, 200 – 1500. A representative 
mass spectrum for NAcArixtra with assigned ion peaks is shown in Figure A2 of the 
Appendix.  
4.2.10. NMR measurements. 
4.2.10.1 Carbon-bound proton resonance assignments. About 1.1 mg of reduced 
chondroitin sulfate A (unsaturated reduced CS-A) tetrasaccharide and 2.0 mg of reduced 
chondroitin sulfate A (unsaturated reduced CS-A) hexasaccharide were dissolved in 700 
µL of 10 mM phosphate buffer, pH 7.40, containing 0.5 mM DSS-d6 and lyophilized. To 
reduce the intensity of the residual HOD peak, the freeze-dried samples were dissolved in 
300 µL of 99.9% D2O, lyophilized again, and reconstituted in 700 µL of 99.9% D2O. The 
unsaturated reduced CS-A tetrasaccharide solution was adjusted to pD 9.10 and the 
unsaturated reduced CS-A hexasaccharide solution was adjusted to pD 9.00 using NaOD 
and DCl prepared from concentrated solutions by dilution with the appropriate volume of 
99.9% D2O). Both solutions were lyophilized and stored at -80 °C. Prior to NMR 
measurements, the solutions were reconstituted in 700 µL of 99.9% D2O and 600 µL 
aliquots transferred to individual 5 mm NMR tubes. 
Similarly, 1.9 mg of NAcArixtra was dissolved in 300 µL of 10 mM phosphate 
buffer, pH 7.40, containing 0.5 mM DSS-d6 and lyophilized. The sample was reconstituted 
in 300 µL of 99.9% D2O, adjusted to pD 7.80 with NaOD and DCl, and lyophilized again. 
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The solid sample was stored at -80 °C and reconstituted for NMR measurements in 300 µL 
of 99.9% D2O before transferring 200 µL to a NE-H5/3-Br NMR tube.  
The 1D
 1
H, and 2D COSY, TOCSY, and ROESY spectra of the unsaturated reduced 
CS-A tetra- and hexasaccharides were acquired at 316.2 K using a Bruker Avance 600 
MHz spectrometer operating at 599.58 MHz and equipped with a BBI probe. The 90° pulse 
lengths ranged between 9.25 - 9.27 µs with solvent suppression of the HOD resonance 
provided by presaturation at a power of 59 dB during the 2.0 s relaxation delay. All spectra 
were referenced to the 
1
H resonance of DSS-d6 (0.00 ppm).  
The 1D 
1
H NMR spectra were acquired using a spectral window of 7002 Hz and 
256 scans coadded into 42,014 complex points. Spectra were zero-filled to 65,536 points 
and apodized using an exponential multiplication window function equivalent 0.3 Hz line 
broadening. The phase-sensitive 2D COSY, TOCSY, and ROESY spectra were acquired 
using States-TPPI with a spectral window of 7002 Hz in both dimensions. COSY spectra 
were acquired into 2048 complex points with 64 coadded scans and 416 t1 increments. 
TOCSY spectra were acquired using a mixing time of 120 ms with a 41 µs spinlock pulse 
at a power of 8.20 dB into 2048 complex points using 48 coadded scans and 416 
experiments. Finally, ROESY spectra were acquired using a 350 ms spinlock pulse at a 
power of 59 dB into 2048 complex points using 48 coadded scans, and 512 experiments. 
The 2D spectra were zero filled to 4096 × 1024 data points and apodized using a cos2 
window function. All spectra were analyzed using TopSpin 3.2. 
The 1D 
1
H, COSY, TOCSY, and ROESY spectra for NAcArixtra were acquired 
using a Bruker Avance 600 MHz spectrometer operating at 599.88 MHz and equipped with 
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a TBI probe at 298.2 K. A 90° pulse length of 10.12 µs was used with solvent suppression 
of the HOD resonance provided by presaturation at a power of 59 dB during the 2.0 s 
relaxation delay. The 1D 
1
H NMR spectra were acquired using a spectral window of 6361 
Hz with 120 scans coadded into 42,014 complex points. The spectra were processed by 
zero filling to 65,536 points and apodized with an exponential multiplication window 
function equivalent to 0.3 Hz line broadening. Phase-sensitive 2D COSY, TOCSY, and 
ROESY spectra were acquired using States-TPPI with a spectral window of 7002 Hz in 
both dimensions. The COSY and TOCSY spectra were acquired into 2048 complex points 
using 40 coadded scans and 416 experiments. The TOCSY were measured using a 120 ms 
mixing time with a 35 µs spinlock pulse at a power of 8.20 dB. Finally, ROESY spectra 
were acquired into 2048 complex points using 48 experiments, each with 512 coadded 
scans using a 350 ms spinlock pulse at a power of 53 dB. All two-dimensional spectra were 
zero filled to 4096 × 1024 data points and apodized using a cos2 window function. All 
spectra were analyzed using the TopSpin 3.2. Chemical shifts assignments for the 
unsaturated reduced CS-A tetra- and hexasaccharides are provided in Tables A4 and A5 
(Appendix), respectively.  The NAcArixtra carbon-bound proton assignments are provided 
in Table 3.1, Chapter 3. 
4.2.10.2. Amide proton resonance assignments. Following completion of the 
carbon-bound proton resonance assignments, the samples of the unsaturated reduced CS-
A tetra- and hexasaccharides were lyophilized, reconstituted in 630 µL of H2O and adjusted 
to pH 7.40 with NaOH and HCl solutions. After pH adjustment, 70 µL of D2O was added 
and 600 µL transferred to individual 5 mm NMR tubes. Similarly, the lyophilized 
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NAcArixtra sample was reconstituted in 270 µL of H2O and adjusted to pH 7.40 before 
adding 30 µL of D2O. A 200 µL aliquot was transferred to the NE-H5/3-Br NMR tube. 
The assignment of the carbon-bound protons and the amide protons of the GlcNAc3S 
monosaccharide was performed using a solution prepared for temperature experiments 
(Section 4.2.10.3).  
The 1D 
1
H, COSY and TOCSY spectra of the unsaturated reduced CS-A tetra- and 
hexasaccharide solutions were acquired at 316.2 K and 308.2 K, respectively, using a 
Bruker Avance spectrometer operating at 599.58 MHz and equipped with a 5 mm BBI 
probe. A 90° pulse length of 8.73 µs (tetrasaccharide) or 8.82 µs (hexasaccharide) were 
used at a power level of -4.00 dB with solvent suppression provided by excitation sculpting. 
The one-dimensional 
1
H NMR spectrum was recorded using a spectral window of 6887 Hz 
and a relaxation delay of 2.0 s with 280 scans coadded into 32,768 complex points. Free 
induction decays (FIDs) were zero-filled to 65,536 points and apodized by multiplication 
with an exponential function equivalent to 0.3 Hz line broadening prior to Fourier 
transformation. The phase-sensitive COSY and TOCSY spectra were acquired into 2048 
complex points over 256 increments using States-TPPI with a 2.0 s relaxation delay and a 
spectral window of 7003 Hz in both dimensions. The COSY spectra were recorded by 
coaddition of 96 and 160 scans for the tetra- and hexasaccharide, respectively, while 72 
(tetrasaccharide) and 96 scans (hexasaccharide) were coadded for the TOCSY spectra. The 
TOCSY spectra were acquired using a mixing time of 120 ms with a 43 µs spinlock pulse. 
The COSY and TOCSY spectra were zero-filled to 4096 × 1024 data points and apodized 
using a cos2 window function.  
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1
H, COSY, and TOCSY spectra of GlcNAc3S and NAcArixtra were acquired using 
a Bruker Avance spectrometer operating at 599.88 MHz equipped with a 5 mm TBI probe. 
All spectra were acquired at 298.2 K using a 90° pulse of 10.4 µs (GlcNAc3S) and 9.83 µs 
(NAcArixtra) at a power level of -4.00 dB with solvent suppression provided by excitation 
sculpting. The 1D 
1
H NMR spectrum was recorded using a spectral window of 6887 Hz 
and a relaxation delay of 2.0 s with 128 scans coadded into 32,768 complex points. FIDs 
were zero filled to 65,536 points and apodized by multiplication with an exponential 
function equivalent to 0.3 Hz line broadening prior to Fourier transformation. Phase-
sensitive COSY and TOCSY spectra were acquired using States-TPPI into 2048 complex 
points over 256 increments using a 2.0 s relaxation delay and a spectral window of 6614 
Hz in both dimensions. The COSY spectrum was recorded by coaddition of 48 scans while 
40 scans were coadded for the TOCSY spectrum. The TOCSY spectrum was acquired 
using a mixing time of 120 ms with a 41 µs (GlcNAc3S) or a 39 µs (NAcArixtra) spinlock 
pulse. The COSY and TOCSY spectra were zero filled to 4096 × 1024 data points and 
apodized using a cos2 window function. Amide protons assignments for the unsaturated 
reduced CS-A tetrasaccharide (Table A6A), unsaturated reduced CS-A hexasaccharide 
(Table A6B), NAcArixtra (Table A6C), and GlcNAc3S (Table A6B) are provided in 
Appendix.  
4.2.10.3. Temperature experiments. Samples of 1.75 mg GlcNAc3S, 0.77 mg 
GalNAc, 0.67 mg GlcNAc, 1.02 mg GlcNAc6S, 1.0 mg ΔUA-GlcNAc, 1.0 mg ΔUA-
GlcNAc6S, 1.0 mg ΔUA2S-GlcNAc, 1.33 mg ΔUA2S-GlcNAc6S, 1.0 mg ΔUA-GalNAc, 
1.14 mg ΔUA-GalNAc4S, 1.0 mg ΔUA-GalNAc6S, 0.97 mg unsaturated reduced CS-A 
162 
hexasaccharide, 1.80 mg unsaturated reduced CS-A tetrasaccharide, 1.90 mg NAcArixtra, 
1.2 mg unsaturated reduced hyaluronic acid (HA) hexasaccharide, 0.90 mg unsaturated HA 
trisaccharide, 1.05 mg unsaturated HA pentasaccharide, 1.26 mg unsaturated HA 
tetrasaccharide, 3.0 mg unsaturated HA hexasaccharide, and 1.12 mg chitin disaccharide 
(GlcNAc-GlcNAc) were each dissolved in 300 µL of an aqueous 10 mM phosphate buffer 
at pH 7.48 containing 0.5 mM DSS-d6. The pH of each solution was adjusted to 7.40 with 
NaOH and HCl, lyophilized and stored frozen. Prior to the NMR experiments, the solid 
samples were reconstituted in 270 µL of H2O and, if necessary, the pH was re-adjusted to 
7.40. Then, 30 µL of D2O was added to provide a lock signal and 200 µL aliquots were 
transferred to NE-H5/3-Br NMR tubes.  
Solutions of GlcNAc and GalNAc were also prepared containing various 
concentrations of the monosaccharides and buffers. For instance, 6.55 mg GlcNAc and 
6.40 mg GalNAc were dissolved in 300 µL of 10 mM phosphate buffer pH 7.48 containing 
0.5 mM DSS-d6. Alternatively, 0.74 mg GlcNAc and 0.62 mg GalNAc were dissolved in 
300 µL of 50 mM phosphate buffer at pH 7.48 containing 0.5 mM DSS-d6. The pH of each 
solution was adjusted to pH 7.40 with NaOH and HCl, followed by lyophilization. Prior to 
NMR experiments, the solid samples were dissolved in 270 µL of H2O and the pH, if 
needed, was re-adjusted to 7.40. Then, 30 µL of D2O was added and 200 µL aliquots were 
transferred to NE-H5/3-Br NMR tubes. 
Variable temperature experiments were performed over the range 283.2 K to 338.2 
K using a Bruker Avance spectrometer operating at 599.88 MHz and equipped with a 5 
mm TBI probe. One-dimensional spectra were acquired using a 90° pulse length between 
163 
9.5 and 10.6 µs at a power level of -4.00 dB with solvent suppression provided by excitation 
sculpting. A total of 128 scans were coadded into 32,768 complex points. A spectral 
window of 6887 Hz and a relaxation delay of 2.0 s were used. FIDs were zero filled to 
65,536 points and apodized by multiplication with an exponential function equivalent to a 
0.3 Hz line broadening prior to Fourier transformation. At least 7 min was allowed for 
sample thermal equilibration at each temperature. Sample temperatures were calibrated 
using an external low temperature methanol standard obtained from Cambridge Isotope 
Labs (Andover, MA) and calculated using the Van Geet equation.21 The spectra were 
referenced to the 1H resonance of DSS-d6 (0.00 ppm) and all spectra were analyzed using 
MestReNova-12.0.1.  
4.2.10.4. pH titrations. Samples of GlcNAc, GlcNAc3S, GlcNAc6S, chitin 
disaccharide, NAcArixtra, and GalNAc used for the temperature experiments were titrated 
with NaOH and HCl solutions prepared in 90% H2O/10% D2O. After adjustment to the 
desired pH, the solutions were transferred to NE-H5/3-Br NMR tubes and the spectra 
measured at 298.2 K using a Bruker Avance spectrometer operating at 599.88 MHz and 
equipped with a 5 mm TBI probe. Spectra were acquired as a function of pH using a 90° 
pulse length between 9.8 and 10.2 µs at a power level of -4.00 dB with solvent suppression 
by excitation sculpting. A total of 128 scans were coadded into 32,768 complex points 
using a spectral window of 6887 Hz and a relaxation delay of 2.0 s. FIDs were zero filled 
to 65,536 points and apodized by multiplication with an exponential function equivalent to 
a 0.3 Hz line broadening prior to Fourier transformation. Spectra were referenced to the 1H 
resonance of DSS-d6 (0.00 ppm) and analyzed using MestReNova-12.0.1. 
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For experiments with N-sulfo-glucosamines, 1.5 mg GlcNS3S6S, 0.9 mg GlcNS, 
1.3 mg GlcNS3S, and 0.9 mg GlcNS were each dissolved in 800 µL of a 90% H2O/10% 
D2O 25 mM phosphate buffer at pH 6.09 containing mM DSS-d6. The samples were titrated 
with NaOH and HCl in 90% H2O/10% D2O and aliquots of the solution at each pH were 
transferred to NE-H5/3-Br NMR tubes. 1H NMR spectra were acquired as a function of pH 
using a Bruker Avance spectrometer operating at 1H frequency of 599.52 MHz and 
equipped with a 5 mm BBI probe. NMR spectra were at 298.2 K using WATERGATE-
W5 solvent suppression.22 A total of 128 scans were coadded into 32,768 complex points 
using a 6887 Hz spectral window and a relaxation delay of 2.0 s. FIDs were zero filled to 
65,536 points and apodized by multiplication with an exponential function equivalent to  
0.3 Hz line broadening prior to Fourier transformation. All spectra were analyzed using the 
MestReNova-12.0.1. 
4.2.11. Molecular dynamics simulations. The AmberTools 16 module xleap23 was 
used to model the structures of the following saccharides in α conformation: GlcNAc, 
GlcNAc3S, GlcNAc6S, GlcNS3S6S, ΔUA-GalNAc4S, ΔUA-GalNAc6S, unsaturated HA 
hexasaccharide, unsaturated CS-A hexasaccharide, and NAcArixtra. These saccharides 
were modeled to generate the parameter, topology, and coordinate files for molecular 
dynamics simulations using a GLYCAM 06g force field.24 The xleap module was used to 
add sodium ions (ff99SB parameters) to oligosaccharide structures to make the system’s 
overall charge neutral (addions function) and to construct a cubic water box with each face 
a distance 12 Å from the solute.23-26 Minimization, heating, equilibration, and molecular 
dynamics simulation production runs were performed using NAMD 2.11.27 To remove 
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possible bad contacts, conjugate-gradient minimization was performed separately in the 
following order: solute, solvent, and the entire system. Periodic boundary conditions were 
applied throughout. The particle mesh Ewald algorithm was used to treat long range 
electrostatic interactions with the grid spacing set to 1 Å.28 Non-bonded interactions were 
cut off at 12 Å and a smooth switching function was applied to 10 Å. The VDW and 
electrostatic 1-4 scaling factors (SCNB and SCEE, respectively) were set to unity for 
consistency with the GLYCAM 06g parameters.24 The SETTLE algorithm was used to 
hold rigid hydrogen-oxygen bonds within water molecules.29 Slow system heating from 0 
K to 298 K was performed in 398 ps, including a 100 ps hold at 298 K using a constant-
NVE ensemble. A constant-NPT ensemble with a pressure of 1 atm and a temperature of 
298 K was used for system equilibration and the production run. Temperature control was 
performed using the Langevin thermostat with a damping coefficient of 5 ps-1, while 
control over pressure was performed by using NAMD’s Nosé-Hoover Langevin piston 
method.27 Trajectory outputs of 11 ns simulations were saved every 500 fs with a time step 
of simulation integration in 1 fs. Monitoring of temperature, pressure, and energy, in 
addition to trajectories visualization, was performed in VMD 1.9.2.30 The hydrogen 
bonding analysis, including a 3.5 Å heavy-atom cutoff distance and a 120° angle cutoff, 
was performed using the AmberTools 16 module cpptraj.23 
 
4.3. Results and Discussion 
To experimentally explore amide proton solvent exchange properties, we generated a 
library of amide-containing saccharides found in GAG polysaccharides, structures shown 
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in Figure 4.2 with descriptions provided in Table 4.1. Figure 4.2 C and Q also shows two 
chemically modified structures that do not occur naturally: 3-O-sulfo-N-acetyl- 
glucosamine (GlcNAc3S) and N-acetylated ArixtraTM (NAcArixtra). The variations in size, 
composition, sulfation position and extent, overall oligosaccharide charge, and glycosidic 
linkage of the compounds listed in Figure 4.2 allow the evaluation of the effect of these 
structural features on amide solvent exchange rates.  
4.3.1. Amide proton temperature coefficients. To characterize the temperature 
dependence of the amide proton chemical shifts and explore the possibility of hydrogen 
bonds involving the amide protons, 1H NMR spectra of each oligosaccharide shown in 
Figure 4.2 were acquired at pH 7.40 over the temperature range 283.2 - 338.2 K. 
Temperature coefficients were calculated by taking the absolute value of the slopes of the 
lines obtained by plotting amide proton chemical shifts as a function of calibrated 
temperatures as previously shown in Figure 3.4. Calculated Δδ/ΔT values for the 
oligosaccharide amide protons are presented in Table 4.2. None of the investigated 
structures produced a temperature coefficient that would suggest formation of an 
intramolecular hydrogen bond involving an amide proton. To help visualize the data shown 
in Table 4.2, it is also depicted in a graphical form in Figure 4.3 with the Δδ/ΔT values 
plotted as a function of the corresponding residue. In Figure 4.3, oligosaccharides are 
arranged in the order of decreasing Δδ/ΔT. Also, because the α conformers are more 
energetically favorable and dominate in aqueous solutions, they are of greater interest. As 
such, in the following discussion, the β conformers are omitted.   
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Figure 4.2. Library of amide-containing saccharides. For oligosaccharide descriptions 
refer to Table 4.1. Oligosaccharide residue numbering order is from right to the left. The 
corresponding residue number is indicated in brackets by Roman numerals.   
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Figure 4.2. Cont’d 
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Table 4.1. Description of oligosaccharide structures shown in Figure 4.2.  
Letter 
code 
Name Oligosaccharide sequence and abbreviation 
A 
N-acetyl-D-
glucosamine 
GlcNAc 
B 
N-acetyl-D-
glucosamine-6-O-
sulfate 
GlcNAc6S 
C 
N-acetyl-D-
glucosamine-3-O-
sulfate 
GlcNAc3S 
D 
N-acetyl-D-
galactosamine 
GalNAc 
E 
HEP disaccharide 
IVA 
ΔUA(II)(β1→4)GlcNAc(I) 
F Chitin disaccharide GlcNAc(II)(β1→4)GlcNAc(I) 
G HEP disaccharide IIA ΔUA(II)(β1→4)GlcNAc6S(I) 
H 
HEP disaccharide 
IIIA 
ΔUA2S(II)(β1→4)GlcNAc(I) 
I HEP disaccharide IA ΔUA2S(II)(β1→4)GlcNAc6S(I) 
J CS/DS disaccharide ΔUA(II)(β1→3)GalNAc(I) 
K CS-A disaccharide ΔUA(II)(β1→3)GalNAc4S(I) 
L CS-C disaccharide ΔUA(II)(β1→3)GalNAc6S(I) 
M 
unsaturated HA 
trisaccharide 
ΔUA(III)(β1→3)GlcNAc(II)(β1→4)GlcA(I) 
N 
unsaturated HA 
tetrasaccharide 
ΔUA(IV)(β1→3)GlcNAc(III)(β1→4)GlcA(II)(β1→3)GlcNAc(I) 
O 
unsaturated reduced 
CS-A tetrasaccharide 
ΔUA(IV)(β1→3)GalNAc4S(III)(β1→4)GlcA(II)(β1→3)GalNAc
4S(I-ol) 
P 
unsaturated HA 
pentasaccharide 
ΔUA(V)(β1→3)GlcNAc(IV)(β1→4)GlcA(III)(β1→3)GlcNAc(II) 
(β1→4)GlcA(I) 
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Q 
N-acetylated 
ArixtraTM 
GlcNAc6S(V)(α1→4)GlcA(IV)(β1→4)GlcNAc3S6S(III)(α1→4)
IdoA2S(II)(α1→4)GlcNAc6S(I)-CH3 
R 
unsaturated HA 
hexasaccharide 
ΔUA(VI)(β1→3)GlcNAc(V)(β1→4)GlcA(IV)(β1→3)GlcNAc(II
I)(β1→4)GlcA(II)(β1→3)GlcNAc(I) 
S 
unsaturated reduced 
HA hexasaccharide 
ΔUA(VI)(β1→3)GlcNAc(V)(β1→4)GlcA(IV)(β1→3)GlcNAc(II
I)(β1→4)GlcA(II)(β1→3)GlcNAc(I-ol) 
T 
unsaturated reduced 
CS-A hexasaccharide 
ΔUA(VI)(β1→3)GalNAc4S(V)(β1→4)GlcA(IV)(β1→3)GalNAc
4S(III)(β1→4)GlcA(II)(β1→3)GalNAc4S(I-ol) 
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Table 4.2. Amide proton temperature coefficients in ppb/K measured at pH 7.40. 
Subdivision of the residues in column I distinguishes temperature coefficients measured 
for the reducing end sugar in the α (I-α) or β (I-β) conformation, or in a single conformation 
such as NAcArixtra, unsaturated reduced CS-A tetra- and hexasaccharides, and unsaturated 
reduced HA hexasaccharide (I)  
Saccharide name / Residue number 
I 
II III IV V 
I-α I-β I 
 
 
       
Chitin disaccharide, GlcNAc-GlcNAc 9.0 7.8  8.3    
Monosaccharide, GlcNAc6S 8.6 7.6      
Monosaccharide, GlcNAc 8.7 7.8      
Disaccharide, ΔUA2S-GlcNAc 8.3 7.4      
Monosaccharide, GalNAc 8.6 7.5      
Disaccharide, ΔUA-GlcNAc6S 8.4 7.5      
Disaccharide, ΔUA-GlcNAc 8.7 7.6      
Disaccharide, ΔUA2S-GlcNAc6S 8.3 7.5      
Disaccharide, ΔUA-GalNAc 8.1 7.2      
Disaccharide, ΔUA-GalNAc6S 8.2 7.4      
Disaccharide, ΔUA-GalNAc4S 7.4 7.2      
Monosaccharide, GlcNAc3S 7.1 8.1      
Unsaturated HA trisaccharide    6.7    
Unsaturated HA tetrasaccharide 8.9 7.6   6.7   
Unsaturated HA pentasaccharide    6.7  6.6  
Unsaturated HA hexasaccharide 8.9 7.5   6.6  6.5 
Unsaturated reduced HA hexasaccharide   8.4  6.1  6.7 
Unsaturated reduced CS-A tetrasaccharide   5.8  6.1   
Unsaturated reduced CS-A hexasaccharide   6.2  6.1  6.1 
NAcArixtra   7.8  7.4  7.8 
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Figure 4.3. Graphical depiction of the data of the amide proton temperature coefficients 
presented in Table 4.2. The graph does not include the temperature coefficient of β 
conformers. The 3-O-sulfated residues are indicated by solid black circles and 4-O-sulfated 
GalNAc residue is highlighted by a solid grey circle. 
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The GlcNAc3S monosaccharide and NAcArixtra pentasaccharide are structurally 
unique and were prepared to facilitate evaluation the effect of a 3-O-sulfo group on an 
adjacent amide moiety. Previously, in Chapter 3, it was shown that the 3-O-sulfo group of 
the internal residue of de-N-sulfated ArixtraTM (dNSA) formed a hydrogen bond with 
amino protons stabilized by a salt bridge. The earlier work of Langeslay et al.1 identified 
that the same 3-O-sulfo group in ArixtraTM was involved in a hydrogen bond with the 
adjacent sulfamate group proton. In this work, the N-sulfo groups of ArixtraTM were 
replaced by N-acetyl groups to evaluate possible hydrogen bond formation involving an 
amide proton and an adjacent 3-O-sulfo group. To our surprise, all three amide groups of 
NAcArixtra gave virtually identical Δδ/ΔT values, a result that does not support the 
formation of a persistent hydrogen bond between the 3-O-sulfo group and the adjacent 
amide group of the internal glucosamine residue. This is in contrast to what was reported 
for the N-sulfated glucosamine of ArixtraTM,1 or observed for the unmodified amine group 
of dNSA in Chapter 2. Moreover, the Δδ/ΔT values of NAcArixtra were slightly higher 
than those of the GlcNAc3S monosaccharide and opposed to the general trend formed by 
the other larger oligosaccharides.  
Interestingly, the 3-O-sulfo group of the GlcNAc3S monosaccharide showed the 
most reduced Δδ/ΔT value of all mono- and disaccharides. A slightly higher Δδ/ΔT value 
was observed for ΔUA(II) (β1→3) GalNAc4S(I). This disaccharide has three distinctive 
features that distinguishes it from the GlcNAc3S monosaccharide, including a 4-O-sulfated 
GalNAc residue (GalNAc4S), and an unsulfated unsaturated uronic acid residue (ΔUA) 
connected to GalNAc4S by a β1→3 glycosidic linkage. The temperature coefficients for 
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GalNAc and GlcNAc are not significantly different, so the effect of sugar type can be 
excluded. Replacement of the GalNAc 4-O-sulfo group with a 6-O-sulfo group in ΔUA(II) 
(β1→3) GalNAc6S(I) led to increased Δδ/ΔT relative to ΔUA(II) (β1→3) GalNAc6S(I). 
Also, there is no difference in the Δδ/ΔT values for ΔUA(II) (β1→3) GalNAc6S(I) and the 
unsubstituted ΔUA(II) (β1→3) GalNAc(I), indicating that the 6-O-sulfo substituent is too 
distant to affect the amide proton.  
Comparison of the effect of different glycosidic linkages for ΔUA(II) (β1→3) 
GalNAc(I) and ΔUA(II) (β1→4) GlcNAc(I) indicates a slightly higher Δδ/ΔT associated 
with the β1→4 linkage. Insertion of the 2-O-sulfo group in the unsaturated uronic acid 
residue of ΔUA2S(II) (β1→4) GlcNAc(I) and produced a slight decrease in Δδ/ΔT 
compared with ΔUA(II) (β1→4) GlcNAc(I). Identical results were obtained for ΔUA2S(II) 
(β1→4) GlcNAc(I) and ΔUA2S(II) (β1→4) GlcNAc6S(I) and, as with GalNAc, no effect 
was observed between the unsulfated and 6-O-sulfated GlcNAc monosaccharides. 
Interestingly, however, replacement of the ΔUA with a GlcNAc residue produced a larger 
Δδ/ΔT for GlcNAc(II) (β1→4) GlcNAc(I).  
Comparison of the amide proton’s Δδ/ΔT within monosaccharides and 
disaccharides revealed the following trends: (1) no difference is observed between types of 
unsulfated amino sugars; (2) the amide protons in disaccharides with a β1→3 glycosidic 
linkage have slightly reduced Δδ/ΔT values relative to the  β1→4 linkage; (3) 6-O-sulfation 
had no or a very little effect on Δδ/ΔT; (4) negatively charged unsaturated uronic acid 
residues decreased Δδ/ΔT, while 2-O-sulfo substituted ΔUA residues contributed to further 
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decreases in Δδ/ΔT; and (5) 4-O-sulfated and 3-O-sulfated amino sugars had significantly 
reduced Δδ/ΔT compared to other mono- and disaccharides.  
The monosaccharide GlcNAc3S gave Δδ/ΔT values comparable to the larger 
oligosaccharides. Across the large oligosaccharides, the most reduced Δδ/ΔT values were 
observed for the unsaturated tetra- and hexasaccharides derived from CS-A, and 
unsaturated HA hexasaccharide. The Δδ/ΔT values of amide protons of the reducing end 
residues were consistent with the Δδ/ΔT’s of mono- and disaccharides. The amides of the 
CS-A oligosaccharides had lower Δδ/ΔT values compared to the unsulfated HA 
oligosaccharides, further supporting the effect of 4-O-sulfation on reduction of Δδ/ΔT 
values.  
Another important observation is that the presence of glucuronic acid (GlcA) in 
reduces the Δδ/ΔT of adjacent amide-containing residues, especially when the amide-
containing residue is situated between two GlcA residues. For disaccharides with an 
unsaturated uronic acid at the non-reducing end, the presence of the ΔUA residue appears 
to slightly reduce the Δδ/ΔT of the preceding N-acetylated amine group. In larger 
oligosaccharides, when the N-acetylated amine group is preceded by a GlcA residue and 
followed by an unsaturated uronic acid, the amide proton Δδ/ΔT value is reduced more 
substantially, as can be observed for the unsaturated HA trisaccharide. Furthermore, the 
GlcNAc6S(I) and GlcNAc6S(V) residues of NAcArixtra, which are linked to only one 
uronic acid, showed higher values of Δδ/ΔT than the amide of GlcNAc3S6S(III) which is 
situated between GlcA(IV) and IdoA2S(II) residues.  
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Because the concentrations of the saccharide samples studied varied due to the 
limited availability of some compounds, we evaluated the effect of sugar and phosphate 
buffer concentrations on our measurements. Temperature coefficients of 10 mM GlcNAc 
in 10 mM phosphate buffer (α = 8.7 ppb/K, β = 7.8 ppb/K), 100 mM GlcNAc in 10 mM 
phosphate buffer (α = 8.6 ppb/K, β = 7.6 ppb/K), and 10 mM GlcNAc in 50 mM phosphate 
buffer (α = 8.6 ppb/K, β = 7.5 ppb/K) showed no large deviations that can be ascribed to 
either the saccharide or buffer concentration. Similarly, 10 mM GalNAc in 10 mM 
phosphate buffer (α = 8.6 ppb/K, β = 7.5 ppb/K), 100 mM GalNAc in 10 mM phosphate 
buffer (α = 8.5 ppb/K, β = 7.5 ppb/K), and 10 mM GalNAc in 50 mM phosphate buffer (α 
= 8.7 ppb/K, β = 7.6 ppb/K) also showed no large deviations. Errors in the experimental 
values of Δδ/ΔT are estimated to be around  0.1 ppb/K due to differences in sample 
preparation, shimming, temperature fluctuations and error in the temperature calibration 
using the external methanol standard.  
4.3.2. Line-shape analysis and energy barriers. The variable temperature 
experiments used for the calculation of temperature coefficients can also provide 
information about the solvent exchange of the labile protons. Resonance line widths are 
related to the rate constant (kex) of the solvent exchange reaction and were measured for 
the amide protons by nonlinear least squares fitting of a Lorentzian peak shape to the 
experimental spectra using MestReNova-12.0.1 as shown in Figure 4.4A. The extracted 
line widths at half height were plotted as a function of the calibrated temperatures as shown 
in Figure 4.4B, followed by fitting into the Eyring-Polanyi equation (Eq. 1.1) to calculate 
the energy barrier, ΔG
‡
, associated with amide proton solvent exchange. Example with  
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Figure 4.4. (A) Example of amide proton resonance peak fitting to extract the line widths 
at half height for a GlcNAc α and β anomer measured at 293.2 K using MestReNova-12.0.1 
software. Experimentally measured spectrum is plotted in black, simulated spectrum in 
blue, fitted spectrum in purple with residuals shown in red. (B) Example plot for the 
determination of activation energy barriers, ΔG
‡
, for GlcNAc α anomer. Each red data 
point corresponds to amide proton resonance line width measured at half height as function 
of calibrated temperature. Blue line is an exponential fit of the data to the Eyring-Polanyi 
equation (Eq. 1.1.). (C) Residual line widths (difference between measured and fitted line 
widths) for plot shown in (B). 
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detailed ΔG
‡
 calculation can be found in Figure A3 (Appendix). The calculated values of 
ΔG
‡
 are summarized in Table 4.3. 
Again, the data presented in Table 4.3 can be more easily visualized as a graph of ΔG
‡
 
plotted as a function of the corresponding amide-containing residue. Figure 4.5 plots the 
measured ΔG
‡
 values using the same saccharide order as in Figure 4.3. Comparison of 
Figures 4.3 and 4.5 reveals that the trend of the ΔG
‡
 values is reciprocal to that for the 
Δδ/ΔT values. In other words, amide protons with reduced values of Δδ/ΔT have generally 
higher activation energy barriers, meaning that their rate of exchange with water molecules 
is slower. This is in contrast to the reduced Δδ/ΔT value and accelerated solvent exchange 
rates observed for the dNSA GlcN3S6S(III) amine protons in Chapter 3.  
Most interesting is the high energy barrier calculated for the internal 
GlcNAc3S6S(III) residue of NAcArixtra. The hydrogen bond identified by Langeslay et 
al. involving the internal ArixtraTM GlcNS3S6S(III) sulfamate proton was supported by 
both a reduced temperature coefficient and a high energy barrier for solvent exchange.1 In 
contrast, despite its higher ΔG
‡ 
value, the absence of a reduced temperature coefficient 
does not support the participation of the NAcArixtra GlcNAc3S6S(III) amide proton in a 
hydrogen bond.  
Distinctively different ΔG
‡
 values were observed for the 3-O- and 4-O-sulfated residues of 
GlcNAc3S and ΔUA(II) (β1→3) GalNAc4S(I), respectively. Their ΔG
‡
 values are 
comparable to those measured for the larger oligosaccharides. Furthermore, the energy 
barrier for amide proton solvent exchange in the chitin disaccharide, which lacks a linkage 
to a uronic acid residue, was the lowest value of all the saccharides examined.   
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Table 4.3. Calculated activation energy barriers, ΔG
‡
 (in kcal/mol) associated with amide 
proton solvent exchange. Errors were calculated through a numerical estimate of the 
covariance matrix and corresponded to ± 2.48 times the standard error for each parameter 
in this two-parameter fit. To compensate for systematic errors, the calculated errors for 
each measurement were rounded up to ± 0.1 kcal/mol. 
Saccharide name / Residue number 
I 
II III IV V 
I-α I-β I 
 
 
       
Chitin disaccharide, GlcNAc-GlcNAc 16.2 15.6  15.8    
Monosaccharide, GlcNAc6S 16.2 15.7      
Monosaccharide, GlcNAc 16.4 15.8      
Disaccharide, ΔUA2S-GlcNAc 16.4 15.9      
Monosaccharide, GalNAc 16.5 15.9      
Disaccharide, ΔUA-GlcNAc6S 16.5 15.7      
Disaccharide, ΔUA-GlcNAc 16.5 15.5      
Disaccharide, ΔUA2S-GlcNAc6S 16.6 16.0      
Disaccharide, ΔUA-GalNAc 16.8 16.0      
Disaccharide, ΔUA-GalNAc6S 16.9 15.9      
Disaccharide, ΔUA-GalNAc4S 17.7 16.2      
Monosaccharide, GlcNAc3S 17.8 17.7      
Unsaturated HA trisaccharide    17.6    
Unsaturated HA tetrasaccharide 16.6 16.0   17.5   
Unsaturated HA pentasaccharide    18.0  17.8  
Unsaturated HA hexasaccharide 16.9 16.0   17.7  17.6 
Unsaturated reduced HA hexasaccharide   16.9  17.7  17.6 
Unsaturated reduced CS-A tetrasaccharide   17.7  17.6   
Unsaturated reduced CS-A hexasaccharide   18.4  17.8  17.6 
NAcArixtra   17.4  19.5  17.4 
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Figure 4.5. Graphical depiction of the amide proton ΔG
‡
 results from Table 4.3 with the β 
conformers omitted. The saccharide order is the same as in Figure 4.3. 3-O-sulfated 
GlcNAc residues are highlighted with solid black diamonds and the 4-O-sulfated GalNAc 
residue is indicated with a solid grey diamond. 
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These observations suggest that charge plays an important role in the energy barriers for 
amide proton exchange with water. Given the role of H+ and OH- ions in catalyzing the 
solvent exchange of labile protons, as described by Eq. 1.2 (kex = kH+[H
+
] + kOH-[OH
-
]), the 
proximity of centers of negative charge nearby an amide proton would be expected to slow 
exchange by repulsing OH- ions, which would be reflected by higher values of ΔG
‡
. To 
examine the effects of negatively charged groups on amide proton exchange, pH titrations 
were performed for a set of saccharides with unique structural differences as described in 
the following section. 
4.3.3. Effects of pH on labile proton resonance linewidths. 1H NMR spectra were 
acquired as a function of pH for GalNAc, GlcNAc, GlcNAc6S, GlcNAc3S, the chitin 
disaccharide and NAcArixtra. The linewidths of the amide proton resonances of these 
saccharides are plotted in Figure 4.6 as a function of pH. It was previously reported that 
amide proton exchange with water occurs through an acid-base catalysis mechanism.31, 32 
As noted in Section 1.4.2, rate constants for the acid and base catalyzed exchange reactions 
are not equal and depend on the chemical system. From Figure 4.6, it is apparent that in 
the acidic region there are no changes in the amide proton line widths even at the lowest 
pH tested (~2.5). In the resonance structure of amide groups, the carbonyl oxygen atom is 
partially negatively charged, while the amide nitrogen carries partial positive charge. 
Consequently, charge repulsion between the partially positively charged nitrogen and 
hydronium ions at low pH prevents acid catalyzed exchange. As the pH is raised, the 
concentration of hydroxyl ions increases and base catalyzed exchange rates increase 
resulting in line broadening.   
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Figure 4.6. pH titration of GalNAc, GlcNAc, chitin disaccharide, GlcNAc6S, GlcNAc3S, 
and NAcArixtra. Line widths of the amide resonances were measured as function of 
solution pH at 298.2 K.  
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Closer examination of the basic region of Figure 4.6 reveals interesting trends 
correlated to the saccharide structures. At pH 9, the uncharged saccharides have the 
broadest resonances reflecting faster solvent exchange. In contrast, for the sulfated sugars, 
the bulky negatively charged sulfate groups repel the negatively charged hydroxyl ions, 
reducing the extent of base catalyzed solvent exchange and producing less line broadening. 
Because of the close spatial proximity of the 3-O-sulfo and amide groups, base catalyzed 
exchange is least effective for the 3-O-sulfated saccharide residues. Though increased line 
broadening is observed for the GlcNAc3S monosaccharide above pH 9, the NAcArixtra 
GlcNAc3S6S(III) amide proton is unaffected by increases in pH. In addition to the 3-O and 
6-O sulfo groups of this residue, the additional negative charges from the adjacent GlcA 
and IdoA2S residues contribute to the negative charge density in the neighborhood of the 
amide proton, essentially shutting down the base catalyzed exchange mechanism. 
To further evaluate the effect of structure and charge repulsion on the solvent 
exchange rates of labile protons, we performed a similar NMR pH titration for the N-
sulfated monosaccharides GlcNS, GlcNS3S, GlcNS6S, and GlcNS3S6S. Because the 
sulfamate nitrogen does not have a resonance structure and the charge on nitrogen is 
neutral, acid and base catalysis of the sulfamate proton exchange is observed in Figure 4.7 
as expected. However, based on the results for the N-acetylated saccharides (Figure 4.6), 
monosaccharides containing a 3-O-sulfo group should repel hydroxide ions and reduce the 
contributions from base catalyzed exchange. Among the monosaccharides examined, only 
GlcNS has no O-sulfo groups and therefore it should experience the greatest base catalyzed 
exchange as observed in Figure 4.7. The pH dependent line broadening experienced by the   
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Figure 4.7. pH titration of N-sulfo glucosamine monosaccharides: D-glucosamine-2-N-
sulfate (GlcNS), D-glucoamine-2-N,3-O-disulfate (GlcNS3S), D-glucosamine-2-N,3-O- 
and 6-O-trisulfate (GlcNS3S6S), and D-glucosamine-2-N,6-O-disulfate (GlcNS3S6S). 
Line widths of the sulfamate resonances were measured as function of solution pH at 298.2 
K.  
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6-O-sulfated GlcNS sulfamate proton is only slightly less than that of GlcNS because the 
6-O-sulfo group is located far from the sulfamate and only weakly repels the hydroxyl ions. 
Finally, the sulfamate line widths of the GlcNS3S and GlcNS3S6S monosaccharides are 
least affected by increasing pH because the adjacent bulky negatively charged 3-O-sulfate 
group effectively repels hydroxyl ions. A similar pH titration curve was reported for the 
sulfamate group of the ArixtraTM GlcNS3S6S(III) residue by Langeslay et al. with narrow 
line widths observed even at pH values near 11.1 Though Langeslay et al. attributed this 
unusual pH stability to the participation of the sulfamate proton in a hydrogen bond with 
the 3-O-sulfo group, based on the results obtained for the N-sulfo glucosamine 
monosaccharides in Figure 4.7 and the similar pH dependence of the NAcArixtra titration 
curve (Figure 4.6) it is clear that the lack of line broadening of the ArixtraTM 
GlcNS3S6S(III) sulfamate proton in basic solution is due to charge repulsion of the 
hydroxide ions and less effective base catalysis. 
In another study, Beecher et al. identified three hydrogen bonds involving the 
hydroxyl protons of ArixtraTM by measurements of the hydroxyl proton solvent exchange 
rates and temperature coefficients.2 The reduced exchange rates measured for two of the 
hydroxyl protons involved in hydrogen bonds were supported by reduced temperature 
coefficients. However, there was a discrepancy between the lower solvent exchange rate 
of the IdoA2S hydroxyl proton (OH3) and its large temperature coefficient. Because of the 
proximity of the IdoA2S 2-O-sulfo group, the reduced exchange rate observed for OH3 
likely reflects charge repulsion of hydroxide ions and a reduction in base catalyzed solvent 
exchange rate.  This information, together with the results presented in Chapter 3 confirm 
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that temperature coefficients are the most reliable indicators of hydrogen bonding, and that 
while exchange rates can provide important insights, their interpretation must include an 
understanding of the effects of local structure on the acid-base catalyzed solvent exchange 
mechanism.  
4.4. Molecular dynamics simulations. To visualize the oligosaccharide 
structures and estimate the distances separating amide protons from the oxygens of O-sulfo 
groups and uronic acid carboxylates, we selected saccharides with variable sulfation 
patterns and size. The structures of mono- and disaccharides shown in Figure 4.8 were 
prepared as described in the experimental section. Figures 4.8 A, B, and C show 
monosaccharides of N-acetylated glucosamines that differ in the sulfation position. We can 
see that the GlcNAc3S 3-O-sulfo group is indeed closest to the amide group. Furthermore, 
the distance for the 4-O-sulfo group of the GalNAc4S residue (Figure 4.8E) is only 2.30 Å 
longer than that of the 3-O-sulfo group, which explains why the amide proton had the 
second highest activation energy of the measured mono- and disaccharides (Table 4.3). A 
shorter distance (4.3 Å) between the sulfamate proton and 3-O sulfo group was also 
measured for the GlcNS3S6S monosaccharide shown in Figure 4.9D. However, because 
the GlcNS3S6S monosaccharide needs to accommodate three negatively charged sulfate 
groups, the distance separating the sulfamate proton and 3-O-sulfo group is slightly longer 
(by 0.20 Å) than in GlcNAc3S. Therefore, all measured distances support charge repulsion 
of hydroxyl ions by neighboring negatively charged groups.  
Interesting results were also obtained from the MD simulations for NAcArixtra, the 
unsaturated HA hexasaccharide, and the unsaturated CS-A hexasaccharide. Representative   
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Figure 4.8. 3D representations of the mono- and disaccharides in the α conformation. (A) 
GlcNAc, (B) GlcNAc3S, (C) GlcNAc6S, (D) GlcNS3S6S, (E) ΔUA-GalNAc4S, and (F) 
ΔUA-GalNAc6S. For convenience, each carbon of the sugar ring is labeled according to 
its position relative to anomeric carbon (C1). Measured average distances separating 
amide/sulfamate proton and the O-sulfo groups are shown.  
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structures of each oligosaccharide taken from one of the simulation frames are shown in 
Figure 4.9. The experimentally observed effect of glucuronic acid on the adjacent amide-
containing residue is reflected by the proximity of the negatively charged carboxylate 
oxygens to the amide protons. Consider, for example, the HA hexasaccharide, shown in 
Figure 4.9B. The amide proton of the GlcNAc(V) residue is only 3.16Å away from the 
GlcA(IV) carboxylate oxygens. Similarly, the amide proton of the GlcNAc(III) residue is 
only 3.01Å from the carboxylate oxygens of the GlcA(II) residue. In contrast, the distance 
between the amide proton in GlcNAc(III) and carboxylate oxygens of GlcA(IV) was 
almost two times greater, approaching 7.55Å. Also, the longer distance separating the 
carboxylate of the ΔUA(VI) residue and the amide proton of GlcNAc(V) residue (~ 6.71Å) 
explains the small effect of the ΔUA residue on solvent exchange rates. These observations 
are also applicable to the GlcA residues of the CS hexasaccharide and NAcArixtra, shown 
in Figure 4.9 C and D, respectively. 
Finally, analysis of the trajectories of the MD simulations for the structures shown 
in Figure 4.9 predicted hydrogen bonds, however, none of the amide protons are involved 
in hydrogen bonds, consistent with experimental data. Hydrogen bond donor-acceptor pairs 
predicted by MD with occupancies greater than 25% lifetime of frames are highlighted 
with black dashed lines. The hydrogen bond that was predicted between the 2-O-sulfo 
group and OH3 hydroxyl proton in IdoA2S(II) (39%) was consistent with what was 
previously reported in ArixtraTM (32%) when IdoA2S residue adopts a 2S0 chair 
conformation. Another hydrogen bond between hydroxyl proton OH3 in GlcNAc6S(I) and 
ring oxygen of IdoA2S(II) (45%) was also previously reported for ArixtraTM (32% when  
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Figure 4.9. 3D representation of the penta- and hexasaccharides (A) N-acetylated 
ArixtraTM (NAcArixtra), (B) unsaturated HA hexasaccharide, and (C) unsaturated 4-O-
sulfated chondroitin sulfate hexasaccharide. In addition to the shortest averaged distances 
separating the amide protons from oxygens of the O-sulfo groups, the distances separating 
amide protons from the uronic acid carboxylate oxygens are also reported, and hydrogen 
bonds, shown by striped bars, with occupancies greater than 25% are indicated.  
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IdoA2S residue adopts 2S0, 60% when IdoA2S residue adopts 
1C4, and 43% overall). For 
the HA hexasaccharide, MD predicted hydrogen bonds involving all ring oxygens in 
internal residues with hydroxyl protons in adjacent residues. However, as can be seen from 
Figure 4.9C for the CS hexasaccharide, disruption of hydrogen bonds was observed 
between GalNAc4S(I) and GlcA(II) and between GalNAc4S(III) and GlcA(IV) when the 
4-O-sulfo group was present in GalNAc residues. 
 
4.4 Conclusions 
By generating a library of N-acetylated saccharides, we evaluated the effect of 
structural features, including size, sulfation, and glycosidic linkage, on amide proton 
solvent exchange. Through the temperature experiment carried out at solution pH 7.4, we 
acquired one-dimensional NMR spectra from which amide proton temperature coefficients 
and energy barriers for solvent exchange were calculated. None of the structures were 
identified to be involved in hydrogen bonds, however, 3-O-sulfated amide-containing 
residues showed very distinctive and high energy barriers associated with reduced 
exchange rates. By comparison of the activation energy barriers for all the saccharides 
studied, we identified certain elements of saccharide structure that slow exchange by 
charge repulsion of hydroxyl ions reducing based catalyzed exchange. Negatively charged 
sulfate and carboxylate groups in close spatial proximity to amide protons reduce the 
exchange rate. The experimental observations were supported by distances calculated from 
MD simulations. Reduced exchange rates or very high activation energies cannot alone be 
used to identify hydrogen bonds involving the labile protons of GAG oligosaccharides and 
191 
should be interpreted in concert with additional evidence supporting hydrogen bond 
participation, such as a reduced temperature coefficient. 
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CHAPTER FIVE 
Conclusions and Future Directions 
 
5.1. Conclusions 
Glycosaminoglycans (GAGs) are important biological players. They are involved 
in a range of life-essential processes, from lubrication of the human joints to modulating 
complex signaling pathways. The family of GAGs, composed of heparin, heparan sulfate, 
chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid, is synthesized 
by non-template driven biosynthetic pathways. Complications in GAG studies arise from 
their structural complexity introduced by post-biosynthetic backbone modifications 
produced by a variety of enzymatic complexes capable of encoding certain specificities 
into their final structures. Some of these elements of structure are required for specific 
binding to proteins or other regulators of biological processes. Additional factors that 
complicate research on GAGs include the structural polydispersity and heterogeneity of 
these linear unbranched polysaccharides, where the molecular weight of some members 
(hyaluronic acid) approach several million Daltons.1  
Many GAG-protein interactions occur through non-specific binding of negatively 
charged polysaccharides with positively charged amino acids in proteins. However, some 
interactions require specific recognition by proteins through different structural motifs and 
elements localized within the polysaccharide chains. Furthermore, some of the interactions 
are highly dependent on particular arrangements of saccharide residues within the 
polysaccharide sequences, aptly illustrated by the well-studied heparin-antithrombin-III 
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interactions. Moreover, certain structural elements present in GAGs may play key roles in 
the pre-organization of the secondary structure of regions found within the polysaccharide 
chains in a manner that facilitates high affinity binding. In the case of heparin-
antithrombin-III, it requires a pentasaccharide sequence that includes a GlcA-GlcNS3S6S-
IdoA2A structural motif as the minimum sequence for high affinity binding.2 Removal of 
the 3-O-sulfo group from GlcNS3S6S residue decreases the antithrombin-III binding 
affinity of an oligosaccharide 1000-fold.3  
Langeslay et al. identified an additional unique feature of the same 3-O-sulfo group 
- its involvement in a persistent hydrogen bond with the adjacent N-sulfo proton of 
GlcNS3S6S in ArixtraTM.4 More recently, Beecher et al. complemented the findings of 
Langeslay et al. with two additional identified hydrogen bonds involving hydroxyl protons 
of ArixtraTM.5 These discoveries suggest that certain structural elements may be 
responsible for the pre-organization of regions of secondary structure that promote  specific 
GAG-protein recognition. The motivation underlying my dissertation research has been the 
deeper exploration of the properties of GAG oligosaccharides in aqueous solution with the 
aim of advancing our understanding of the relationship between elements of primary 
structure and how they can stabilize secondary structure. Knowledge of these aspects can 
in turn enhance our understanding of GAG-protein interactions.  
Investigation of the structures and physico-chemical properties of GAGs by NMR 
requires sufficient amounts of relatively pure materials, typically about 1 mg of each 
compound. Because of the heterogeneity and polydispersity of GAGs, structural studies 
typically rely on oligosaccharides derived from polysaccharides. The desired 
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oligosaccharide structures can often be obtained through chemical or enzymatic 
depolymerization of suitable polysaccharide substrates followed by chromatographic 
isolation. However, for rare but biologically important motifs, isolation from GAG digests 
can be quite challenging given the labor-intensive nature of this process. In vitro 
chemoenzymatic and organic synthesis approaches under development show promise for 
the preparation of tailor-made heparin and heparan sulfate oligosaccharides but these 
methods are not yet robust or routine6, 7. The approach described in Chapter 2 relies on 
chemical modification of more abundant oligosaccharides to prepare novel 
oligosaccharides with desired structural elements. These oligosaccharides then were used 
in studies to explore their solution properties as discussed in Chapters 3 and 4. For example, 
to obtain access to heparan sulfate-like oligosaccharides containing the rare 3-O-sulfated 
glucosamine residue, the synthetic pentasaccharide ArixtraTM was modified by the 
chemical removal of the N-sulfo groups. As a result of the solvolytic de-N-sulfation 
reaction, we obtained the zwitterionic structure of de-N-sulfated ArixtraTM (dNSA) which 
provides an excellent substrate to examine the potential for salt bridge formation in heparan 
sulfate. Then, dNSA was further transformed by chemoselective N-acetylation into N-
acetylated ArixtraTM (NAcArixtra). This unique semi-synthetic oligosaccharide provided 
an excellent substrate for the study of the solvent exchange properties of oligosaccharide 
amide protons, discussed in Chapter 4. Another important chemical modification of GAGs 
was the conversion of the reducing end aldose to an alditol through the reduction reaction 
with sodium borohydride. The isolation and structure elucidation of reduced 
oligosaccharides is simplified because the complexity introduced by the presence of  and 
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 anomers is removed. Finally, because these structural modifications involve chemical 
reactions that can potentially alter or degrade the targeted structures, all prepared 
oligosaccharides were structurally elucidated and confirmed by MS and NMR. 
The hydrogen bond identified by Langeslay et al. in ArixtraTM between the 3-O-
sulfo group and the adjacent N-sulfamate proton suggests that a hydrogen bond or salt 
bridge could also be structurally important in the 3-O-sulfated glucosamine residues 
prevalent in heparan sulfate. In Chapter 3, the amino proton solvent exchange properties 
of dNSA and a structurally similar de-N-sulfated heparin tetrasaccharide (dNSt) are 
explored through measurements of temperature coefficients, exchange rates, and pKa 
values. Reduced temperature coefficients, highly accelerated exchange rates promoted by 
neighboring negatively charged groups and altered the pKa values of amino and 
carboxylate groups served as indicators of potential electrostatic interactions involving an 
amino group of the internal dNSA residue (GlcN3S6S(III)) and two negatively charged 
groups—the adjacent 3-O-sulfo group and the carboxylate group of the IdoA2S residue. 
To complement the experimental findings and visualize the trajectories of dNSA in water, 
we performed a 300 ns MD simulation using the GLYCAM 06g force field with custom 
adjusted partial charges on nitrogen and hydrogens of amino groups using GAUSSIAN 
B3LYP/6-31G. 
In Chapter 4, a library of 20 saccharide structures was assembled differing in size, 
extent of sulfation, position of sulfation, glycosidic linkage, and type of amino sugar and 
uronic acid residue. Using this library, the effects of saccharide structure on amide proton 
solvent exchange were evaluated using temperature coefficients, the calculation of energy 
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barriers for exchange (ΔG
‡
) obtained by line-shape analysis of NMR spectra acquired as a 
function of temperature, and pH titration to examine the role of structural elements, in 
particular sulfate and carboxylate groups, on the acid-base catalysis of amide proton-
solvent exchange. We identified that charge repulsion of negatively charged hydroxyl ions 
takes place when negatively charged sulfates and carboxylates are in close spatial 
proximity to the amide protons. The strongest charge repulsion of hydroxyl ions is caused 
by the proximate 3-O-sulfo group, and as result the labile amide protons adjacent to the 3-
O-sulfo group experience the highest energy barriers for solvent exchange and 
consequently the slowest exchange rates. The effects of charge repulsion on sulfamate 
proton exchange was also examined a for series of N-sulfated saccharides yielding similar 
observations and clarifying previous studies identifying hydrogen bonds involving the 
ArixtraTM sulfamate and hydroxyl protons. Although charge repulsion by the 4-O-sulfo 
group is less, its effect on amide proton exchange can be observed. In contrast the 6-O-
sulfo group, which is much further away, has little to no effect on amide proton solvent 
exchange. Surprisingly, adjacent GlcA residues, especially those on the reducing end side 
of a GlcNAc residue exhibit a charge repulsion effect, reducing the magnitude of base-
catalyzed amide exchange. The MD simulations revealed that the distance separating 
carboxylate oxygens of GlcA the adjacent residue (on the reducing end side) of the GlcNAc 
amide group proton is comparable to the distance separating the 3-O- and 4-O-sulfo groups 
from amide protons. 
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5.2. Future directions 
Future research should be focused in two directions. One aspect would continue 
exploration of the properties of GAG oligosaccharides in aqueous solution with the aim of 
advancing our understanding of the relationship between elements of primary structure and 
how they stabilize secondary structure. The second direction is exploration of the biological 
properties of the novel dNSA and NAcArixtra oligosaccharides reported for the first time 
in this dissertation research.  
The structure of ArixtraTM, which contains the key structural elements required for 
high affinity binding to antithrombin-III, also provided an excellent substrate for further 
chemical modification to produce a model oligosaccharide with a 3-O-sulfated 
glucosamine residue mimicking a saccharide sequence occurring rarely in natural heparan 
sulfate. This modification led us to identify salt bridge involving amino group of the 
internal residue GlcN3S6S residue with the adjacent 3-O-sulfo group. Though this work 
suggested an additional electrostatic interaction between the GlcN3S6S(III) amino group 
and the adjacent IdoA2S residue carboxylate moiety, the evidence supporting this 
interaction was not conclusive. Therefore, we propose to measure and compare solvent 
exchange rates and pKa values for the dNSA amino groups in the presence and absence of 
carboxylates. For this purpose, carboxylate groups will be replaced by neutral groups such 
as alcohols. This chemical modification can potentially be performed by using lithium 
aluminum hydride (LiAlH4) which reduces the carboxylates to 1° alcohols. The chemical 
modification by the strong reducing agent LiAlH4 will require preliminary optimization of 
the reaction followed by structural elucidation of resultant product. For example, because 
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the reduction reaction is typically performed in diethyl ether or tetrahydrofuran, it may be 
necessary to form the pyridinium salt of sulfated oligosaccharides to increase their 
solubility. Should this reaction prove difficult to execute, we will attempt to react the 
oligosaccharide carboxylate groups to generate the methyl ester. 
In Chapter 4, the structures produced by chemical modification of NAcArixtra and 
GlcNAc3S were used to evaluate the effect of neighboring negatively charged groups on 
the catalysis of amide proton exchange with water. The effects of charge repulsion of the 
hydroxyl ions exerted by the negatively charged 3-O- and 4-O-sulfo groups was clear, 
however the strong dependence of neighboring negatively charged groups on exchange 
catalysis, rather than on overall oligosaccharide charge, was only postulated. Here we 
propose to selectively de-6-O-sulfate NAcArixtra using a solution composed of 90% 
DMSO and 10% methanol.8 By comparison of the energy barriers for amide exchange in 
NAcArixtra and de-6-O-sulfated NAcArixtra, the effect of overall oligosaccharide charge 
on hydroxyl ions repulsion will be ascertained.  
Perhaps the most exciting potential of this future work is the exploration of the 
biological properties of the novel dNSA and NAcArixtra oligosaccharides prepared in 
Chapter 2. Multiple research groups are pioneering novel methods of oligosaccharide 
preparation to explore the biological functions of 3-O-sulfated oligosaccharides.7, 9 As 
mentioned in Chapter 3, specific 3-O-sulfated residues in heparan sulfate are believed to 
be responsible for assistance of herpes simplex virus 1 entry into the cells through their 
interactions with glycoprotein gD.  Moreover, some reports link the specific binding of 
viral glycoprotein gD to polysaccharide chains of heparan sulfate containing -IdoA2S-
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GlcN3S- and -IdoA2S-GlcN3S6S- residues in their sequences.9-11 There are seven different 
types of heparan sulfate 3-O-sulfotransferases acting at the last stages of polysaccharide 
biosynthesis to insert 3-O-sulfo groups in the heparan sulfate polysaccharide.12-15 
Considering the other modifications incorporated by sulfotransferases and epimerases into 
the heparan sulfate polysaccharide chain at earlier steps of biosynthesis, the diversity of 3-
O-sulfated structural variations is great. As a result, the precise 3-O-sulfated heparan 
sulfate oligosaccharide sequence required for gD binding is largely unknown.  
To advance our current knowledge of the interactions of 3-O-sulfated residues of 
heparan sulfate with proteins and to better understand the biosynthetic mechanism of 
heparan sulfate, we propose to use our new compounds in biological studies designed to 
explore a structural role for 3-O-sulfated heparan sulfate. dNSA and NAcArixtra expand 
the library of available 3-O-sulfated oligosaccharides and provide another opportunity to 
investigate the relationships between 3-O-sulfated saccharides and biological function. 
Additionally, dNSA and NAcArixtra, can also be used for the discovery of novel proteins 
whose binding to heparan sulfate depends on 3-O-sulfation (expansion of the “3-O-sulfate 
proteome”).16 Recently, Thaker et al. reported utilization of the affinity matrices containing 
immobilized 3-O-sulfated heparan sulfate oligosaccharides on CNBr-activated Sepharose 
for screening potential proteins binding of whose influenced by 3-O-sulfation.16 Through 
this work, they identified several proteins not previously known for preferential binding to 
3-O-sulfated heparan sulfate. This approach is particularly well-suited for dNSA and 
NAcArixtra because it requires low quantities of the oligosaccharide (about 0.6 mg).  
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APPENDIX 
 
 
Figure A1. Mass spectrum of dNSt measured using an ESI Q-TOF mass spectrometer 
operating in negative ionization mode. The expected mass of dNSt, 993.54 U, was 
confirmed. 
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Figure A2. Mass spectrum of N-acetylated Arixtra (NAcArixtra) obtained using an ESI Q-
TOF mass spectrometer operating in negative ionization mode. The expected mass of 
NAcArixtra, 1393.11 U, was confirmed. In contrast to the results for dNSA and dNSt, the 
NAcArixtra molecular ions were also accompanied by potassium adducts introduced 
during pH measurement due to a leaky pH electrode. Even though sample was desalted it 
still retained potassium ions. The spectrum also indicates that the sample contains other 
trace impurities possibly arising from unreacted or partially reacted reaction mixture 
components.  
207 
Table A1. Assignment of the carbon-bound protons of dNSt at pD 11.5 in 10 mM 
phosphate buffer acquired at 298.2 K. Chemical shift values from COSY spectra are 
reported to two decimal places while those extracted from the 1D spectra are reported to 
three decimal places. 
Residue Proton 
1H Chemical shift, ppm 
dNSt, pD 11.5 
GlcN6S (I) 1 (α) 5.052 
 1 (β) 5.024 
 2 (α) 2.73 
 2 (β) 2.71 
 3 3.58 
 4 3.74 
 5 3.97 
 6 4.20 
 6’ 4.35 
IdoA2S (II) 1 (α) 5.145 
 1 (β) 5.174 
 2 (α) 4.26 
 2 (β) 4.29 
 3 (α) 4.18 
 3 (β) 4.20 
 4 (α) 4.05 
 4 (β) 4.06 
 5 (α) 4.844 
 5 (β) 4.829 
GlcN6S (III) 1 5.365 
 2 (α) 2.75 
 2 (β) 2.73 
 3 3.57 
 4 3.72 
 5 3.99 
 6 4.18 
 6’ 4.33 
ΔUA2S (IV) 1 5.477 
 2 4.621 
 3 4.31 
 4 5.982 
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Table A2. Comparison table of carbon-bound chemical shifts for heparin tetrasaccharide1 
and dNSt, structures shown in Figure 3.1D and E. Chemical shifts of heparin 
tetrasaccharide were measured at 293.2 K in 10 mM phosphate buffer, pD 7.0. Chemical 
shifts of dNSt were measured at 298.2 K in 10 mM phosphate buffer, pD 8.7. Chemical 
shift values from COSY spectra are reported to two decimal places while those extracted 
from the 1D spectra are reported to three decimal places. 
Residue Proton 
1H Chemical shift, ppm 
Heparin tetrasaccharide dNSt, pD 8.7 
GlcN6S (I) 1  5.43 5.303 (α) / 5.367 (β) 
 2 3.251 3.186 (α) / 3.084 (β) 
 3 3.69 3.84 
 4 3.74 3.71 
 5 4.12 3.94 
 6 4.30 4.16 
 6’ 4.36 4.29 
IdoA2S (II) 1  5.209 5.21 
 2 4.31 4.31 
 3 4.20 4.27 
 4 4.10 4.12 
 5 4.75 4.86 
GlcN6S (III) 1 5.414 5.530 
 2 3.292 3.142 
 3 3.64 3.79 
 4 3.83 3.75 
 5 4.03 3.99 
 6 4.25 4.20 
 6’ 4.35 4.34 
ΔUA2S (IV) 1 5.496 5.487 
 2 4.62 4.623 
 3 4.31 4.306 
 4 5.991 6.000 
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Table A3. Amino proton assignment in dNSt acquired in 85% H2O/15% acetone-d6 
solution 
Residue 1H Chemical shift, ppm 
Solution conditions 
pH T, K 
GlcN6S (I) α 8.044 
1.6 259.5 
GlcN6S (I) β 8.471 
GlcN6S (III) α 8.351 
GlcN6S (III) β 8.327 
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Table A4. Assignment of the carbon-bound proton of the reduced chondroitin sulfate 
tetrasaccharide at pD 9.10 in 10 mM phosphate buffer acquired at 316.2 K. Chemical shift 
values from COSY spectra are reported to two decimal places while those extracted from 
the 1D spectra are reported to three decimal places. 
Residue Proton 
1H Chemical shift, ppm 
pD 9.1 
GalNAc4S-ol (I) 1 3.69 
 1’ 3.70 
 2 4.27 
 3 4.24 
 4 4.484 
 5 4.13 
 6 3.68 
 6’ 3.70 
 amide -CH3 2.089 
GlcA (II) 1 4.62 
 2 3.456 
 3 3.632 
 4 3.86 
 5 3.77 
GalNAc4S (III) 1 4.655 
 2 4.071 
 3 4.15 
 4 4.62 
 5 3.86 
 6 3.76 
 6’ 3.80 
 amide -CH3 2.004 
ΔUA (IV) 1 5.262 
 2 3.83 
 3 3.936 
 4 5.952 
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Table A5. Assignments of the carbon-bound protons of the reduced chondroitin sulfate 
hexasaccharide at pD 9.0 in 10 mM phosphate buffer acquired at 316.2 K. Chemical shift 
values from COSY spectra are reported to two decimal places while those extracted from 
the 1D spectra are reported to three decimal places. 
Residue Proton 
1H Chemical shift, ppm 
pD 9.0 
GalNAc4S-ol (I) 1 3.67 
 1’ 3.71 
 2 4.271 
 3 4.239 
 4 4.476 
 5 4.12 
 6 3.67 
 6’ 3.69 
 amide -CH3 2.091 
GlcA (II) 1 4.62 
 2 3.450 
 3 3.631 
 4 3.86 
 5 3.77 
GalNAc4S (III) 1 4.74 
 2 4.02 
 3 4.04 
 4 4.60 
 5 3.99 
 6 3.78 
 6’ 3.80 
 amide -CH3 2.027 
GlcA (IV) 1 4.47 
 2 3.377 
 3 3.571 
 4 3.80 
 5 3.70 
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Table A5. Cont’d 
Residue Proton 
1H Chemical shift, ppm 
pD 9.0 
GalNAc4S (V) 1 4.64 
 2 4.07 
 3 4.14 
 4 4.62 
 5 3.85 
 6 3.74 
 6’ 3.76 
 amide -CH3 2.003 
ΔUA (VI) 1 5.254 
 2 3.82 
 3 3.937 
 4 5.948 
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Table A6. Amide proton chemical shifts assignments. (A) Reduced CS-A tetrasaccharide 
(ΔUA-GalNAc4S-GlcA-GalNAc4S-ol), (B) reduced CS-A hexasaccharide (ΔUA-
GalNAc4S-GlcA-GalNAc4S-GlcA-GalNAc4S-ol), (C) N-acetylated Arixtra 
(NAcArixtra), (D) N-acetylated GlcN3S (GlcNAc3S). 
A 
Residue 1H Chemical shift, ppm 
Solution conditions 
pH T, K 
GalNAc4s-ol (I) 8.008 
7.4 316.2 
GalNAc4S (III) 7.652 
 
B 
Residue 1H Chemical shift, ppm 
Solution conditions 
pH T, K 
GalNAc4s-ol (I) 8.042 
7.4 308.2 GalNAc4S (III) 7.926 
GalNAc4S (V) 7.702 
 
C 
Residue 1H Chemical shift, ppm 
Solution conditions 
pH T, K 
GlcNAc6S (I) 8.085 
7.4 298.2 GlcNAc3S6S (III) 7.912 
GlcNAc6S (V) 8.289 
 
D 
Residue 1H Chemical shift, ppm 
Solution conditions 
pH T, K 
GlcNAc3S (α) 7.825 
7.4 289.2 
GlcNAc3S (β) 8.135 
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Table A7. N-acetylated GlcN3S (GlcNAc3S) carbon-bound proton chemical shifts 
assignments made in 90% H2O/10% D2O solution at 298.2K. Chemical shift values from 
COSY spectra are reported to two decimal places while those extracted from the 1D spectra 
are reported to three decimal places. 
Residue Proton 
1H Chemical shift, ppm 
pH 7.4 
GlcNAc3S (α) 1 5.235 
 2 4.044 
 3 4.493 
 4 3.663 
 5 3.92 
 6 3.82 
 6’ 3.86 
 amide -CH3 2.029 
GlcNAc3S (β) 1 4.84 
 2 3.79 
 3 4.351 
 4 3.628 
 5 3.92 
 6 3.78 
 6’ 3.80 
 amide -CH3 2.016 
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Figure A3. Example of fit for activation energy barriers, ΔG
‡
 for GlcNAc α anomer.  
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Figure A3. Cont’d  
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Figure A3. Cont’d  
218 
 
Figure A3. Cont’d 
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Figure A3. Cont’d 
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